<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Mechanical and surgical interventions for treating primary postpartum haemorrhage - Kellie, FJ - 2020 | Cochrane Library</title> <meta content="Mechanical and surgical interventions for treating primary postpartum haemorrhage - Kellie, FJ - 2020 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013663/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Mechanical and surgical interventions for treating primary postpartum haemorrhage - Kellie, FJ - 2020 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013663/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD013663" name="dc.identifier" scheme="DOI"/> <meta content="Mechanical and surgical interventions for treating primary postpartum haemorrhage" name="citation_title"/> <meta content="Frances J Kellie" name="citation_author"/> <meta content="The University of Liverpool" name="citation_author_institution"/> <meta content="f.kellie@liverpool.ac.uk" name="citation_author_email"/> <meta content="Julius N Wandabwa" name="citation_author"/> <meta content="Busitema University" name="citation_author_institution"/> <meta content="Hatem A Mousa" name="citation_author"/> <meta content="Leicester Royal Infirmary" name="citation_author_institution"/> <meta content="Andrew D Weeks" name="citation_author"/> <meta content="The University of Liverpool" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="7" name="citation_issue"/> <meta content="10.1002/14651858.CD013663" name="citation_doi"/> <meta content="2020" name="citation_date"/> <meta content="2020/07/01" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013663/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013663/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013663/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Bias; Blood Transfusion [statistics &amp; numerical data]; Hemostasis, Surgical [methods]; Hemostatic Techniques; Hysterectomy [methods]; Postpartum Hemorrhage [*therapy]; Pressure; Randomized Controlled Trials as Topic; Suture Techniques; Uterine Artery Embolization; Uterine Balloon Tamponade [methods]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013663&amp;doi=10.1002/14651858.CD013663&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013663&amp;doi=10.1002/14651858.CD013663&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013663&amp;doi=10.1002/14651858.CD013663&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013663&amp;doi=10.1002/14651858.CD013663&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013663&amp;doi=10.1002/14651858.CD013663&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013663&amp;doi=10.1002/14651858.CD013663&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013663&amp;doi=10.1002/14651858.CD013663&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013663&amp;doi=10.1002/14651858.CD013663&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013663&amp;doi=10.1002/14651858.CD013663&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013663&amp;doi=10.1002/14651858.CD013663&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013663&amp;doi=10.1002/14651858.CD013663&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013663&amp;doi=10.1002/14651858.CD013663&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013663&amp;doi=10.1002/14651858.CD013663&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013663&amp;doi=10.1002/14651858.CD013663&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013663&amp;doi=10.1002/14651858.CD013663&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013663&amp;doi=10.1002/14651858.CD013663&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013663&amp;doi=10.1002/14651858.CD013663&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013663&amp;doi=10.1002/14651858.CD013663&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013663&amp;doi=10.1002/14651858.CD013663&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013663&amp;doi=10.1002/14651858.CD013663&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013663&amp;doi=10.1002/14651858.CD013663&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013663&amp;doi=10.1002/14651858.CD013663&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013663&amp;doi=10.1002/14651858.CD013663&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="nnwvukoo";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD013663\x26doi\x3d10\x2e1002\x2f14651858\x2eCD013663\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013663\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013663\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","th","ko","ms","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD013663",title:"Mechanical and surgical interventions for treating primary postpartum haemorrhage",firstPublishedDate:"Jul 1, 2020 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pregnancy and Childbirth Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=nnwvukoo&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013663&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013663';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD013663/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD013663/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013663%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD013663/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013663/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD013663/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013663/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD013663" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD013663/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD013663" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD013663/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD013663/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>10510 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD013663" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013663/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013663/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013663/full#CD013663-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013663/full#CD013663-sec-0200"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013663/full#CD013663-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013663/full#CD013663-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013663/full#CD013663-sec-0016"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013663/full#CD013663-sec-0017"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013663/full#CD013663-sec-0054"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013663/full#CD013663-sec-0194"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD013663/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013663/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013663/appendices#CD013663-sec-0205"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013663/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013663/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/table_n/CD013663StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/table_n/CD013663StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013663/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013663/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013663/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013663/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013663/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD013663/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD013663/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Mechanical and surgical interventions for treating primary postpartum haemorrhage</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013663/information#CD013663-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Frances J Kellie</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013663/information#CD013663-cr-0005">Julius N Wandabwa</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013663/information#CD013663-cr-0006">Hatem A Mousa</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013663/information#CD013663-cr-0007">Andrew D Weeks</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD013663/information/en#CD013663-sec-0209">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 01 July 2020 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD013663/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD013663">https://doi.org/10.1002/14651858.CD013663</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD013663-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013663-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013663-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013663-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013663-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD013663-abs-0007">한국어</a> </li> <li class="section-language"> <a class="" href="full/th#CD013663-abs-0005">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013663-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD013663-abs-0001" lang="en"> <section id="CD013663-sec-0001"> <h3 class="title" id="CD013663-sec-0001">Background</h3> <p>Primary postpartum haemorrhage (PPH) is commonly defined as bleeding from the genital tract of 500 mL or more within 24 hours of birth. It is one of the most common causes of maternal mortality worldwide and causes significant physical and psychological morbidity. </p> <p>An earlier Cochrane Review considering any treatments for the management of primary PPH, has been split into separate reviews. This review considers treatment with mechanical and surgical interventions. </p> </section> <section id="CD013663-sec-0002"> <h3 class="title" id="CD013663-sec-0002">Objectives</h3> <p>To determine the effectiveness and safety of mechanical and surgical interventions used for the treatment of primary PPH. </p> </section> <section id="CD013663-sec-0003"> <h3 class="title" id="CD013663-sec-0003">Search methods</h3> <p>We searched Cochrane Pregnancy and Childbirth’s Trials Register, <a href="http://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a>, the WHO International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">ICTRP</a>) (26 July 2019) and reference lists of retrieved studies. </p> </section> <section id="CD013663-sec-0004"> <h3 class="title" id="CD013663-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) of mechanical/surgical methods for the treatment of primary PPH compared with standard care or another mechanical/surgical method. Interventions could include uterine packing, intrauterine balloon insertion, artery ligation/embolism, or uterine compression (either with sutures or manually). </p> <p>We included studies reported in abstract form if there was sufficient information to permit risk of bias assessment. Trials using a cluster‐RCT design were eligible for inclusion, but quasi‐RCTs or cross‐over studies were not. </p> </section> <section id="CD013663-sec-0005"> <h3 class="title" id="CD013663-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed studies for inclusion and risk of bias, independently extracted data and checked data for accuracy. We used GRADE to assess the certainty of the evidence. </p> </section> <section id="CD013663-sec-0006"> <h3 class="title" id="CD013663-sec-0006">Main results</h3> <p>We included nine small trials (944 women) conducted in Pakistan, Turkey, Thailand, Egypt (four trials), Saudi Arabia, Benin and Mali. Overall, included trials were at an unclear risk of bias. Due to substantial differences between the studies, it was not possible to combine any trials in meta‐analysis. Many of this review's important outcomes were not reported. GRADE assessments ranged from very low to low, with the majority of outcome results rated as very low certainty. Downgrading decisions were mainly based on study design limitations and imprecision; one study was also downgraded for indirectness. </p> <p><b>External uterine compression</b> <b>versus normal care (1 trial, 64 women)</b> </p> <p>Very low‐certainty evidence means that we are unclear about the effect on blood transfusion (risk ratio (RR) 2.33, 95% confidence interval (CI) 0.66 to 8.23). </p> <p><b>Uterine arterial embolisation</b> <b>versus surgical devascularisation plus B‐Lynch (1 trial, 23 women)</b> </p> <p>The available evidence for hysterectomy to control bleeding (RR 0.73, 95% CI 0.15 to 3.57) is unclear due to very low‐certainty evidence. The available evidence for intervention side effects is also unclear because the evidence was very low certainty (RR 1.09; 95% CI 0.08 to 15.41). </p> <p><b>Intrauterine Tamponade</b> </p> <p>Studies included various methods of intrauterine tamponade: the commercial Bakri balloon, a fluid‐filled condom‐loaded latex catheter ('condom catheter'), an air‐filled latex balloon‐loaded catheter ('latex balloon catheter'), or traditional packing with gauze. </p> <p><b>Balloon tamponade versus normal care (2 trials, 356 women)</b> </p> <p>One study(116 women) used the condom catheter. This study found that it may increase blood loss of 1000 mL or more (RR 1.52, 95% CI 1.15 to 2.00; 113 women), very low‐certainty evidence. For other outcomes the results are unclear and graded as very low‐certainty evidence: mortality due to bleeding (RR 6.21, 95% CI 0.77 to 49.98); hysterectomy to control bleeding (RR 4.14, 95% CI 0.48 to 35.93); total blood transfusion (RR 1.49, 95% CI 0.88 to 2.51); and side effects. A second study of 240 women used the latex balloon catheter together with cervical cerclage. Very low‐certainty evidence means we are unclear about the effect on hysterectomy (RR 0.14, 95% CI 0.01 to 2.74) and additional surgical interventions to control bleeding (RR 0.20, 95% CI 0.01 to 4.12). </p> <p><b>Bakri balloon tamponade versus haemostatic square suturing of the uterus (1 trial, 13 women)</b> </p> <p>In this small trial there was no mortality due to bleeding, serious maternal morbidity or side effects of the intervention, and the results are unclear for blood transfusion (RR 0.57, 95% CI 0.14 to 2.36; very low certainty). Bakri balloon tamponade may reduce mean 'intraoperative' blood loss (mean difference (MD) ‐426 mL, 95% CI ‐631.28 to ‐220.72), very low‐certainty evidence. </p> <p><b>Comparison of intrauterine tamponade methods (3 trials, 328 women)</b> </p> <p>One study (66 women) compared the Bakri balloon and the condom catheter, but it was uncertain whether the Bakri balloon reduces the risk of hysterectomy to control bleeding due to very low‐certainty evidence (RR 0.50, 95% CI 0.05 to 5.25). Very low‐certainty evidence also means we are unclear about the results for the risk of blood transfusion (RR 0.97, 95% CI 0.88 to 1.06). </p> <p>A second study (50 women) compared Bakri balloon, with and without a traction stitch. Very low‐certainty evidence means we are unclear about the results for hysterectomy to control bleeding (RR 0.20, 95% CI 0.01 to 3.97). </p> <p>A third study (212 women) compared the condom catheter to gauze packing and found that it may reduce fever (RR 0.47, 95% CI 0.38 to 0.59), but again the evidence was very low certainty. </p> <p><b>Modified B‐Lynch compression suture</b> <b>versus standard B‐Lynch compression suture (1 trial, 160 women)</b> </p> <p>Low‐certainty evidence suggests that a modified B‐Lynch compression suture may reduce the risk of hysterectomy to control bleeding (RR 0.33, 95% CI 0.11 to 0.99) and postoperative blood loss (MD ‐244.00 mL, 95% CI ‐295.25 to ‐192.75). </p> </section> <section id="CD013663-sec-0007"> <h3 class="title" id="CD013663-sec-0007">Authors' conclusions</h3> <p>There is currently insufficient evidence from RCTs to determine the relative effectiveness and safety of mechanical and surgical interventions for treating primary PPH. High‐quality randomised trials are urgently needed, and new emergency consent pathways should facilitate recruitment. </p> <p>The finding that intrauterine tamponade may increase total blood loss &gt; 1000 mL suggests that introducing condom‐balloon tamponade into low‐resource settings on its own without multi‐system quality improvement does not reduce PPH deaths or morbidity. The suggestion that modified B‐Lynch suture may be superior to the original requires further research before the revised technique is adopted. In high‐resource settings, uterine artery embolisation has become popular as the equipment and skills become more widely available. However, there is little randomised trial evidence regarding efficacy and this requires further research. We urge new trial authors to adopt PPH core outcomes to facilitate consistency between primary studies and subsequent meta‐analysis. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD013663-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013663-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013663-abs-0015">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013663-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013663-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD013663-abs-0008">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD013663-abs-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/th#CD013663-abs-0006">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013663-abs-0004">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD013663-abs-0002" lang="en"> <h3>Mechanical and surgical interventions for treating women with severe bleeding after childbirth </h3> <p>This review considers evidence from randomised controlled trials on using mechanical and surgical interventions for stopping severe bleeding after giving birth. Other Cochrane Reviews consider the use of drugs that promote blood clotting or contractions of the uterus. </p> <p><b>What is the issue?</b> </p> <p>Primary postpartum haemorrhage (PPH) occurs when a mother has excessive vaginal bleeding within 24 hours of giving birth (typically &gt; 500 mL or &gt; 1000 mL). The most common cause of primary PPH is failure of the uterus to contract after birth, and usual care is based on using drugs to reverse this. Other causes include retained placenta, vaginal or cervical tears, and failure of the blood to clot. Surgical and mechanical methods apply direct pressure on blood vessels to reduce uterine blood flow. Pressure can be applied from inside the uterus by inflating a balloon within the uterus. Alternatively, pressure can be applied on the outside surface of the uterus. This can be directly (using a hand), or by passing a stitch through the front and back walls of the uterus to compress the uterine walls together. Blood flow can also be stopped by tying off or blocking the blood vessels that feed the uterus. </p> <p><b>Why is this important?</b> </p> <p>PPH is a common cause of maternal death and illness worldwide. Nearly 300,000 pregnant women die annually across the world with approximately 25% of those deaths caused by haemorrhage. It can also lead to the mother having significant long‐term medical and psychological problems. </p> <p><b>What evidence did we find?</b> </p> <p>We searched for evidence (July 2019) and included nine small randomised controlled trials (944 women). The studies were conducted in hospital settings in Pakistan, Turkey, Thailand, Egypt (four studies) and Saudi Arabia, and health facilities in Benin and Mali. Overall, the studies were very different, with various interventions being compared. The small number of women in each study, few or zero events, lack of data on important outcomes, and wide variation in results meant that few clear findings were obtained. It was not possible to pool the results from the studies. Our certainty assessments for the trials ranged from low to very low, with the majority rated as very low certainty. This means that we cannot be confident about the results. </p> <p>Two studies (356 women) compared internal pressure using non‐commercial balloons (a water‐filled condom  and a sterilised, air‐filled 'party' balloon) and normal care. The condom catheter may result in increased blood loss, but no other important effects were seen in either study. A third study found that the condom catheter may reduce postpartum fever compared to packing of the uterus with gauze, but no other effects. </p> <p>Three studies used a commercially available balloon (Bakri). This was compared to external pressure with stitches in one study (13 women) and it was found that Bakri balloon may reduce blood loss but no other effects were seen. Another study (66 women) compared the Bakri balloon to a condom system and found little to no differences between groups. The third study (50 women) looked to see if using a stitch to tether the upper end of the balloon to the top of the uterus had any benefit, but found little to no effect. </p> <p>One study (64 women) compared external compression of the uterus with normal care but with no clear findings. Another study of 160 women compared a standard compression suture with a modified version in which the uterus is not only compressed, but the main vessel supplying the uterus was tied off. The results suggested that the modified suture may reduce blood loss and the risk of hysterectomy. </p> <p>One study (23 women) compared using imaging to block the blood vessels to the uterus (uterine artery embolisation) with surgical techniques to cut off the blood supply and compress the uterus but found little to no effect. </p> <p><b>What does this mean?</b> </p> <p>We did not find sufficient high‐quality evidence to determine the effectiveness and safety of mechanical and surgical interventions for treating primary PPH. High‐quality randomised trials are urgently needed to test some of the findings of this review. We urge new trial authors to adopt standardised PPH core outcomes. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD013663-sec-0200" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD013663-sec-0200"></div> <h3 class="title" id="CD013663-sec-0201">Implications for practice</h3> <section id="CD013663-sec-0201"> <p>The evidence presented in this review is generally not of high enough quality to have major effects on clinical practice. The available evidence is restricted to small, single‐centre studies providing low‐grade certainty evidence. However, two studies in this review are important and could have implications for practice. First, the study by <a href="./references#CD013663-bbs2-0005" title='El-SokkaryM , WahbaK , El-ShahawyY . Uterine salvage management for atonic postpartum hemorrhage using "modified lynch suture". BMC Pregnancy and Childbirth2016;16:251. '>El‐Sokkary 2016</a> provides low‐certainty evidence that use of the modified B‐Lynch suture (where the suture is combined with uterine artery obliteration) may be superior to that originally described. However, it was only conducted in a single centre and without long‐term follow‐up to assess effects on future fertility. This study deserves to be repeated.<br/><br/>The other study of note is that of <a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a>, where the use of a condom‐loaded Foley catheter in two low‐income African settings led to increased rates of blood loss (very low‐certainty evidence). The findings are supported by the <a href="./references#CD013663-bbs2-0010" title="NCT02910310. Introduction of a uterine balloon tamponade for postpartum hemorrhage in three low income countries: a stepped wedge cluster randomized trial. clinicaltrials.gov/show/NCT02910310 (first received 22 September 2016). ">Anger 2016</a> step‐wedge cluster‐randomised trial. The reason for the failures are unclear, but do suggest that the global roll‐out of condom catheters alone will not reduce mortality or morbidity from primary postpartum haemorrhage (PPH) in these settings. The reasons for the surprising findings are explored in <a href="./references#CD013663-bbs2-0111" title="WeeksAD . Does balloon tamponade really make postpartum haemorrhage worse?BJOG2019;126:1622. [DOI: 10.1111/1471-0528.15948]">Weeks 2019</a>. They are not thought to be necessarily a failure of the device itself, but more due to the setting in which the technique was introduced. It is suggested that in these settings, balloon tamponade is only introduced alongside multi‐system improvements in PPH care, including quality improvements in blood transfusion, operating theatres and staffing.  </p> </section> <h3 class="title" id="CD013663-sec-0202">Implications for research</h3> <section id="CD013663-sec-0202"> <p>High‐quality randomised trials into mechanical and surgical methods for the treatment of PPH are urgently needed. Given the large number of deaths from PPH seen each year globally, and that all PPH treatment pathways end with either mechanical or surgical interventions, it is disappointing that there is so little research in this area. The new emergency consent pathways will facilitate recruitment, and research networks in all income settings should consider large‐scale randomised trials in which women are initially recruited with minimal or no consent so as to compare techniques.<br/><br/>The findings of the <a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a> are very surprising, but supported by a large step‐wedge cluster‐randomised trial (<a href="./references#CD013663-bbs2-0010" title="NCT02910310. Introduction of a uterine balloon tamponade for postpartum hemorrhage in three low income countries: a stepped wedge cluster randomized trial. clinicaltrials.gov/show/NCT02910310 (first received 22 September 2016). ">Anger 2016</a>) (excluded from this review as it included both women with and without PPH). Whilst the use of the condom‐loaded Foley used in <a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a> and <a href="./references#CD013663-bbs2-0010" title="NCT02910310. Introduction of a uterine balloon tamponade for postpartum hemorrhage in three low income countries: a stepped wedge cluster randomized trial. clinicaltrials.gov/show/NCT02910310 (first received 22 September 2016). ">Anger 2016</a> is an attractive low‐cost option, it may be that it is too pliable or that it takes too long to make up to be effective in poorer settings where surgeons commonly act alone or with little support. Future studies could explore whether its failure in these studies were due to the setting, the type of balloon, or whether balloon tamponade is in fact an ineffective intervention.<br/><br/>A wide array of uterine compression sutures have been described and, whilst appearing to be effective in the short term, they have been associated with future infertility and placental implantation abnormalities. Although the study of <a href="./references#CD013663-bbs2-0007" title="KavakSB , AtilganR , DemirelI , CelikE , IlhanR , SapmazE . Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa. Journal of Perinatal Medicine2013;41(6):705-9. ">Kavak 2013</a> only recruited 13 women, it shows that research is possible in this area, and that an intrauterine balloon may be as effective but less invasive mode of treatment even for women with uterine bleeding during caesarean section.<br/><br/>The study by <a href="./references#CD013663-bbs2-0005" title='El-SokkaryM , WahbaK , El-ShahawyY . Uterine salvage management for atonic postpartum hemorrhage using "modified lynch suture". BMC Pregnancy and Childbirth2016;16:251. '>El‐Sokkary 2016</a> provides evidence that use of the modified B‐Lynch suture may be superior to that originally described, and with minimal adverse effects. However, it is low‐certainty evidence and the study should be repeated before clinicians adopt the revised technique.<br/><br/>In high‐resource settings, uterine artery embolisation has become popular as the equipment and skills required have become more widely available. There is little randomised trial evidence for its efficacy, however and its comparative clinical and cost‐benefits compared with surgical devascularisation, compression sutures or balloon tamponade have not been established. Given its high costs and clinical importance, this will be an important area for new research.<br/><br/>Future studies could ensure that they collect minimum data for the PPH Core Outcome set (<a href="./references#CD013663-bbs2-0082" title="MeherS , CuthbertA , KirkhamJJ , WilliamsonP , AbalosE , AflaifelN , et al. Core outcome sets for prevention and treatment of postpartum haemorrhage: an international Delphi consensus study. BJOG: an international journal of obstetrics and gynaecology2019;126(1):83-93.">Meher 2019</a>) so as to facilitate future meta‐analysis. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD013663-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD013663-sec-0008"></div> <div class="table" id="CD013663-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">External uterine compression (all methods) plus normal care compared to normal care for treating primary postpartum haemorrhage</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>External uterine compression (all methods) compared to normal care for treating primary postpartum haemorrhage</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women diagnosed with primary PPH following vaginal birth. PPH was defined as quote: "blood loss &gt; 500mL after delivery" p 601<br/><b>Setting:</b> hospital setting in Bangkok, Thailand (<a href="./references#CD013663-bbs2-0002" title="ChantrapitakW , SrijanteokK , Puangsa-artS . Lower uterine segment compression for management of early postpartum hemorrhage after vaginal delivery at Charoenkrung Pracharak Hospital. Journal of the Medical Association of Thailand2009;92(5):600-5. [PMID: 19459518]">Chantrapitak 2009</a>)<br/><b>Intervention:</b> external lower uterine compression (either by grasping the uterus through a lax abdominal wall or compressing the uterus against the sacrum and lower vertebrae) for a duration of 10 minutes (plus standard care)<br/><b>Comparison:</b> normal care alone ‐ consisting of "massage, oxytocin (10‐20 units in 1,000 ml of intravenous solution, 200 ml/min), intravenous ergometrine (Methergin<sup>®</sup>, 0.2 mg), placed cold pack on uterus, and urinary catheterisation" p 601. </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with normal care</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with external uterine compression (all methods)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mortality due to bleeding ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hysterectomy to control bleeding ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of women with total blood loss 1000 mL or more after randomisation ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean blood loss (mL) (trialist defined)</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Blood transfusion (red cell or whole blood)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.33<br/>(0.66 to 8.23) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>64<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>94 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>218 per 1000<br/>(62 to 772) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Side effects of the intervention (e.g. trauma, necrosis) ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded (1) level for serious limitations in study design (risk of bias) </p> <p><sup>2</sup> We downgraded (2) levels for very serious imprecision due to small sample size, few events and wide confidence interval crossing the line of no effect </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD013663-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">One uterine devascularisation technique (uterine arterial embolisation) versus another uterine devascularisation technique (surgical devascularisation plus B‐Lynch)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>One uterine devascularisation technique (uterine arterial embolisation) versus another uterine devascularisation technique (surgical devascularisation plus B‐Lynch)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> treating primary postpartum haemorrhage<br/><b>Setting:</b> Ain‐Shams University Maternity Hospital, Egypt (<a href="./references#CD013663-bbs2-0006" title="FaroukO , ElbasuonyW , ElbohoutyA . Uterine artery embolization versus surgical management in primary atonic postpartum hemorrhage: A randomized clinical trial. Egyptian Journal of Radiology and Nuclear Medicine2016;47(3):817-23. ">Farouk 2016</a>)<br/><b>Intervention:</b> uterine devascularisation (uterine arterial embolisation)<br/><b>Comparison:</b> another uterine devascularisation technique (surgical devascularisation plus B‐Lynch compression sutures) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with another uterine devascularisation technique (surgical devascularisation plus B‐Lynch compression suture)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with uterine arterial embolisation</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mortality due to bleeding ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Hysterectomy to control bleeding</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.73<br/>(0.15 to 3.57) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>23<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>250 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>183 per 1000<br/>(38 to 893) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of women with total blood loss 1000 mL or more after randomisation</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean blood loss (mL) (trialist defined)</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion (red cell or whole blood)</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Side effects of the intervention (e.g. trauma, necrosis)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.09<br/>(0.08 to 15.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>23<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>83 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>91 per 1000<br/>(7 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded (1) level for serious limitations in study design </p> <p><sup>2</sup> We downgraded (2) levels for very serious imprecision due to small sample size with few events and wide confidence intervals crossing the line of no effect </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD013663-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Intrauterine balloon tamponade plus normal care (misoprostol) compared to normal care (misoprostol) for treating primary postpartum haemorrhage</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Intrauterine balloon tamponade plus normal care (misoprostol) compared to normal care (misoprostol) for treating primary postpartum haemorrhage</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women diagnosed with primary PPH following vaginal birth. Women were suspected to have PPH due to clinical atony and who were quote: "unresponsive to oxytocin and who needed additional uterotonics" p1. PPH was defined as quote: "visual estimation of excessive blood loss and patient status (blood pressure and cardiac frequency)" p 2 (<a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a>) </p> <p><b>Setting:</b> 7 healthcare facilities in Benin and Mail<br/><b>Intervention:</b> intrauterine balloon tamponade (plus misoprostol 'standard care')<br/><b>Comparison:</b> standard care (misoprostol) alone </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with normal care</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with intrauterine balloon tamponade (all methods)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Mortality due to bleeding</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 6.21<br/>(0.77 to 49.98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>116<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>17 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>105 per 1000<br/>(13 to 847) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Hysterectomy to control bleeding</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 4.14<br/>(0.48 to 35.93) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>116<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>17 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>70 per 1000<br/>(8 to 609) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of women with total blood loss 1000 mL or more after randomisation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.52<br/>(1.15 to 2.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>113<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>525 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>799 per 1000<br/>(604 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean blood loss (mL) (trialist defined)</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Blood transfusion (red cell or whole blood)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.49<br/>(0.88 to 2.51) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>116<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>271 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>404 per 1000<br/>(239 to 681) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Side effects of the intervention (e.g. trauma, necrosis) ‐ Severe shivering, diarrhoea, vomiting or high temperature </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>116<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/>(0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded (‐2) levels for very serious limitations in study design (risk of bias) </p> <p><sup>2</sup> We downgraded (‐2) levels for very serious imprecision due to small sample size, few events and wide confidence interval crossing the line of no effect </p> <p><sup>3</sup> We downgraded (‐1) level for serious imprecision due to a small sample size </p> <p><sup>4</sup> We downgraded (‐2) levels for very serious imprecision due to small sample size, and wide confidence interval crossing the line of no effect </p> <p><sup>5</sup> We downgraded (‐2) levels for very serious imprecision due to small sample size and zero events </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD013663-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Intrauterine balloon tamponade (latex balloon inflated with air) plus cerclage and normal care compared to normal care for treating primary postpartum haemorrhage</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Intrauterine balloon tamponade (latex balloon inflated with air) plus cerclage and normal care compared to normal care for treating primary postpartum haemorrhage</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with PPH, due to atony, following vaginal birth at home or in hospital (<a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a>) </p> <p><b>Setting:</b> Hospital (Egypt)<br/><b>Intervention:</b> Latex balloon‐loaded Nelson catheter intrauterine tamponade (air filled) plus stitch and standard care (uterine massage and uterotonics)<br/><b>Comparison:</b> standard care (uterine massage and uterotonics) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with normal care</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with intrauterine balloon tamponade (all methods)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Mortality due to bleeding</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>240<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>There were no maternal deaths due to bleeding</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Hysterectomy to control bleeding</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.14<br/>(0.01 to 2.74) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>240<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>25 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4 per 1,000</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of women with total blood loss 1000 mL or more after randomisation</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean blood loss (mL) (trialist defined)</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion (red cell or whole blood)</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Side effects of the intervention (e.g. trauma, necrosis) ‐ trauma, pyrexia, allergic reaction </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>240</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>There were no side effects of the intervention (reported as trauma, pyrexia, or allergic reaction) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded (‐1) level for serious limitations in study design (risk of bias) </p> <p><sup>2</sup> We downgraded (‐2) levels for very serious indirectness (the study population included all women with PPH (UBT used as a first‐line treatment), rather than only those who did not respond to treatment with uterotonics </p> <p>3 We downgraded (‐2) levels for very serious imprecision (small sample size, no events, not estimable) </p> <p><sup>4</sup> We downgraded (‐2) levels for very serious imprecision due to small sample size, few events and wide confidence interval including appreciable benefit and appreciable harm </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD013663-tbl-0005"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (intrauterine tamponade versus another mechanical/surgical method) for treating primary postpartum haemorrhage</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (intrauterine tamponade versus another mechanical/surgical method) for treating primary postpartum haemorrhage</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with complete placenta praevia and intractable bleeding following caesarean section<br/><b>Setting:</b> university hospital setting in Turkey (<a href="./references#CD013663-bbs2-0007" title="KavakSB , AtilganR , DemirelI , CelikE , IlhanR , SapmazE . Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa. Journal of Perinatal Medicine2013;41(6):705-9. ">Kavak 2013</a>)<br/><b>Intervention:</b> intrauterine tamponade (Bakri balloon)<br/><b>Comparison:</b> endouterine compression suturing to the lower segment of the uterus </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with another mechanical/surgical method (endouterine compression sutures)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with Intrauterine Bakri balloon tamponade</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Mortality due to bleeding</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>13<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>There were zero events</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/>(0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Hysterectomy to control bleeding</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>13<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>There were zero events</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/>(0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>13<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>There were zero events</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/>(0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of women with total blood loss 1000 mL or more after randomisation</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean blood loss (mL) (trialist defined)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean blood loss in endouterine compression suture group was 1946 mL</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean difference in blood loss (mL) in the intervention group was 426 mL lower (631.28 lower to 220.72 mL lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/>VERY LOW </p> <p><sup>1 3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Blood transfusion (red cell or whole blood)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.57<br/>(0.14 to 2.36) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>13<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>500 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>285 per 1000<br/>(70 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Side effects of the intervention (e.g. trauma, necrosis)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>13<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/>(0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded (2) levels for very serious limitations in study design (risk of bias) </p> <p><sup>2</sup> We downgraded (2) levels for very serious imprecision due to small sample size and zero events (not estimable) </p> <p><sup>3</sup> We downgraded (1) level for serious imprecision due to a small sample size (continuous data) </p> <p><sup>4</sup> We downgraded (2) levels for very serious imprecision due to small sample size, few events and wide confidence interval crossing the line of no effect </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD013663-tbl-0006"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Bakri balloon tamponade versus condom‐loaded Foley Catheter (one intrauterine tamponade compared to another intrauterine tamponade technique) for treating primary postpartum haemorrhage</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Bakri balloon tamponade versus condom‐loaded Foley Catheter (one intrauterine tamponade compared to another intrauterine tamponade technique for treating primary postpartum haemorrhage)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with primary atonic postpartum haemorrhage following vaginal delivery<br/><b>Setting:</b> Assuit Women's Health Hospital in Egypt (<a href="./references#CD013663-bbs2-0003" title="DarwishAM , AbdallahMM , ShaabanOM , AliMK , KhalafM , SabraAM . Bakri balloon versus condom-loaded foley's catheter for treatment of atonic postpartum hemorrhage secondary to vaginal delivery: a randomized controlled trial. Journal of Maternal-Fetal &amp; Neonatal Medicine2018;31(6):747-53. NCT02430155. Comparison of condom-loaded foley's catheter versus bakri balloon for treatment of primary postpartum hemorrhage: a randomized controlled trial. clinicaltrials.gov/show/NCT02430155 (first received 30 April 2015). ">Darwish 2018</a>)<br/><b>Intervention:</b> 1 intrauterine tamponade: Bakri balloon<br/><b>Comparison:</b> another intrauterine tamponade technique: condom‐loaded Foley catheter </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with condom‐loaded Foley catheter</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with Bakri balloon tamponade</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mortality due to bleeding</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Hysterectomy to control bleeding</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.50<br/>(0.05 to 5.25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>66<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>61 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>30 per 1000<br/>(3 to 318) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of women with total blood loss 1000 mL or more after randomisation</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean blood loss (mL) (trialist defined)</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Blood transfusion (red cell or whole blood)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.97<br/>(0.88 to 1.06) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>58<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Note: the trial report states that analysis for this and other trial secondary outcomes excluded those women in whom there was treatment failure. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1000 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>970 per 1000<br/>(880 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Side effects of the intervention (e.g. trauma, necrosis)</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded (1) level for serious limitations in study design (risk of bias) </p> <p><sup>2</sup> We downgraded (2) levels for very serious imprecision (small sample size, few events, and wide confidence interval including appreciable benefit and appreciable harm) </p> <p><sup>3</sup> We downgraded (1) level for serious imprecision due to small sample size </p> <p><sup>4</sup> We downgraded (2) levels for very serious limitations in study design (post‐randomisation exclusions ‐ analysis excluded those women in whom there was treatment failure) </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD013663-tbl-0007"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Bakri balloon tamponade+traction stitch versus Bakri balloon (one intrauterine tamponade compared to another intrauterine tamponade technique) for treating primary postpartum haemorrhage)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Bakri balloon tamponade+traction stitch versus Bakri balloon (one intrauterine tamponade compared to another intrauterine tamponade technique) for treating primary postpartum haemorrhage</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with primary atonic postpartum haemorrhage<br/><b>Setting:</b> a security forces hospital in Riyadh, Saudi Arabia (<a href="./references#CD013663-bbs2-0008" title="KhalilMI , Al-DohamiH , AldahishMM . A method to improve the effectiveness of the Bakri balloon for management of postpartum hemorrhage at cesarean. International Journal of Gynecology &amp; Obstetrics2011;115(2):198-200. ">Khalil 2011</a>)<br/><b>Intervention:</b> intrauterine tamponade: Bakri balloon with traction stitch<br/><b>Comparison:</b> another intrauterine tamponade technique: Bakri balloon without traction stitch </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with Bakri balloon tamponade (without traction stitch)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with Bakri balloon tamponade+traction stitch)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mortality due to bleeding</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Hysterectomy to control bleeding</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.20<br/>(0.01 to 3.97) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>50<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>80 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16 per 1000<br/>(1 to 318) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of women with total blood loss 1000 mL or more after randomisation</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean blood loss (mL) (trialist defined)</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion (red cell or whole blood)</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Side effects of the intervention (e.g. trauma, necrosis)</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Total blood loss &gt;= 1000 mL (before and after randomisation, outcome not pre‐specified in our protocol) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.00<br/>(0.93 to 1.08) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>50<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1000 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1000 per 1000<br/>(930 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded (1) level for serious limitations in study design (risk of bias) </p> <p><sup>2</sup> We downgraded (2) levels for very serious imprecision due to small sample sizes, few events and wide confidence interval crossing the line of no effect </p> <p><sup>3</sup> We downgraded (1) level for serious imprecision due to small sample size </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD013663-tbl-0008"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Intrauterine balloon tamponade (condom‐loaded catheter) versus uterovaginal packing (intrauterine tamponade versus another intrauterine tamponade method) for treating primary postpartum haemorrhage</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Intrauterine balloon tamponade (condom‐loaded catheter) versus uterovaginal packing (intrauterine tamponade versus another intrauterine tamponade method) for treating primary postpartum haemorrhage</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> Women (aged between 20 and 40) diagnosed with primary PPH following 'normal' vaginal birth and unresponsive to medical treatment (<a href="./references#CD013663-bbs2-0001" title="AshrafN , AshrafA , KhursheedK . Efficacy and safety of intrauterine balloon tamponade versus ueterovaginal roll gauze packing in patient presenting with primary postpartum haemorrhage after normal vaginal delivery. Annals of King Edward Medical University2018;24(Special Issue):889-92. ">Ashraf 2018</a>) </p> <p><b>Setting:</b> Hospital setting in Pakistan<br/><b>Intervention:</b> Condom‐loaded catheter intrauterine balloon tamponade<br/><b>Comparison:</b> uterovaginal packing </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with normal care</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with intrauterine balloon tamponade (all methods)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mortality due to bleeding</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hysterectomy to control bleeding</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of women with total blood loss 1000 mL or more after randomisation</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean blood loss (mL) (trialist defined)</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean blood loss is reported as 600.28 mL (+/‐ 25.33 mL) in the condom catheter group and 699 mL (+/‐ 70.176 mL) in the intrauterine packing group. However, it is unclear whether this is pre‐ or post‐randomisation, especially as this is also presented in a table detailing participant characteristics of each group (age, parity, gestational age, and blood loss). For this reason, we have not included these data in our data and analysis tables. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion (red cell or whole blood)</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Side effects of the intervention (e.g. trauma, necrosis) ‐ fever</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.47<br/>(0.38 to 0.59) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>212</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>925 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>435 per 1000<br/>(351 to 545) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded (2) levels for very serious limitations in study design (risk of bias) </p> <p><sup>2</sup> We downgraded (1) level for serious imprecision (small sample size) </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD013663-tbl-0009"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 9.</span> <span class="table-title">Modified B‐Lynch compression suture technique versus standard B‐Lynch compression suture (one uterine compression suture technique versus another uterine compression suture technique) for treating primary postpartum haemorrhage</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Modified B‐Lynch compression suture technique versus standard B‐Lynch compression suture (one uterine compression suture technique versus another uterine compression suture technique) for treating primary postpartum haemorrhage</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with uncontrolled atonic PPH following caesarean section, and not responding to standard care (uterine massage, ecbolics and bimanual compression). </p> <p><b>Setting:</b> university hospital in Cairo, Egypt (<a href="./references#CD013663-bbs2-0005" title='El-SokkaryM , WahbaK , El-ShahawyY . Uterine salvage management for atonic postpartum hemorrhage using "modified lynch suture". BMC Pregnancy and Childbirth2016;16:251. '>El‐Sokkary 2016</a>)<br/><b>Intervention:</b> 1 uterine compression suture technique: modified B‐Lynch compression suture<br/><b>Comparison:</b> another uterine compression suture technique: standard B‐Lynch compression suture </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with standard B‐Lynch uterine compression suture technique</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with modified B‐Lynch compression suture technique</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mortality due to bleeding</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Hysterectomy to control bleeding</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.33<br/>(0.11 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>160<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>150 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>50 per 1000<br/>(17 to 149) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of women with total blood loss 1000 mL or more after randomisation</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean blood loss (mL) (trialist defined)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean blood loss in the classic B‐Lynch group was 568 mL</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean difference in blood loss (mL) in the modified B‐Lynch group was 244 mL lower (295.25 mL lower to ‐ 192.75 mL lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/>LOW <sup>1 3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion (red cell or whole blood)</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Side effects of the intervention (e.g. trauma, necrosis)</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded (1) level for serious limitations in study design (risk of bias) </p> <p><sup>2</sup> We downgraded (1) level for serious imprecision due to small sample size and few events </p> <p><sup>3</sup> We downgraded (1) level for serious imprecision due to small sample size </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD013663-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD013663-sec-0009"></div> <p>An earlier Cochrane Review (<a href="./references#CD013663-bbs2-0087" title="MousaHA , BlumJ , Abou El SenounG , ShakurH , AlfirevicZ . Treatment for primary postpartum haemorrhage. Cochrane Database of Systematic Reviews2014, Issue 2. [DOI: 10.1002/14651858.CD003249.pub3]">Mousa 2014c</a>) considered various treatments for the management of primary postpartum haemorrhage (PPH). That review has now been split, with different treatment types considered in separate reviews. </p> <p> <ul id="CD013663-list-0001"> <li> <p>Antifibrinolytic agents for treating primary PPH is covered by <a href="./references#CD013663-bbs2-0102" title="ShakurH , BeaumontD , PavordS , Gayet-AgeronA , KerK , MousaHA . Antifibrinolytic drugs for treating primary postpartum haemorrhage. Cochrane Database of Systematic Reviews2018, Issue 2. [DOI: 10.1002/14651858.CD012964]">Shakur 2018</a>. </p> </li> <li> <p>Mechanical and surgical interventions are considered in this review.</p> </li> <li> <p>Uterotonic agents for treating primary PPH are covered by a new review on First‐line uterotonics for treating postpartum haemorrhage: a systematic review and network meta‐analysis (<a href="./references#CD013663-bbs2-0093" title="Parry SmithWR , GallosID , WilliamsHM , WidmerM , AngolkarM , TobiasA , et al. First-line uterotonics for treating postpartum haemorrhage: a systematic review and network meta-analysis. Cochrane Database of Systematic Reviews2017, Issue 8. [DOI: 10.1002/14651858.CD012754]">Parry Smith 2017</a>). </p> </li> </ul> </p> <section id="CD013663-sec-0010"> <h3 class="title" id="CD013663-sec-0010">Description of the condition</h3> <p>Primary PPH is defined as bleeding from the genital tract of 500 mL or more in the first 24 hours following delivery of the baby (<a href="./references#CD013663-bbs2-0113" title="WHO. WHO Recommendations for the Prevention and Treatment of Postpartum Haemorrhage. World Health Organization, 2012.">WHO 2012</a>; <a href="./references#CD013663-bbs2-0114" title="WHO. WHO Guidelines for the Management of Postpartum Haemorrhage and Retained Placenta. World Health Organization, 2009.">WHO 2015</a>) and severe PPH is defined as blood loss more than 1000 mL, regardless of the route of delivery (<a href="./references#CD013663-bbs2-0066" title="HoveydaF , MacKenzieIZ . Secondary postpartum haemorrhage: incidence, morbidity and current management. BJOG: an international journal of obstetrics and gynaecology2001;108(9):927-30. [PMID: 11563461]">Hoveyda 2001</a>; <a href="./references#CD013663-bbs2-0100" title="SentilhesL , VayssiereC , Deneux-TharauxC , AyaAG , BayoumeuF , BonnetMP , et al. Postpartum hemorrhage: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF): in collaboration with the French Society of Anesthesiology and Intensive Care (SFAR). European Journal of Obstetrics, Gynecology, and Reproductive Biology2016;198:12-21. [PMID: 26773243]">Sentilhes 2016</a>). Secondary PPH occurs when women have abnormal or heavy vaginal bleeding between 24 hours and 12 weeks after the birth and it affects fewer than two in 100 women (<a href="./references#CD013663-bbs2-0113" title="WHO. WHO Recommendations for the Prevention and Treatment of Postpartum Haemorrhage. World Health Organization, 2012.">WHO 2012</a>). </p> <p>Primary PPH, with a global prevalence rate of about 6%, is one of the most common causes of maternal morbidity and mortality worldwide (<a href="./references#CD013663-bbs2-0046" title="CarroliG , CuestaC , AbalosE , GulmezogluAM . Epidemiology of postpartum hemorrhage: a systematic review. Best Practice and Research. Clinical Obstetrics and Gynaecology2008;22(6):999–1020. [DOI: 10.1016/j.bpobgyn.2008.08.004 ]">Carroli 2008</a>). Nearly 300,000 women die annually across the world from causes related to pregnancy and childbirth (<a href="./references#CD013663-bbs2-0039" title="AlkemaL , ChouD , HoganD , ZhangS , MollerAB , GemmillA , et al. Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Maternal Mortality Estimation Inter-Agency Group. Lancet2016;387(10017):462-74. [PMID: 26584737]">Alkema 2016</a>; <a href="./references#CD013663-bbs2-0076" title="LozanoR , WangH , ForemanKJ , RajaratnamJK , NaghaviM , MarcusJR , et al. Progress towards Millennium Development Goals 4 and 5 on maternal and child mortality: an updated systematic analysis. Lancet2011;378(9797):1139-65. [PMID: 21937100]">Lozano 2011</a>), and approximately a quarter of these are due to primary PPH (<a href="./references#CD013663-bbs2-0113" title="WHO. WHO Recommendations for the Prevention and Treatment of Postpartum Haemorrhage. World Health Organization, 2012.">WHO 2012</a>). In high‐income countries there is an increasing rate of primary PPH (<a href="./references#CD013663-bbs2-0072" title="KnightM , CallaghanWM , BergC , AlexanderS , Bouvier-ColleMH , FordJB , et al. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy and Childbirth2009;9:55. [DOI: 10.1186/1471-2393-9-55]">Knight 2009</a>). In the Netherlands there was an increase from 4.1% in 2000 to 6.4% by 2013 (<a href="./references#CD013663-bbs2-0109" title="vanStralenG , vonSchmidt Auf AltenstadtJF , BloemenkampKW , vanRoosmalenJ , HukkelhovenCW . Increasing incidence of postpartum hemorrhage: the Dutch piece of the puzzle. Acta Obstetricia et Gynecologica Scandinavica2016;95(10):1104-10. [PMID: 27460955]">van Stralen 2016</a>). Similar trends have been reported in the United States of America with a rise from 1.9% in 1999 to 4.2% in 2008 (<a href="./references#CD013663-bbs2-0074" title="KramerMS , BergC , AbenhaimH , DahhouM , RouleauJ , MehrabadiA , et al. Incidence, risk factors, and temporal trends in severe postpartum hemorrhage. American Journal of Obstetrics and Gynecology2013;209(5):449.e1-7. [PMID: 23871950]">Kramer 2013</a>). In sub‐Saharan Africa the rate of primary PPH is reported as high at 10.5% (<a href="./references#CD013663-bbs2-0046" title="CarroliG , CuestaC , AbalosE , GulmezogluAM . Epidemiology of postpartum hemorrhage: a systematic review. Best Practice and Research. Clinical Obstetrics and Gynaecology2008;22(6):999–1020. [DOI: 10.1016/j.bpobgyn.2008.08.004 ]">Carroli 2008</a>). In the low‐ and middle‐income countries, primary PPH remains the leading cause of maternal death, accounting for one‐third of maternal deaths in Asia and Africa (<a href="./references#CD013663-bbs2-0046" title="CarroliG , CuestaC , AbalosE , GulmezogluAM . Epidemiology of postpartum hemorrhage: a systematic review. Best Practice and Research. Clinical Obstetrics and Gynaecology2008;22(6):999–1020. [DOI: 10.1016/j.bpobgyn.2008.08.004 ]">Carroli 2008</a>; <a href="./references#CD013663-bbs2-0069" title="KassebaumNJ , Bertozzi-VillaA , CoggeshallMS , ShackelfordKA , SteinerC , HeutonKR , et al. Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet2014;384(9947):980-1004. [DOI: 10.1016/S0140-6736(14)60696-6]">Kassebaum 2014</a>; <a href="./references#CD013663-bbs2-0071" title="KhanKS , WojdylaD , SayL , GülmezogluAM , Van LookPF . WHO analysis of causes of maternal death: a systematic review. Lancet2006;367(9516):1066–74. [DOI: 10.1016/S0140-6736(06)68397-9]">Khan 2006</a>). </p> <p>Major primary PPH can lead to significant maternal morbidity including shock, renal failure, respiratory failure and/or liver failure (<a href="./references#CD013663-bbs2-0044" title="BonnarJ . Massive obstetric haemorrhage. Baillieres Best Practice and Research in Clinical Obstetrics and Gynaecology2000;14(1):1-18.">Bonnar 2000</a>). Severe PPH can cause ischaemic pituitary necrosis (Sheehan’s syndrome) which can be life‐threatening (<a href="./references#CD013663-bbs2-0080" title="MatsuzakiS , EndoM , UedaY , MimuraK , KakiganoA , Egawa-TakataT , et al. A case of acute Sheehan's syndrome and literature review: a rare but life-threatening complication of postpartum hemorrhage. BMC Pregnancy and Childbirth2017;17(1):188. [PMID: 28615049]">Matsuzaki 2017</a>). Furthermore, PPH may have a long‐term psychological impact on women's health in the form of negative memories of childbirth and postpartum period with the main fear being of death (<a href="./references#CD013663-bbs2-0099" title="SentilhesL , GromezA , ClavierE , ReschB , DescampsP , MarpeauL . Long-term psychological impact of severe postpartum hemorrhage. Acta Obstetricia et Gynecologica Scandinavica2011;90(6):615-20. [PMID: 21370999]">Sentilhes 2011a</a>). </p> <p>Visual assessment of blood loss is the most frequently used method of determining blood loss following childbirth (<a href="./references#CD013663-bbs2-0062" title="HancockA , WeeksAD , LavenderDT . Is accurate and reliable blood loss estimation the 'crucial step' in early detection of postpartum haemorrhage: an integrative review of the literature. BMC Pregnancy and Childbirth2015;15:230. [DOI: 10.1186/s12884-015-0653-6]">Hancock 2015</a>). Unfortunately, this method often under‐estimates blood loss. Compared to measured blood loss following delivery, visual (clinical) assessment underestimates blood loss by 100 mL to 150 mL (<a href="./references#CD013663-bbs2-0070" title="KerrR , EckertLO , WinikoffB , DurocherJ , MeherS , FawcusS , et al. Postpartum haemorrhage: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine2016;34(49):6102-9. [DOI: 10.1016/j.vaccine.2016.03.039]">Kerr 2016</a>; <a href="./references#CD013663-bbs2-0103" title="SloanNL , DurocherJ , AldrichT , BlumJ , WinikoffB . What measured blood loss tells us about postpartum bleeding: a systematic review. BJOG: an international journal of obstetrics and gynaecology2010;117(7):788-800. [DOI: 10.1111/j.1471-0528.2010.02567.x]">Sloan 2010</a>). For accurate measurement of blood loss, many clinicians use a combination of direct measurement and gravimetric methods. </p> <section id="CD013663-sec-0011"> <h4 class="title">Causes and risk factors</h4> <p>Uterine atony is considered the most common cause of primary PPH. Other aetiological factors include retained parts of the placenta, vaginal or cervical tears, and coagulation failure. Uterine rupture and uterine inversion are extremely rare but, when they occur, could result in heavy bleeding (<a href="./references#CD013663-bbs2-0114" title="WHO. WHO Guidelines for the Management of Postpartum Haemorrhage and Retained Placenta. World Health Organization, 2009.">WHO 2015</a>). Investigators have identified risk factors for PPH as first pregnancy (<a href="./references#CD013663-bbs2-0059" title="GilbertL , PorterW , BrownVA . Postpartum haemorrhage: a continuing problem. British Journal of Obstetrics and Gynaecology1987;94(1):67-71. [PMID: 3493028]">Gilbert 1987</a>), maternal obesity (<a href="./references#CD013663-bbs2-0037" title="AisakaK , AndoS , KokuhoK , TawadaT , KanedaS , YoshimatsuJ . Effects of obesity and weight gain during pregnancy on obstetrical factors. Acta Obstetrica et Gynaecologica Japonica1988;63:1851–8.">Aisaka 1988</a>), a large baby (<a href="./references#CD013663-bbs2-0105" title="StonesRW , PatersonCM , SaundersNJ . Risk factors for major obstetric haemorrhage. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1993;48(1):15-8. [PMID: 8449256]">Stones 1993</a>), twin pregnancy (<a href="./references#CD013663-bbs2-0051" title="CombsCA , MurphyEL , Laros RK Jr. Factors associated with postpartum haemorrhage with vaginal birth. Obstetrics &amp; Gynecology1991;77(1):69-76. [PMID: 1984230]">Combs 1991</a>; <a href="./references#CD013663-bbs2-0106" title="SuzukiS , HiraizumiY , MiyakeH . Risk factors for postpartum hemorrhage requiring transfusion in cesarean deliveries for Japanese twins: comparison with those for singletons. Archives of Gynecology and Obstetrics2012;286(6):1363-7. [DOI: 10.1007/s00404-012-2461-9]">Suzuki 2012</a>), prolonged or augmented labour (<a href="./references#CD013663-bbs2-0059" title="GilbertL , PorterW , BrownVA . Postpartum haemorrhage: a continuing problem. British Journal of Obstetrics and Gynaecology1987;94(1):67-71. [PMID: 3493028]">Gilbert 1987</a>), chorioamnionitis, pre‐eclampsia, maternal anaemia and placenta praevia and abruptio placenta (antepartum haemorrhage) (<a href="./references#CD013663-bbs2-0073" title="KramerMS , DahhouM , VallerandD , ListonR , JosephKS . Risk factors for postpartum hemorrhage: can we explain the recent temporal increase?Journal of Obstetrics and Gynaecology Canada2011;33(8):810-9. [PMID: 21846436]">Kramer 2011</a>; <a href="./references#CD013663-bbs2-0112" title="WettaLA , SzychowskiJM , SealsS , MancusoMS , BiggioJR , TitaAT . Risk factors for uterine atony/postpartum hemorrhage requiring treatment after vaginal delivery. American Journal of Obstetrics and Gynecology2013;209(1):51.e1–51.e6. [DOI: 10.1016/j.ajog.2013.03.011]">Wetta 2013</a>). The largest bleeds occur usually in women with retained placenta, emergency caesarean section, and placental abruption and praevia (<a href="./references#CD013663-bbs2-0060" title="GreenL , KnightM , SeeneyFM , HopkinsonC , CollinsPW , CollisRE , et al. The epidemiology and outcomes of women with postpartum haemorrhage requiring massive transfusion with eight or more units of red cells: a national cross-sectional study. BJOG: an international journal of obstetrics and gynaecology2016;123(13):2164-70. [DOI: 10.1111/1471-0528.13831]">Green 2016</a>). However women with no potential risk factors often unpredictably develop primary PPH (<a href="./references#CD013663-bbs2-0086" title="MousaHA , CordingV , AlfirevicZ . Risk factors and interventions associated with major primary postpartum hemorrhage unresponsive to first-line conventional therapy. Acta Obstetricia et Gynecologica Scandinavica2008;87(6):652-61. [PMID: 10.1080/00016340802087660]">Mousa 2008</a>; <a href="./references#CD013663-bbs2-0110" title="WeeksA . The prevention and treatment of postpartum haemorrhage: what do we know, and where do we go to next?BJOG: an international journal of obstetrics and gynaecology2015;122(2):202-10. [PMID: 25289730]">Weeks 2015a</a>). </p> <p>The morbidity and mortality due to PPH in low‐income countries is aggravated by poor nutritional status, lack of easy access to treatment, inadequate intensive care and blood bank services (<a href="./references#CD013663-bbs2-0056" title="El AyadiA , RaifmanS , JegaF , ButrickE , OjoY , GellerS , et al. Comorbidities and lack of blood transfusion may negatively affect maternal outcomes of women with obstetric hemorrhage treated with NASG. PLOS One2013;8(8):e70446. [DOI: 10.1371/journal.pone.0070446]">El Ayadi 2013</a>; <a href="./references#CD013663-bbs2-0071" title="KhanKS , WojdylaD , SayL , GülmezogluAM , Van LookPF . WHO analysis of causes of maternal death: a systematic review. Lancet2006;367(9516):1066–74. [DOI: 10.1016/S0140-6736(06)68397-9]">Khan 2006</a>). </p> </section> <section id="CD013663-sec-0012"> <h4 class="title">Treatment approaches</h4> <p>Treatment for primary PPH requires a multidisciplinary team approach. The treatment involves resuscitation to manage obstetric haemorrhage, identification of the causes, and management. After exclusion of lower genital tract tears and coagulopathy, uterine atony is managed by using uterotonics that increase the efficiency of uterine contraction, and tranexamic acid to promote coagulation (<a href="./references#CD013663-bbs2-0115" title="WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet2017;389(10084):2105-16. [DOI: 10.1016/S0140-6736(17)30638-4]">WOMAN 2017</a>). If uterine bleeding is ongoing despite these interventions, the use of haemostatic drugs with mechanical methods to compress the uterus is advisable. Several mechanical methods have been described to control the bleeding and these are described below under <a href="#CD013663-sec-0013">Description of the intervention</a>. </p> <p>The non‐pneumatic anti‐shock garment (NASG) has also been used in the management of primary PPH. It is used before transport of patients with shock due to primary PPH to stabilise them for referral to higher level hospitals (<a href="./references#CD013663-bbs2-0083" title="MillerS , BergelEF , El AyadiAM , GibbonsL , ButrickEA , MagwaliT , et al. Non-pneumatic anti-shock garment (NASG), a first-aid device to decrease maternal mortality from obstetric hemorrhage: a cluster randomized trial. PLOS One2013;8(10):e76477. [PMID: 24194839]">Miller 2013b</a>). This technique will be the focus of another Cochrane Review. </p> <p>Hysterectomy works by ligating the blood vessels to the uterus and removing the uterus which is the bleeding site. Peripartum hysterectomy is a major operation and is performed only in the event of life threatening haemorrhage during or immediately after abdominal or vaginal deliveries when all other options have been exhausted (<a href="./references#CD013663-bbs2-0077" title="MachadoLS . Emergency peripartum hysterectomy: Incidence, indications, risk factors and outcome. North American Journal of Medical Sciences2011;3(8):358-61. [PMID: 22171242]">Machado 2011</a>). Indeed, the first caesarean hysterectomy ever described was conducted in order to prevent death from uterine haemorrhage (<a href="./references#CD013663-bbs2-0095" title="PorroE . Della amputazione utero-ovarica comecomplemento di taglio cesareo (Italian). https://catalog.hathitrust.org/Record/009895279 (accessed July 2018)1876;237.">Porro 1876</a>). In this review it is included as an outcome rather than an intervention, as it is the last resort to control intractable bleeding, and is therefore unlikely to be ever be an intervention tested in a randomised trial. </p> <p>The choice of the type of mechanical intervention depends on several factors and, in particular, the experience of the surgeon. </p> <p>Other relevant published Cochrane Reviews on management of PPH are <a href="./references#CD013663-bbs2-0087" title="MousaHA , BlumJ , Abou El SenounG , ShakurH , AlfirevicZ . Treatment for primary postpartum haemorrhage. Cochrane Database of Systematic Reviews2014, Issue 2. [DOI: 10.1002/14651858.CD003249.pub3]">Mousa 2014c</a> which evaluated the comprehensive treatment of PPH, <a href="./references#CD013663-bbs2-0043" title="BegleyCM , GyteGM , DevaneD , McGuireW , WeeksA , BiestyLM . Active versus expectant management for women in the third stage of labour. Cochrane Database of Systematic Reviews2019, Issue 2. [DOI: 10.1002/14651858.CD007412.pub5]">Begley 2019</a>, which compares active with expectant third‐stage management; <a href="./references#CD013663-bbs2-0075" title="LiabsuetrakulT , ChoobunT , PeeyananjarassriK , IslamQM . Prophylactic use of ergot alkaloids in the third stage of labour. Cochrane Database of Systematic Reviews2018, Issue 6. [DOI: 10.1002/14651858.CD005456.pub3]">Liabsuetrakul 2018</a>; <a href="./references#CD013663-bbs2-0081" title="McDonaldSJ . Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour. Cochrane Database of Systematic Reviews2004, Issue 1. [DOI: 10.1002/14651858.CD000201.pub2]">McDonald 2004</a>; <a href="./references#CD013663-bbs2-0092" title="PantojaT , AbalosE , ChapmanE , VeraC , SerranoVP . Oxytocin for preventing postpartum haemorrhage (PPH) in non-facility birth settings. Cochrane Database of Systematic Reviews2016, Issue 4. [DOI: 10.1002/14651858.CD011491.pub2]">Pantoja 2016</a>; <a href="./references#CD013663-bbs2-0108" title="Tunçalp Ö, HofmeyrGJ , GülmezogluAM . Prostaglandins for preventing postpartum haemorrhage. Cochrane Database of Systematic Reviews2012, Issue 8. [DOI: 10.1002/14651858.CD009336.pub2]">Tunçalp 2012</a> and <a href="./references#CD013663-bbs2-0091" title="OladapoOT , OkusanyaBO , AbalosE . Intramuscular versus intravenous prophylactic oxytocin for the third stage of labour. Cochrane Database of Systematic Reviews2018, Issue 9. [DOI: 10.1002/14651858.CD009332.pub3]">Oladapo 2018</a>, which considered the role of different prophylactic uterotonics in third‐stage management; <a href="./references#CD013663-bbs2-0035" title="Abdel-AleemH , Abdel-AleemMA , ShaabanOM . Nitroglycerin for management of retained placenta. Cochrane Database of Systematic Reviews2015, Issue 11. [DOI: 10.1002/14651858.CD007708.pub3]">Abdel‐Aleem 2015</a>, <a href="./references#CD013663-bbs2-0061" title="Grillo-ArdilaCF , Ruiz-ParraAI , GaitánHG , Rodriguez-MalagonN . Prostaglandins for management of retained placenta. Cochrane Database of Systematic Reviews2014, Issue 5. [DOI: 10.1002/14651858.CD010312.pub2]">Grillo‐Ardila 2014</a>; <a href="./references#CD013663-bbs2-0084" title="MoriR , NardinJM , YamamotoN , CarroliG , WeeksA . Umbilical vein injection for the routine management of third stage of labour. Cochrane Database of Systematic Reviews2012, Issue 3. [DOI: 10.1002/14651858.CD006176.pub2]">Mori 2012</a>, which examined the treatment of retained placenta; <a href="./references#CD013663-bbs2-0090" title="OladapoOT , FawoleB , BlumJ , AbalosE . Advance misoprostol distribution for preventing and treating postpartum haemorrhage. Cochrane Database of Systematic Reviews2012, Issue 2. [DOI: 10.1002/14651858.CD009336.pub2]">Oladapo 2012</a>, which evaluated advance community distribution of misoprostol for preventing or treating PPH; <a href="./references#CD013663-bbs2-0088" title="NovikovaN , HofmeyrGJ , CluverC . Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database of Systematic Reviews2015, Issue 6. [DOI: 10.1002/14651858.CD007872.pub3]">Novikova 2015a</a>, <a href="./references#CD013663-bbs2-0102" title="ShakurH , BeaumontD , PavordS , Gayet-AgeronA , KerK , MousaHA . Antifibrinolytic drugs for treating primary postpartum haemorrhage. Cochrane Database of Systematic Reviews2018, Issue 2. [DOI: 10.1002/14651858.CD012964]">Shakur 2018</a>, which evaluated the place of tranexamic acid for preventing PPH, and <a href="./references#CD013663-bbs2-0038" title="AlexanderJ , ThomasPW , SangheraJ . Treatments for secondary postpartum haemorrhage. Cochrane Database of Systematic Reviews2002, Issue 1. [DOI: 10.1002/14651858.CD002867]">Alexander 2002</a>, which examined drug treatment for secondary PPH. Other Cochrane Reviews have looked at the use of uterine massage (<a href="./references#CD013663-bbs2-0065" title="HofmeyrGJ , GulmezogluAM , NovikovaN , LawrieTA . Postpartum misoprostol for preventing maternal mortality and morbidity. Cochrane Database of Systematic Reviews2013, Issue 7. [DOI: 10.1002/14651858.CD008982.pub2]">Hofmeyr 2013b</a>) and breastfeeding or nipple stimulation (<a href="./references#CD013663-bbs2-0036" title="AbediP , JahanfarS , NamvarF , LeeJ . Breastfeeding or nipple stimulation for reducing postpartum haemorrhage in the third stage of labour. Cochrane Database of Systematic Reviews2016, Issue 1. [DOI: 10.1002/14651858.CD010845.pub2]">Abedi 2016</a>) for preventing PPH. </p> </section> </section> <section id="CD013663-sec-0013"> <h3 class="title" id="CD013663-sec-0013">Description of the intervention</h3> <p>In the event of failure of the uterotonics, PPH management turns to mechanical and surgical methods (<a href="./references#CD013663-bbs2-0113" title="WHO. WHO Recommendations for the Prevention and Treatment of Postpartum Haemorrhage. World Health Organization, 2012.">WHO 2012</a>). Whilst this review will consider mechanical and surgical methods, there is no clear distinction between the two approaches. Both approaches act through direct pressure on the placental bed, by reducing uterine blood flow through external pressure on the uterus, or through the interruption of vascular flow to the uterus. </p> <p>Direct pressure on the placental bed can be achieved by internal balloon tamponade using the Sengstaken‐Blakemore tube (<a href="./references#CD013663-bbs2-0048" title="ChanC , RazviK , ThamKF , ArulkumaranS . The use of a Sengstaken-Blakemore tube to control post-partum hemorrhage. International Journal of Gynaecology and Obstetrics1997;58(2):251-2. [PMID: 9252266]">Chan 1997</a>), the Rusch catheter (<a href="./references#CD013663-bbs2-0067" title="JohansonR , KumarM , ObhraiM , YoungP . Management of massive postpartum haemorrhage: use of a hydrostatic balloon catheter to avoid laparotomy. BJOG: an international journal of obstetrics and gynaecology2001;108(4):420-2. [PMID: 11305551]">Johanson 2001</a>), the Bakri balloon (<a href="./references#CD013663-bbs2-0042" title="BakriYN , AmriA , Abdul JabbarF . Tamponade-balloon for obstetrical bleeding. International Journal of Gynaecology and Obstetrics2001;74(2):139-42. [PMID: 11502292]">Bakri 2001</a>), or by packing the uterine cavity with several metres of gauze (<a href="./references#CD013663-bbs2-0055" title="EastmanNJ . Anomalies of the third stage of labor. In: William’s Obstetrics. 10th edition. New York: Appleton-Century Crofts, 1950:917–9.">Eastman 1950</a>). The overall success rate for packing is reported to be around 80% (<a href="./references#CD013663-bbs2-0054" title="DoumouchtsisSK , PapageorghiouAT , ArulkumaranS . Systematic review of conservative management of postpartum hemorrhage: what to do when medical treatment fails. Obstetrical and Gynecological Survey2007;62(8):540-7. [DOI: 10.1097/01.ogx.0000271137.81361.93]">Doumouchtsis 2007</a>; <a href="./references#CD013663-bbs2-0058" title="GeorgiouC . Balloon tamponade in the management of postpartum haemorrhage: a review. BJOG: an international journal of obstetrics and gynaecology2009;116(6):748-57. [DOI: 10.1111/j.1471-0528.2009.02113.x]">Georgiou 2009</a>). </p> <p>External pressure on the uterus can be achieved with uterine compression sutures (<a href="./references#CD013663-bbs2-0041" title="B-LynchC , CokerA , LawalAH , AbuJ , CowenMJ . The B-Lynch surgical technique for the control of massive postpartum haemorrhage: an alternative to hysterectomy? Five cases reported. British Journal of Obstetrics and Gynaecology1997;104(3):372–5.">B‐Lynch 1997</a>; <a href="./references#CD013663-bbs2-0079" title="MarasingheJP , CondousG , SeneviratneHR , MarasingheU . Modified anchored B-Lynch uterine compression suture for post partum bleeding with uterine atony. Acta Obstetricia et Gynecologica Scandinavica2011;90(3):280-3. [DOI: 10.1111/j.1600-0412.2010.01048.x]">Marasinghe 2011</a>; <a href="./references#CD013663-bbs2-0116" title="ZhengJ , XiongX , MaQ , ZhangX , LiM . A new uterine compression suture for postpartum haemorrhage with atony. BJOG: an international journal of obstetrics and gynaecology2011;118(3):370-4. [DOI: 10.1111/j.1471-0528.2010.02809.x]">Zheng 2011</a>). B‐Lynch was the first to describe a suture that runs through the full thickness of both uterine walls (anterior and posterior; <a href="./references#CD013663-bbs2-0041" title="B-LynchC , CokerA , LawalAH , AbuJ , CowenMJ . The B-Lynch surgical technique for the control of massive postpartum haemorrhage: an alternative to hysterectomy? Five cases reported. British Journal of Obstetrics and Gynaecology1997;104(3):372–5.">B‐Lynch 1997</a>). When tied, the suture allows tight compression of the uterine walls and stops the bleeding (<a href="./references#CD013663-bbs2-0085" title="MousaHA , WalkinshawS . Major postpartum haemorrhage. Current Opinion in Obstetrics and Gynecology2001;13(6):595-603. [PMID: 11707663]">Mousa 2001</a>). The modifications of this include the simple brace suture (<a href="./references#CD013663-bbs2-0063" title="HaymanRG , ArulkumaranS , SteerPJ . Uterine compression sutures: surgical management of postpartum hemorrhage. Obstetrics &amp; Gynecology2002;99(3):502-6. [PMID: 11864681]">Hayman 2002</a>) or square sutures (<a href="./references#CD013663-bbs2-0049" title="ChoJH , JunHS , LeeCN . Hemostatic suturing technique for uterine bleeding during cesarean delivery. Obstetrics &amp; Gynecology2000;96(1):129-31. [PMID: 10928901]">Cho 2000</a>). Uterine compression sutures have been found to be effective in stopping uterine bleeding (<a href="./references#CD013663-bbs2-0047" title="CekmezY , OzkayaE , OcalFD , KucukozkanT . Experience with different techniques for the management of postpartum hemorrhage due to uterine atony: compression sutures, artery ligation and Bakri balloon. Irish Journal of Medical Science2015;184(2):399-402. [DOI: 10.1007/s11845-014-1130-3]">Cekmez 2015a</a>), but complications of intrauterine synechiae (<a href="./references#CD013663-bbs2-0096" title="PoujadeO , GrossettiA , MougelL , CeccaldiPF , DucarmeG , LutonD . Risk of synechiae following uterine compression sutures in the management of major postpartum haemorrhage. BJOG: an international journal of obstetrics and gynaecology2011;118(4):433-9. [PMID: 21199289]">Poujade 2011</a>; <a href="./references#CD013663-bbs2-0097" title="RathatG , Do TrinhP , MercierG , ReyftmannL , DechanetC , BoulotP , et al. Synechia after uterine compression sutures. Fertility and Sterility2011;95(1):405-9. [DOI: 10.1016/j.fertnstert.2010.08.055]">Rathat 2011</a>) and/or infection (<a href="./references#CD013663-bbs2-0089" title="OchoaM , AllaireAD , StitelyML . Pyometria after hemostatic square suture technique. Obstetrics and Gynecology2002;99(3):506-9. [PMID: 11864682]">Ochoa 2002</a>) can occur. </p> <p>Vascular flow to the uterus can be interrupted by uterine devascularisation, ligation of the uterine or internal iliac arteries, embolisation or aortic compression. These are considered in selected cases where bleeding is persistent (<a href="./references#CD013663-bbs2-0047" title="CekmezY , OzkayaE , OcalFD , KucukozkanT . Experience with different techniques for the management of postpartum hemorrhage due to uterine atony: compression sutures, artery ligation and Bakri balloon. Irish Journal of Medical Science2015;184(2):399-402. [DOI: 10.1007/s11845-014-1130-3]">Cekmez 2015a</a>; <a href="./references#CD013663-bbs2-0068" title="JouppilaP . Postpartum haemorrhage. Current Opinion in Obstetrics and Gynecology1995;7(6):446–50. [PMID: 8620078]">Jouppila 1995</a>). The success rate of devascularisation appears to be less than 50% (<a href="./references#CD013663-bbs2-0050" title="ClarkSL , PhelanJP , YehSY , BruceSR , PaulRH . Hypogastric artery ligation for obstetric hemorrhage. Obstetrics &amp; Gynecology1985;66(3):353-6. [PMID: 3875064]">Clark 1985</a>). A simple way of achieving temporary uterine devascularisation is through compression of the aorta. This techniquemay be especially useful for PPH with a retained placenta. </p> </section> <section id="CD013663-sec-0014"> <h3 class="title" id="CD013663-sec-0014">How the intervention might work</h3> <p>Compression of the aorta through the abdomen is an emergency manoeuvre proposed to reduce PPH and permit time for resuscitation and control of bleeding. This technique involves compression of the aorta by placing a fist or the heel of the hand onto the aorta through the lax postnatal abdominal wall. The femoral pulse is checked to ensure occlusion, and the compression can be maintained for up to 90 minutes (<a href="./references#CD013663-bbs2-0094" title="PereiraA , NunesF , PedrosoS , SaraivaJ , RettoH , MeirinhoM . Compressive uterine sutures to treat postpartum bleeding secondary to uterine atony. Obstetrics and Gynecology2005;106(3):569-72. [PMID: 16135589]">Pereira 2005</a>). This cuts off the blood supply to the uterus and hence reduces uterine bleeding. </p> <p>The packing of the uterus with gauze or Sengstaken‐Blakemore tube or the Rusch catheter balloon applies pressure on the placental site and this reduces uterine bleeding (<a href="./references#CD013663-bbs2-0058" title="GeorgiouC . Balloon tamponade in the management of postpartum haemorrhage: a review. BJOG: an international journal of obstetrics and gynaecology2009;116(6):748-57. [DOI: 10.1111/j.1471-0528.2009.02113.x]">Georgiou 2009</a>). </p> <p>The devascularisation or ligation of uterine blood vessels and/or occasionally internal iliac arteries that supply blood to the uterus cuts off the blood supply to the uterus and stops uterine bleeding (<a href="./references#CD013663-bbs2-0047" title="CekmezY , OzkayaE , OcalFD , KucukozkanT . Experience with different techniques for the management of postpartum hemorrhage due to uterine atony: compression sutures, artery ligation and Bakri balloon. Irish Journal of Medical Science2015;184(2):399-402. [DOI: 10.1007/s11845-014-1130-3]">Cekmez 2015a</a>). The B‐Lynch suture reinforces the contraction of the uterus by keeping the uterus contracted, thus reducing uterine bleeding (<a href="./references#CD013663-bbs2-0047" title="CekmezY , OzkayaE , OcalFD , KucukozkanT . Experience with different techniques for the management of postpartum hemorrhage due to uterine atony: compression sutures, artery ligation and Bakri balloon. Irish Journal of Medical Science2015;184(2):399-402. [DOI: 10.1007/s11845-014-1130-3]">Cekmez 2015a</a>; <a href="./references#CD013663-bbs2-0085" title="MousaHA , WalkinshawS . Major postpartum haemorrhage. Current Opinion in Obstetrics and Gynecology2001;13(6):595-603. [PMID: 11707663]">Mousa 2001</a>). The Bakri balloon stops the bleeding by exerting pressure at the placental site (<a href="./references#CD013663-bbs2-0047" title="CekmezY , OzkayaE , OcalFD , KucukozkanT . Experience with different techniques for the management of postpartum hemorrhage due to uterine atony: compression sutures, artery ligation and Bakri balloon. Irish Journal of Medical Science2015;184(2):399-402. [DOI: 10.1007/s11845-014-1130-3]">Cekmez 2015a</a>). </p> </section> <section id="CD013663-sec-0015"> <h3 class="title" id="CD013663-sec-0015">Why it is important to do this review</h3> <p>This review is dedicated to assessing the effectiveness and safety of mechanical and surgical methods for the treatment of primary PPH and aims to inform local and national practices and guide clinicians and midwives on their role when managing PPH. Whilst first‐line treatment is usually pragmatic, using uterotonics, ongoing bleeding is managed with a combination of uterotonics, mechanical and surgical methods depending on the underlying cause of the bleeding (<a href="./references#CD013663-bbs2-0113" title="WHO. WHO Recommendations for the Prevention and Treatment of Postpartum Haemorrhage. World Health Organization, 2012.">WHO 2012</a>). These can be used successively or in combination. Much of our current practice is based on expert opinion as randomised trials in this area are difficult to carry out (<a href="./references#CD013663-bbs2-0110" title="WeeksA . The prevention and treatment of postpartum haemorrhage: what do we know, and where do we go to next?BJOG: an international journal of obstetrics and gynaecology2015;122(2):202-10. [PMID: 25289730]">Weeks 2015a</a>). </p> <p>An earlier Cochrane Review (<a href="./references#CD013663-bbs2-0087" title="MousaHA , BlumJ , Abou El SenounG , ShakurH , AlfirevicZ . Treatment for primary postpartum haemorrhage. Cochrane Database of Systematic Reviews2014, Issue 2. [DOI: 10.1002/14651858.CD003249.pub3]">Mousa 2014c</a>), considered all of the various treatment modalities for the management of primary PPH; the review has now been split in order to facilitate a more detailed analysis of different types of interventions. The use of antifibrinolytic drugs for treating primary PPH is covered in a recent new Cochrane review (<a href="./references#CD013663-bbs2-0102" title="ShakurH , BeaumontD , PavordS , Gayet-AgeronA , KerK , MousaHA . Antifibrinolytic drugs for treating primary postpartum haemorrhage. Cochrane Database of Systematic Reviews2018, Issue 2. [DOI: 10.1002/14651858.CD012964]">Shakur 2018</a>). In contrast, our review will focus on the use of mechanical and surgical interventions for treating primary PPH. The topic of uterotonic agents for treating primary PPH will be covered by another review. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD013663-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD013663-sec-0016"></div> <p>To determine the effectiveness and safety of mechanical and surgical interventions used for the treatment of primary postpartum haemorrhage. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD013663-sec-0017" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD013663-sec-0017"></div> <section id="CD013663-sec-0018"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD013663-sec-0019"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs) of mechanical and surgical management of postpartum haemorrhage (PPH). In future updates of this review, if identified, trials using a cluster‐RCT design will be included, and studies reported as abstracts will only be included if there is sufficient information to allow assessment of risk bias. </p> <p>Quasi‐RCTs or cross‐over studies are not eligible for inclusion in this review.</p> </section> <section id="CD013663-sec-0020"> <h4 class="title">Types of participants</h4> <p>Women after delivery following a pregnancy of at least 24 weeks’ gestation with a diagnosis of primary PPH, regardless of mode of delivery (vaginal or caesarean section) or other aspects of third‐stage management. </p> <p>We did not include trials of 'all' women that also happened to include women with PPH. We also did not include trials of all women including those with PPH (where the trial authors did not provide subgrouped results for women with PPH). </p> <p>Obtaining a blood loss measurement can be difficult, therefore trials may have different ways of defining PPH: </p> <p> <ul id="CD013663-list-0002"> <li> <p>women with blood loss of 500 mL or more; and/or</p> </li> <li> <p>women with primary PPH requiring blood transfusion and/or blood products; and/or</p> </li> <li> <p>women with a clinical diagnosis of primary PPH (as defined by the trialists).</p> </li> </ul> </p> <section id="CD013663-sec-0021"> <h5 class="title">Exclusion criteria</h5> <p> <ul id="CD013663-list-0003"> <li> <p>Women with PPH with gestational age less than 24 weeks.</p> </li> <li> <p>Women with heavy vaginal bleeding after 24 hours of birth (secondary PPH).</p> </li> </ul> </p> </section> </section> <section id="CD013663-sec-0022"> <h4 class="title">Types of interventions</h4> <p>Mechanical or surgical interventions such as uterine packing or intrauterine balloon insertion, artery ligation, uterine compression (sutures or manually). </p> <p>We compared one mechanical/surgical method (or a combined methods) versus standard care or another mechanical/surgical method, or combined methods. </p> <p>For example, the following interventions were eligible.</p> <p> <ol id="CD013663-list-0004"> <li> <p>External uterine compression (all methods) versus normal care</p> </li> <li> <p>External uterine compression (all methods) versus another mechanical/surgical method</p> </li> <li> <p>One external uterine compression technique verus another external uterine compression technique </p> </li> <li> <p>Uterine devascularisation (all methods) versus normal care</p> </li> <li> <p>Uterine devascularisation (all methods) versus another mechanical/surgical method</p> </li> <li> <p>One uterine devascularisation versus another uterine devascularisation technique</p> </li> <li> <p>Intrauterine tamponade (all methods) versus normal care</p> </li> <li> <p>Intrauterine tamponade (all methods) versus another mechanical/surgical method</p> </li> <li> <p>One intrauterine tamponade versus another intrauterine tamponade technique</p> </li> <li> <p>Uterine compression sutures (all methods) versus normal care</p> </li> <li> <p>Uterine compression sutures (all methods) versus another mechanical/surgical method</p> </li> <li> <p>One uterine compression suture technique versus another uterine compression suture technique </p> </li> </ol> </p> <p>Use of non‐pneumatic antishock garment, or arterial embolisation were not considered in this review. </p> <p>We present results stratified by the type of mechanical or surgical method.</p> </section> <section id="CD013663-sec-0023"> <h4 class="title">Types of outcome measures</h4> <p>Types of outcome measures are shown below.</p> <section id="CD013663-sec-0024"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD013663-list-0005"> <li> <p>Mortality due to bleeding</p> </li> <li> <p>Hysterectomy to control bleeding</p> </li> <li> <p>Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) </p> </li> </ol> </p> </section> <section id="CD013663-sec-0025"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD013663-list-0006"> <li> <p>All‐cause mortality*</p> </li> <li> <p>Mortality from causes other than bleeding</p> </li> <li> <p>Shock as defined by trialist*</p> </li> <li> <p>Coagulopathy as defined by trialist*</p> </li> <li> <p>Number of women with total blood loss 500 mL or more after randomisation*</p> </li> <li> <p>Number of women with total blood loss 1000 mL or more after randomisation*</p> </li> <li> <p>Mean blood loss (mL) (trialist defined)*</p> </li> <li> <p>Blood transfusion (red cell or whole blood)*</p> </li> <li> <p>Blood product transfusion*</p> </li> <li> <p>Post‐randomisation additional uterotonic agent used to control bleeding*</p> </li> <li> <p>Post‐randomisation additional surgical interventions used to control bleeding (arterial ligation, compressive, uterine sutures, arterial embolisation, laparotomy)* </p> </li> <li> <p>Post‐randomisation additional non‐surgical intervention to control bleeding (uterine packing, bimanual uterine massage, tamponade, external aortic compression and compression garments) </p> </li> <li> <p>Admission to higher level of care*</p> </li> <li> <p>Side effects of the intervention (e.g. trauma, necrosis)</p> </li> <li> <p>Days in hospital</p> </li> <li> <p>Breastfeeding (defined as any breastfeeding at hospital discharge)*</p> </li> <li> <p>Maternal satisfaction with therapy (trialist defined)*</p> </li> <li> <p>Quality of life, including physiological activity and social and emotional changes (sense of well‐being) (trialist defined)* </p> </li> </ol> </p> <p>*outcomes form part of a core outcome set that will be used in all PPH reviews.</p> <p>NOTE: we anticipated that assessment of blood loss could vary between trials. We considered that measurement of blood and blood clots in jars and weighing of linen are likely to be more precise than clinical judgement. The latter is known to underestimate blood loss. The way of reporting the amount of loss as ’greater than’ or ’greater than or equal to’ a certain cut‐off level (e.g. greater than 500 mL or greater than or equal to 500 mL) may affect the total reported amount of blood loss. </p> </section> </section> </section> <section id="CD013663-sec-0026"> <h3 class="title">Search methods for identification of studies</h3> <p>The following methods section of this protocol is based on a standard template used by Cochrane Pregnancy and Childbirth. </p> <section id="CD013663-sec-0027"> <h4 class="title">Electronic searches</h4> <p>We searched Cochrane Pregnancy and Childbirth’s Trials Register by contacting their Information Specialist (26 July 2019). </p> <p>The Register is a database containing over 25,000 reports of controlled trials in the field of pregnancy and childbirth. It represents over 30 years of searching. For full current search methods used to populate Pregnancy and Childbirth’s Trials Register including the detailed search strategies for CENTRAL, MEDLINE, Embase and CINAHL; the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service, please follow this <a href="https://pregnancy.cochrane.org/pregnancy-and-childbirth-groups-trials-register" target="_blank">link</a> </p> <p>Briefly, Cochrane Pregnancy and Childbirth’s Trials Register is maintained by their Information Specialist and contains trials identified from: </p> <p> <ol id="CD013663-list-0007"> <li> <p>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>weekly searches of MEDLINE (Ovid);</p> </li> <li> <p>weekly searches of Embase (Ovid);</p> </li> <li> <p>monthly searches of CINAHL (EBSCO);</p> </li> <li> <p>handsearches of 30 journals and the proceedings of major conferences;</p> </li> <li> <p>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts. </p> </li> </ol> </p> <p>Search results are screened by two people and the full text of all relevant trial reports identified through the searching activities described above is reviewed. Based on the intervention described, each trial report is assigned a number that corresponds to a specific Pregnancy and Childbirth review topic (or topics), and is then added to the Register. The Information Specialist searches the Register for each review using this topic number rather than keywords. This results in a more specific search set that has been fully accounted for in the relevant review sections (<a href="./references#CD013663-bbs1-0001" title="">Included studies</a>; <a href="./references#CD013663-bbs1-0002" title="">Excluded studies</a>; <a href="./references#CD013663-bbs1-0004" title="">Ongoing studies</a>). </p> <p>In addition, we searched <a href="http://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a> and the WHO International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">ICTRP</a>) for unpublished, planned and ongoing trial reports (26 July 2019) using the methods detailed in <a href="./appendices#CD013663-sec-0206">Appendix 1</a>. </p> </section> <section id="CD013663-sec-0028"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of retrieved studies.</p> <p>We did not apply any language or date restrictions.</p> </section> </section> <section id="CD013663-sec-0029"> <h3 class="title" id="CD013663-sec-0029">Data collection and analysis</h3> <p>The following methods section of this review is based on a standard template used by Cochrane Pregnancy and Childbirth. </p> <section id="CD013663-sec-0030"> <h4 class="title">Selection of studies</h4> <p>Three review authors (AW/FK/JW) independently assessed for inclusion all the potential studies we identified as a result of the search strategy. We resolved any disagreement through discussion and had no need to consult with the other member of the review team. </p> <p>We created a study flow diagram to map out the number of records identified, included and excluded. </p> </section> <section id="CD013663-sec-0031"> <h4 class="title">Data extraction and management</h4> <p>We designed a form to extract data. Extracted data included trial dates, sources of trial funding and trial authors' declarations of interest. For eligible studies, at least two review authors extracted the data using the agreed form. We resolved discrepancies through discussion or, where required, we consulted with a third member of the review team. We entered data into Review Manager software (<a href="./references#CD013663-bbs2-0098" title="The Nordic Cochrane Centre, The Cochrane CollaborationReview Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">RevMan 2014</a>) and checked them for accuracy. When information regarding any of the above is unclear, we attempted to contact authors of the original reports to provide further details; where we contacted trial authors, information is listed in <a href="./references#CD013663-sec-0215" title="">Characteristics of included studies.</a> </p> </section> <section id="CD013663-sec-0032"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013663-bbs2-0064" title="HigginsJP , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). We resolved any disagreement by discussion or by involving a third assessor. </p> <section id="CD013663-sec-0033"> <h5 class="title">(1) Random sequence generation (checking for possible selection bias)</h5> <p>We describe for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. </p> <p>We assessed the method as:</p> <p> <ul id="CD013663-list-0008"> <li> <p>low risk of bias (any truly random process, e.g. random number table; computer random number generator); </p> </li> <li> <p>high risk of bias (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD013663-sec-0034"> <h5 class="title">(2) Allocation concealment (checking for possible selection bias)</h5> <p>We describe for each included study the method used to conceal allocation to interventions prior to assignment and assessed whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. </p> <p>We assessed the methods as:</p> <p> <ul id="CD013663-list-0009"> <li> <p>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes); </p> </li> <li> <p>high risk of bias (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD013663-sec-0035"> <h5 class="title">(3.1) Blinding of participants and personnel (checking for possible performance bias)</h5> <p>We describe for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered that studies are at low risk of bias if they were blinded, or if we judged that the lack of blinding would be unlikely to affect results. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed the methods as:</p> <p> <ul id="CD013663-list-0010"> <li> <p>low, high or unclear risk of bias for participants;</p> </li> <li> <p>low, high or unclear risk of bias for personnel.</p> </li> </ul> </p> </section> <section id="CD013663-sec-0036"> <h5 class="title">(3.2) Blinding of outcome assessment (checking for possible detection bias)</h5> <p>We describe for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed methods used to blind outcome assessment as:</p> <p> <ul id="CD013663-list-0011"> <li> <p>low, high or unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD013663-sec-0037"> <h5 class="title">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data) </h5> <p>We describe for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We state whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or could be supplied by the trial authors, we re‐included missing data in the analyses which we undertook. </p> <p>We assessed methods as:</p> <p> <ul id="CD013663-list-0012"> <li> <p>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups); </p> </li> <li> <p>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; ‘as treated’ analysis done with substantial departure of intervention received from that assigned at randomisation); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD013663-sec-0038"> <h5 class="title">(5) Selective reporting (checking for reporting bias)</h5> <p>We describe for each included study how we investigated the possibility of selective outcome reporting bias and what we found. </p> <p>We assessed the methods as:</p> <p> <ul id="CD013663-list-0013"> <li> <p>low risk of bias (where it is clear that all of the study’s pre‐specified outcomes and all expected outcomes of interest to the review have been reported); </p> </li> <li> <p>high risk of bias (where not all the study’s pre‐specified outcomes have been reported; one or more reported primary outcomes were not pre‐specified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD013663-sec-0039"> <h5 class="title">(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)</h5> <p>We describe for each included study any important concerns we have about other possible sources of bias. </p> <p>We assessed whether each study was free of other problems that could put it at risk of bias: </p> <p> <ul id="CD013663-list-0014"> <li> <p>low risk of other bias;</p> </li> <li> <p>high risk of other bias;</p> </li> <li> <p>unclear whether there is risk of other bias.</p> </li> </ul> </p> </section> <section id="CD013663-sec-0040"> <h5 class="title">(7) Overall risk of bias</h5> <p>We made explicit judgements about whether studies are at high risk of bias, according to the criteria given in the <i>Handbook</i> (<a href="./references#CD013663-bbs2-0064" title="HigginsJP , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). With reference to (1) to (6) above, we assessed the likely magnitude and direction of the bias and whether we considered it likely to impact on the findings. We planned to explore the impact of the level of bias through undertaking sensitivity analyses ‐ <i>see</i><a href="#CD013663-sec-0052">Sensitivity analysis</a>. </p> </section> </section> <section id="CD013663-sec-0041"> <h4 class="title">Measures of treatment effect</h4> <section id="CD013663-sec-0042"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous data, we presented results as summary risk ratio with 95% confidence intervals. </p> </section> <section id="CD013663-sec-0043"> <h5 class="title">Continuous data</h5> <p>For continuous data, we used the mean difference if outcomes are measured in the same way between trials. In future updates, we will use the standardised mean difference to combine trials that measure the same outcome, but use different methods. </p> </section> </section> <section id="CD013663-sec-0044"> <h4 class="title">Unit of analysis issues</h4> <section id="CD013663-sec-0045"> <h5 class="title">Cluster‐randomised trials</h5> <p>We did not identify any cluster‐RCTs for inclusion in this review. In future updates, if we identify any cluster‐RCTs we will include them in our analyses along with individually‐randomised trials. We will adjust their sample sizes using the methods described in the <i>Handbook</i> [Section 16.3.4 or 16.3.6] using an estimate of the intracluster correlation co‐efficient (ICC) derived from the trial (if possible), from a similar trial, or from a study of a similar population. If we use ICCs from other sources, we will report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we identify both cluster‐randomised trials and individually‐randomised trials, we plan to synthesise the relevant information. We will consider it reasonable to combine the results from both if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely. </p> <p>We will also acknowledge heterogeneity in the randomisation unit and perform a sensitivity analysis to investigate the effects of the randomisation unit. </p> </section> <section id="CD013663-sec-0046"> <h5 class="title">Cross‐over trials</h5> <p>A cross‐over trial is not a valid methodology for trials of PPH as it is an acute emergency. </p> </section> </section> <section id="CD013663-sec-0047"> <h4 class="title">Dealing with missing data</h4> <p>For included studies, we noted levels of attrition. In future updates, if appropriate, we will explore the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using sensitivity analysis. </p> <p>For all outcomes, we carried out our analyses, as far as possible, on an intention‐to‐treat basis, i.e. we attempted to include all participants randomised to each group in the analyses, and all participants were analysed in the group to which they were allocated, regardless of whether or not they received the allocated intervention. The denominator for each outcome in each trial is the number randomised minus any participants whose outcomes are known to be missing. </p> </section> <section id="CD013663-sec-0048"> <h4 class="title">Assessment of heterogeneity</h4> <p>In future updates, we will assess statistical heterogeneity in each meta‐analysis using the Tau², I² and Chi² statistics. We will regard heterogeneity as substantial if the I² is greater than 30% and either the Tau² is greater than zero, or if there is a low P value (less than 0.10) in the Chi² test for heterogeneity. </p> </section> <section id="CD013663-sec-0049"> <h4 class="title">Assessment of reporting biases</h4> <p>In future updates, if there are 10 or more studies in the meta‐analysis we will investigate reporting biases (such as publication bias) using funnel plots. We will assess funnel plot asymmetry visually. If asymmetry is suggested by a visual assessment, we will perform exploratory analyses to investigate it. </p> </section> <section id="CD013663-sec-0050"> <h4 class="title">Data synthesis</h4> <p>We did not combine data in meta‐analysis due to clinical heterogeneity. In future updates, is appropriate, we will carry out statistical analysis using the Review Manager software (<a href="./references#CD013663-bbs2-0098" title="The Nordic Cochrane Centre, The Cochrane CollaborationReview Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">RevMan 2014</a>). We will use fixed‐effect meta‐analysis for combining data where it is reasonable to assume that studies are estimating the same underlying treatment effect: i.e. where trials are examining the same intervention, and the trials’ populations and methods are judged sufficiently similar. If there is clinical heterogeneity sufficient to expect that the underlying treatment effects differ between trials, or if substantial statistical heterogeneity is detected, we will use random‐effects meta‐analysis to produce an overall summary, if an average treatment effect across trials is considered clinically meaningful. The random‐effects summary will be treated as the average of the range of possible treatment effects and we will discuss the clinical implications of treatment effects differing between trials. If the average treatment effect is not clinically meaningful, we will not combine trials. </p> <p>If we use random‐effects analyses, the results will be presented as the average treatment effect with 95% confidence intervals, and the estimates of Tau² and I². </p> </section> <section id="CD013663-sec-0051"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>In future updates, if we identify substantial heterogeneity, we will investigate it using subgroup analyses. We will consider whether an overall summary is meaningful, and if it is, use random‐effects analysis to produce it. </p> <p>Our planned subgroup analysis:</p> <p> <ul id="CD013663-list-0015"> <li> <p>placenta praevia versus no placenta praevia;</p> </li> <li> <p>mode of delivery (caesarean section versus vaginal birth)</p> </li> </ul> </p> <p>Subgroup analysis will be restricted to the review’s primary outcomes.</p> <p>We will assess subgroup differences by interaction tests available within RevMan (<a href="./references#CD013663-bbs2-0098" title="The Nordic Cochrane Centre, The Cochrane CollaborationReview Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">RevMan 2014</a>). We will report the results of subgroup analyses quoting the Chi<sup>2</sup> statistic and P value, and the interaction test I² value. </p> </section> <section id="CD013663-sec-0052"> <h4 class="title">Sensitivity analysis</h4> <p>In future updates, if appropriate, we will undertake sensitivity analyses to explore the effect of risk of bias by temporarily excluding trials at high or unclear risk of bias (for selection bias or attrition bias) to see if it makes a difference in the overall result. We will also carry out sensitivity analysis to explore the impact of including studies with high levels of missing data in the overall assessment of treatment effect. We will also carry out sensitivity analysis to investigate the effect of the randomisation unit where we combine cluster‐RCTs and individually‐randomised trials in meta‐analysis. Sensitivity analysis will only be performed for the review's primary outcomes. </p> </section> <section id="CD013663-sec-0053"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>The certainty of the evidence was assessed using the GRADE approach as outlined in the <a href="http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html" target="_blank">GRADE handbook</a> in order to assess the certainty of the body of evidence relating to the following outcomes for the main comparisons. </p> <p> <ul id="CD013663-list-0016"> <li> <p>External uterine compression (all methods) versus normal care</p> </li> <li> <p>External uterine compression (all methods) versus another surgical/mechanical method</p> </li> <li> <p>One external uterine compression technique verus another external uterine compression technique </p> </li> <li> <p>Uterine devascularisation (all methods) versus normal care</p> </li> <li> <p>Uterine devascularisation (all methods) versus another surgical/mechanical method</p> </li> <li> <p>One uterine devascularisation versus another uterine devascularisation technique</p> </li> <li> <p>Intrauterine tamponade (all methods) versus normal care</p> </li> <li> <p>Intrauterine tamponade (all methods) versus another surgical/mechanical method</p> </li> <li> <p>One intrauterine tamponade versus another intrauterine tamponade technique</p> </li> <li> <p>Uterine compression sutures (all methods) versus normal care</p> </li> <li> <p>Uterine compression sutures (all methods) versus another mechanical or surgical method</p> </li> <li> <p>One uterine compression suture technique versus another uterine compression suture technique </p> </li> </ul> </p> <p>We assessed the following outcomes.</p> <p> <ol id="CD013663-list-0017"> <li> <p>Mortality due to bleeding</p> </li> <li> <p>Hysterectomy to control bleeding</p> </li> <li> <p>Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure </p> </li> <li> <p>Number of women with total blood loss 1000 mL or more after randomisation*</p> </li> <li> <p>Mean blood loss (mL) (trialist defined)*</p> </li> <li> <p>Blood transfusion (red cell or whole blood)*</p> </li> <li> <p>Side effects of the intervention (e.g. trauma, necrosis)</p> </li> </ol> </p> <p>We used the <a href="http://www.guidelinedevelopment.org/" target="_blank">GRADEpro</a> Guideline Development Tool to import data from Review Manager 5.3 (<a href="./references#CD013663-bbs2-0098" title="The Nordic Cochrane Centre, The Cochrane CollaborationReview Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">RevMan 2014</a>) in order to create ’Summary of findings’ tables. A summary of the intervention effect and a measure of quality for each of the above outcomes was produced using the GRADE approach. The GRADE approach uses five considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence for each outcome. The evidence can be downgraded from 'high certainty' by one level for serious (or by two levels for very serious) limitations, depending on assessments for risk of bias, indirectness of evidence, serious inconsistency, imprecision of effect estimates or potential publication bias. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD013663-sec-0054" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD013663-sec-0054"></div> <section id="CD013663-sec-0055"> <h3 class="title">Description of studies</h3> <p>Studies contained within this review are described below.</p> <section id="CD013663-sec-0056"> <h4 class="title">Results of the search</h4> <p>See: <a href="#CD013663-fig-0001">Figure 1</a> </p> <div class="figure" id="CD013663-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD013663-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>We retrieved 35 study reports to assess. In addition, we identified two further trials (<a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a>; <a href="./references#CD013663-bbs2-0001" title="AshrafN , AshrafA , KhursheedK . Efficacy and safety of intrauterine balloon tamponade versus ueterovaginal roll gauze packing in patient presenting with primary postpartum haemorrhage after normal vaginal delivery. Annals of King Edward Medical University2018;24(Special Issue):889-92. ">Ashraf 2018</a>) from correspondence. We included nine trials (12 trial reports), excluded 17 trials, and six trials are ongoing (see <a href="./references#CD013663-sec-0218" title="">Characteristics of ongoing studies</a>). There are also two trials listed in <a href="./references#CD013663-sec-0217" title="">Characteristics of studies awaiting classification</a> ‐ these trials are listed in trials registries as 'completed' and we have contacted the authors for more information about whether the results are currently available. </p> </section> <section id="CD013663-sec-0057"> <h4 class="title">Included studies</h4> <p>We included nine trials (involving a total of 944 women) (<a href="./references#CD013663-bbs2-0001" title="AshrafN , AshrafA , KhursheedK . Efficacy and safety of intrauterine balloon tamponade versus ueterovaginal roll gauze packing in patient presenting with primary postpartum haemorrhage after normal vaginal delivery. Annals of King Edward Medical University2018;24(Special Issue):889-92. ">Ashraf 2018</a>; <a href="./references#CD013663-bbs2-0002" title="ChantrapitakW , SrijanteokK , Puangsa-artS . Lower uterine segment compression for management of early postpartum hemorrhage after vaginal delivery at Charoenkrung Pracharak Hospital. Journal of the Medical Association of Thailand2009;92(5):600-5. [PMID: 19459518]">Chantrapitak 2009</a>; <a href="./references#CD013663-bbs2-0003" title="DarwishAM , AbdallahMM , ShaabanOM , AliMK , KhalafM , SabraAM . Bakri balloon versus condom-loaded foley's catheter for treatment of atonic postpartum hemorrhage secondary to vaginal delivery: a randomized controlled trial. Journal of Maternal-Fetal &amp; Neonatal Medicine2018;31(6):747-53. NCT02430155. Comparison of condom-loaded foley's catheter versus bakri balloon for treatment of primary postpartum hemorrhage: a randomized controlled trial. clinicaltrials.gov/show/NCT02430155 (first received 30 April 2015). ">Darwish 2018</a>; <a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a>; <a href="./references#CD013663-bbs2-0005" title='El-SokkaryM , WahbaK , El-ShahawyY . Uterine salvage management for atonic postpartum hemorrhage using "modified lynch suture". BMC Pregnancy and Childbirth2016;16:251. '>El‐Sokkary 2016</a>; <a href="./references#CD013663-bbs2-0006" title="FaroukO , ElbasuonyW , ElbohoutyA . Uterine artery embolization versus surgical management in primary atonic postpartum hemorrhage: A randomized clinical trial. Egyptian Journal of Radiology and Nuclear Medicine2016;47(3):817-23. ">Farouk 2016</a>; <a href="./references#CD013663-bbs2-0007" title="KavakSB , AtilganR , DemirelI , CelikE , IlhanR , SapmazE . Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa. Journal of Perinatal Medicine2013;41(6):705-9. ">Kavak 2013</a>; <a href="./references#CD013663-bbs2-0008" title="KhalilMI , Al-DohamiH , AldahishMM . A method to improve the effectiveness of the Bakri balloon for management of postpartum hemorrhage at cesarean. International Journal of Gynecology &amp; Obstetrics2011;115(2):198-200. ">Khalil 2011</a>; <a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a>). </p> <section id="CD013663-sec-0058"> <h5 class="title">Methods, trial dates and settings</h5> <section id="CD013663-sec-0059"> <h6 class="title">Methods</h6> <p><a href="./references#CD013663-bbs2-0001" title="AshrafN , AshrafA , KhursheedK . Efficacy and safety of intrauterine balloon tamponade versus ueterovaginal roll gauze packing in patient presenting with primary postpartum haemorrhage after normal vaginal delivery. Annals of King Edward Medical University2018;24(Special Issue):889-92. ">Ashraf 2018</a>, <a href="./references#CD013663-bbs2-0002" title="ChantrapitakW , SrijanteokK , Puangsa-artS . Lower uterine segment compression for management of early postpartum hemorrhage after vaginal delivery at Charoenkrung Pracharak Hospital. Journal of the Medical Association of Thailand2009;92(5):600-5. [PMID: 19459518]">Chantrapitak 2009</a>, <a href="./references#CD013663-bbs2-0003" title="DarwishAM , AbdallahMM , ShaabanOM , AliMK , KhalafM , SabraAM . Bakri balloon versus condom-loaded foley's catheter for treatment of atonic postpartum hemorrhage secondary to vaginal delivery: a randomized controlled trial. Journal of Maternal-Fetal &amp; Neonatal Medicine2018;31(6):747-53. NCT02430155. Comparison of condom-loaded foley's catheter versus bakri balloon for treatment of primary postpartum hemorrhage: a randomized controlled trial. clinicaltrials.gov/show/NCT02430155 (first received 30 April 2015). ">Darwish 2018</a>, <a href="./references#CD013663-bbs2-0005" title='El-SokkaryM , WahbaK , El-ShahawyY . Uterine salvage management for atonic postpartum hemorrhage using "modified lynch suture". BMC Pregnancy and Childbirth2016;16:251. '>El‐Sokkary 2016</a>, <a href="./references#CD013663-bbs2-0006" title="FaroukO , ElbasuonyW , ElbohoutyA . Uterine artery embolization versus surgical management in primary atonic postpartum hemorrhage: A randomized clinical trial. Egyptian Journal of Radiology and Nuclear Medicine2016;47(3):817-23. ">Farouk 2016</a>, <a href="./references#CD013663-bbs2-0007" title="KavakSB , AtilganR , DemirelI , CelikE , IlhanR , SapmazE . Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa. Journal of Perinatal Medicine2013;41(6):705-9. ">Kavak 2013</a>, <a href="./references#CD013663-bbs2-0008" title="KhalilMI , Al-DohamiH , AldahishMM . A method to improve the effectiveness of the Bakri balloon for management of postpartum hemorrhage at cesarean. International Journal of Gynecology &amp; Obstetrics2011;115(2):198-200. ">Khalil 2011</a> and <a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a> were randomised controlled trials (RCTs). <a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a>, was a multi‐centre RCT. Sample sizes ranged between 13 (<a href="./references#CD013663-bbs2-0007" title="KavakSB , AtilganR , DemirelI , CelikE , IlhanR , SapmazE . Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa. Journal of Perinatal Medicine2013;41(6):705-9. ">Kavak 2013</a>) and 240 (<a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a>). </p> </section> <section id="CD013663-sec-0060"> <h6 class="title">Trial dates</h6> <p>The trials were conducted between 2003 and 2015:</p> <p> <ul id="CD013663-list-0018"> <li> <p>the <a href="./references#CD013663-bbs2-0001" title="AshrafN , AshrafA , KhursheedK . Efficacy and safety of intrauterine balloon tamponade versus ueterovaginal roll gauze packing in patient presenting with primary postpartum haemorrhage after normal vaginal delivery. Annals of King Edward Medical University2018;24(Special Issue):889-92. ">Ashraf 2018</a> trial report does not provide the study dates but states the study took place over one year; </p> </li> <li> <p><a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a> 2003 to 2004; </p> </li> <li> <p><a href="./references#CD013663-bbs2-0008" title="KhalilMI , Al-DohamiH , AldahishMM . A method to improve the effectiveness of the Bakri balloon for management of postpartum hemorrhage at cesarean. International Journal of Gynecology &amp; Obstetrics2011;115(2):198-200. ">Khalil 2011</a> April 2004 until April 2009; </p> </li> <li> <p>January to August 2008 <a href="./references#CD013663-bbs2-0002" title="ChantrapitakW , SrijanteokK , Puangsa-artS . Lower uterine segment compression for management of early postpartum hemorrhage after vaginal delivery at Charoenkrung Pracharak Hospital. Journal of the Medical Association of Thailand2009;92(5):600-5. [PMID: 19459518]">Chantrapitak 2009</a>; </p> </li> <li> <p><a href="./references#CD013663-bbs2-0006" title="FaroukO , ElbasuonyW , ElbohoutyA . Uterine artery embolization versus surgical management in primary atonic postpartum hemorrhage: A randomized clinical trial. Egyptian Journal of Radiology and Nuclear Medicine2016;47(3):817-23. ">Farouk 2016</a> May 2011 until May 2013; </p> </li> <li> <p>August 2011 to August 2012 <a href="./references#CD013663-bbs2-0007" title="KavakSB , AtilganR , DemirelI , CelikE , IlhanR , SapmazE . Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa. Journal of Perinatal Medicine2013;41(6):705-9. ">Kavak 2013</a>; </p> </li> <li> <p>January 2013 to October 2015 <a href="./references#CD013663-bbs2-0005" title='El-SokkaryM , WahbaK , El-ShahawyY . Uterine salvage management for atonic postpartum hemorrhage using "modified lynch suture". BMC Pregnancy and Childbirth2016;16:251. '>El‐Sokkary 2016</a>; </p> </li> <li> <p>May 2013 to December 2015 <a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a>; </p> </li> <li> <p><a href="./references#CD013663-bbs2-0003" title="DarwishAM , AbdallahMM , ShaabanOM , AliMK , KhalafM , SabraAM . Bakri balloon versus condom-loaded foley's catheter for treatment of atonic postpartum hemorrhage secondary to vaginal delivery: a randomized controlled trial. Journal of Maternal-Fetal &amp; Neonatal Medicine2018;31(6):747-53. NCT02430155. Comparison of condom-loaded foley's catheter versus bakri balloon for treatment of primary postpartum hemorrhage: a randomized controlled trial. clinicaltrials.gov/show/NCT02430155 (first received 30 April 2015). ">Darwish 2018</a> October 2014 until December 2015. </p> </li> </ul> </p> </section> <section id="CD013663-sec-0061"> <h6 class="title">Settings</h6> <p>Settings included a university hospital setting in Pakistan (<a href="./references#CD013663-bbs2-0001" title="AshrafN , AshrafA , KhursheedK . Efficacy and safety of intrauterine balloon tamponade versus ueterovaginal roll gauze packing in patient presenting with primary postpartum haemorrhage after normal vaginal delivery. Annals of King Edward Medical University2018;24(Special Issue):889-92. ">Ashraf 2018</a>), Turkey (<a href="./references#CD013663-bbs2-0007" title="KavakSB , AtilganR , DemirelI , CelikE , IlhanR , SapmazE . Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa. Journal of Perinatal Medicine2013;41(6):705-9. ">Kavak 2013</a>), hospital settings in Thailand (<a href="./references#CD013663-bbs2-0002" title="ChantrapitakW , SrijanteokK , Puangsa-artS . Lower uterine segment compression for management of early postpartum hemorrhage after vaginal delivery at Charoenkrung Pracharak Hospital. Journal of the Medical Association of Thailand2009;92(5):600-5. [PMID: 19459518]">Chantrapitak 2009</a>), Egypt (<a href="./references#CD013663-bbs2-0003" title="DarwishAM , AbdallahMM , ShaabanOM , AliMK , KhalafM , SabraAM . Bakri balloon versus condom-loaded foley's catheter for treatment of atonic postpartum hemorrhage secondary to vaginal delivery: a randomized controlled trial. Journal of Maternal-Fetal &amp; Neonatal Medicine2018;31(6):747-53. NCT02430155. Comparison of condom-loaded foley's catheter versus bakri balloon for treatment of primary postpartum hemorrhage: a randomized controlled trial. clinicaltrials.gov/show/NCT02430155 (first received 30 April 2015). ">Darwish 2018</a>; <a href="./references#CD013663-bbs2-0005" title='El-SokkaryM , WahbaK , El-ShahawyY . Uterine salvage management for atonic postpartum hemorrhage using "modified lynch suture". BMC Pregnancy and Childbirth2016;16:251. '>El‐Sokkary 2016</a>; <a href="./references#CD013663-bbs2-0006" title="FaroukO , ElbasuonyW , ElbohoutyA . Uterine artery embolization versus surgical management in primary atonic postpartum hemorrhage: A randomized clinical trial. Egyptian Journal of Radiology and Nuclear Medicine2016;47(3):817-23. ">Farouk 2016</a>; <a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a>), a security forces hospital in Saudi Arabia (<a href="./references#CD013663-bbs2-0008" title="KhalilMI , Al-DohamiH , AldahishMM . A method to improve the effectiveness of the Bakri balloon for management of postpartum hemorrhage at cesarean. International Journal of Gynecology &amp; Obstetrics2011;115(2):198-200. ">Khalil 2011</a>), and healthcare facilities in Benin and Mali (<a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a>). </p> </section> </section> <section id="CD013663-sec-0062"> <h5 class="title">Participants</h5> <p>All of the women in the included studies were reported as having primary postpartum haemorrhage (PPH). In five of the studies, PPH was due to uterine atony (<a href="./references#CD013663-bbs2-0003" title="DarwishAM , AbdallahMM , ShaabanOM , AliMK , KhalafM , SabraAM . Bakri balloon versus condom-loaded foley's catheter for treatment of atonic postpartum hemorrhage secondary to vaginal delivery: a randomized controlled trial. Journal of Maternal-Fetal &amp; Neonatal Medicine2018;31(6):747-53. NCT02430155. Comparison of condom-loaded foley's catheter versus bakri balloon for treatment of primary postpartum hemorrhage: a randomized controlled trial. clinicaltrials.gov/show/NCT02430155 (first received 30 April 2015). ">Darwish 2018</a>; <a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a>) or suspected uterine atony (<a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a>) following vaginal birth or either vaginal birth or and caesarean in <a href="./references#CD013663-bbs2-0006" title="FaroukO , ElbasuonyW , ElbohoutyA . Uterine artery embolization versus surgical management in primary atonic postpartum hemorrhage: A randomized clinical trial. Egyptian Journal of Radiology and Nuclear Medicine2016;47(3):817-23. ">Farouk 2016</a>. Women in the <a href="./references#CD013663-bbs2-0002" title="ChantrapitakW , SrijanteokK , Puangsa-artS . Lower uterine segment compression for management of early postpartum hemorrhage after vaginal delivery at Charoenkrung Pracharak Hospital. Journal of the Medical Association of Thailand2009;92(5):600-5. [PMID: 19459518]">Chantrapitak 2009</a> and <a href="./references#CD013663-bbs2-0001" title="AshrafN , AshrafA , KhursheedK . Efficacy and safety of intrauterine balloon tamponade versus ueterovaginal roll gauze packing in patient presenting with primary postpartum haemorrhage after normal vaginal delivery. Annals of King Edward Medical University2018;24(Special Issue):889-92. ">Ashraf 2018</a> studies had a vaginal birth, but the precise cause of PPH was not reported by the trial authors. The women in <a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a> had given birth either at home or in hospital. </p> <p>In two trials, women had PPH due to atony following caesarean section (<a href="./references#CD013663-bbs2-0005" title='El-SokkaryM , WahbaK , El-ShahawyY . Uterine salvage management for atonic postpartum hemorrhage using "modified lynch suture". BMC Pregnancy and Childbirth2016;16:251. '>El‐Sokkary 2016</a>; <a href="./references#CD013663-bbs2-0008" title="KhalilMI , Al-DohamiH , AldahishMM . A method to improve the effectiveness of the Bakri balloon for management of postpartum hemorrhage at cesarean. International Journal of Gynecology &amp; Obstetrics2011;115(2):198-200. ">Khalil 2011</a>). The women in <a href="./references#CD013663-bbs2-0007" title="KavakSB , AtilganR , DemirelI , CelikE , IlhanR , SapmazE . Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa. Journal of Perinatal Medicine2013;41(6):705-9. ">Kavak 2013</a> had PPH due to complete placenta praevia and intractable bleeding following a caesarean section (<a href="./references#CD013663-bbs2-0007" title="KavakSB , AtilganR , DemirelI , CelikE , IlhanR , SapmazE . Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa. Journal of Perinatal Medicine2013;41(6):705-9. ">Kavak 2013</a>). </p> </section> <section id="CD013663-sec-0063"> <h5 class="title">How was PPH defined in the trials?</h5> <p>We recorded the trial authors' definitions of PPH ‐ these are provided below.</p> <p><a href="./references#CD013663-bbs2-0001" title="AshrafN , AshrafA , KhursheedK . Efficacy and safety of intrauterine balloon tamponade versus ueterovaginal roll gauze packing in patient presenting with primary postpartum haemorrhage after normal vaginal delivery. Annals of King Edward Medical University2018;24(Special Issue):889-92. ">Ashraf 2018</a> defined PPH as "excessive blood loss from genital tract occurring during third stage of labour and within first 24 hours after parturition" p 890. </p> <p><a href="./references#CD013663-bbs2-0002" title="ChantrapitakW , SrijanteokK , Puangsa-artS . Lower uterine segment compression for management of early postpartum hemorrhage after vaginal delivery at Charoenkrung Pracharak Hospital. Journal of the Medical Association of Thailand2009;92(5):600-5. [PMID: 19459518]">Chantrapitak 2009</a> defined PPH as "blood loss &gt; 500ml after delivery" p 601. </p> <p><a href="./references#CD013663-bbs2-0003" title="DarwishAM , AbdallahMM , ShaabanOM , AliMK , KhalafM , SabraAM . Bakri balloon versus condom-loaded foley's catheter for treatment of atonic postpartum hemorrhage secondary to vaginal delivery: a randomized controlled trial. Journal of Maternal-Fetal &amp; Neonatal Medicine2018;31(6):747-53. NCT02430155. Comparison of condom-loaded foley's catheter versus bakri balloon for treatment of primary postpartum hemorrhage: a randomized controlled trial. clinicaltrials.gov/show/NCT02430155 (first received 30 April 2015). ">Darwish 2018</a> provided no definition of PPH, nor was there a systematic method of diagnosis. </p> <p><a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a> defined PPH as, "visual estimation of excessive blood loss and patient status (blood pressure and cardiac frequency)" p 2. </p> <p><a href="./references#CD013663-bbs2-0005" title='El-SokkaryM , WahbaK , El-ShahawyY . Uterine salvage management for atonic postpartum hemorrhage using "modified lynch suture". BMC Pregnancy and Childbirth2016;16:251. '>El‐Sokkary 2016</a> did not define PPH. </p> <p><a href="./references#CD013663-bbs2-0006" title="FaroukO , ElbasuonyW , ElbohoutyA . Uterine artery embolization versus surgical management in primary atonic postpartum hemorrhage: A randomized clinical trial. Egyptian Journal of Radiology and Nuclear Medicine2016;47(3):817-23. ">Farouk 2016</a> defined PPH as blood loss more than 1000 mL within two hours of birth. </p> <p><a href="./references#CD013663-bbs2-0007" title="KavakSB , AtilganR , DemirelI , CelikE , IlhanR , SapmazE . Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa. Journal of Perinatal Medicine2013;41(6):705-9. ">Kavak 2013</a> did not define PPH. </p> <p><a href="./references#CD013663-bbs2-0008" title="KhalilMI , Al-DohamiH , AldahishMM . A method to improve the effectiveness of the Bakri balloon for management of postpartum hemorrhage at cesarean. International Journal of Gynecology &amp; Obstetrics2011;115(2):198-200. ">Khalil 2011</a> did not define PPH. </p> <p><a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a> did not define PPH in the trial report, and there is no information on how blood loss was assessed. </p> </section> <section id="CD013663-sec-0064"> <h5 class="title">Interventions and comparisons</h5> <section id="CD013663-sec-0065"> <h6 class="title">External uterine compression versus usual care (comparison 1)</h6> <p>One trial (<a href="./references#CD013663-bbs2-0002" title="ChantrapitakW , SrijanteokK , Puangsa-artS . Lower uterine segment compression for management of early postpartum hemorrhage after vaginal delivery at Charoenkrung Pracharak Hospital. Journal of the Medical Association of Thailand2009;92(5):600-5. [PMID: 19459518]">Chantrapitak 2009</a>) compared external uterine compression versus usual care. The study compared external lower uterine compression with 'usual care'. External lower uterine compression (either by grasping the uterus through a lax abdominal wall or compressing the uterus against the sacrum and lower vertebrae) was applied for a duration of 10 minutes. The usual care group involved "massage, oxytocin (10‐20 units in 1000 mL of intravenous solution, 200 mL/min), intravenous ergometrine (Methergin<sup>®</sup>, 0.2 mg), placed cold pack on uterus, and urinary catheterisation" p 601. </p> </section> <section id="CD013663-sec-0066"> <h6 class="title">One uterine devascularisation technique versus another uterine devascularisation technique</h6> <p>One trial compared one uterine devascularisation technique with another technique of uterine devascularisation (<a href="./references#CD013663-bbs2-0006" title="FaroukO , ElbasuonyW , ElbohoutyA . Uterine artery embolization versus surgical management in primary atonic postpartum hemorrhage: A randomized clinical trial. Egyptian Journal of Radiology and Nuclear Medicine2016;47(3):817-23. ">Farouk 2016</a>). </p> <section id="CD013663-sec-0067"> <p><b>Uterine arterial embolisation versus surgical devascularisation plus B‐Lynch (comparison 2)</b></p> <p><a href="./references#CD013663-bbs2-0006" title="FaroukO , ElbasuonyW , ElbohoutyA . Uterine artery embolization versus surgical management in primary atonic postpartum hemorrhage: A randomized clinical trial. Egyptian Journal of Radiology and Nuclear Medicine2016;47(3):817-23. ">Farouk 2016</a> compared uterine arterial embolisation with surgical devascularisation plus B‐Lynch compression sutures. </p> </section> </section> <section id="CD013663-sec-0068"> <h6 class="title">Intrauterine balloon tamponade versus normal care</h6> <section id="CD013663-sec-0069"> <p><b>Condom‐loaded Foley catheter plus normal care (misoprostol) versus normal care (misoprostol) (comparison 3)</b></p> <p><a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a> compared uterine balloon tamponade (condom‐loaded Foley catheter) and usual care (misoprostol) with usual care (misoprostol) alone. All women received rectal misoprostol (1000 ug) or sublingually (600 ug) following randomisation. In the balloon tamponade group, the condom was inflated "by increments of 250 mL of solute" p2. Further increments were added (up to a maximum of 1000 mL) if bleeding was still evident five minutes after adding the solution. </p> </section> <section id="CD013663-sec-0070"> <p><b>Latex balloon (air filled) tamponade + cervical stitch and normal care (comparison 4)</b></p> <p><a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a> compared uterine balloon tamponade the El‐Menia balloon tamponade versus normal care alone. The El‐Menia balloon tamponade is a standard latex party balloon (19 mm thick) inflated to 140 mmHg and attached to a Nelton catheter with suture silk. To keep the balloon in place, cervical cerclage was applied ("at 3 and 9 o'clock" p54). Women in the balloon tamponade group also received antibiotic prophylaxis immediately after balloon insertion and every eight hours thereafter for the subsequent three days. Both groups received normal care, which consisted of uterine massage and ecbolics as per the World Health Organization (WHO) protocol. </p> </section> </section> <section id="CD013663-sec-0071"> <h6 class="title">Intrauterine tamponade versus another mechanical/surgical method</h6> <section id="CD013663-sec-0072"> <p><b>Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (comparison 5)</b></p> <p>The <a href="./references#CD013663-bbs2-0007" title="KavakSB , AtilganR , DemirelI , CelikE , IlhanR , SapmazE . Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa. Journal of Perinatal Medicine2013;41(6):705-9. ">Kavak 2013</a> trial compared Bakri balloon tamponade with haemostatic square suturing to the lower segment of the uterus. The Bakri balloon tamponade was inflated with saline (100 mL to 200 mL) "according to the uterine size" p 706. Endouterine haemostatic square suturing (four to five sutures) was applied to the lower segment of the uterus. </p> <p>All women were given prophylactic antibiotics.</p> </section> </section> <section id="CD013663-sec-0073"> <h6 class="title">One intrauterine tamponade technique versus another intrauterine tamponade technique</h6> <p>Two trials compared one intrauterine tamponade technique versus another intrauterine tamponade technique (<a href="./references#CD013663-bbs2-0003" title="DarwishAM , AbdallahMM , ShaabanOM , AliMK , KhalafM , SabraAM . Bakri balloon versus condom-loaded foley's catheter for treatment of atonic postpartum hemorrhage secondary to vaginal delivery: a randomized controlled trial. Journal of Maternal-Fetal &amp; Neonatal Medicine2018;31(6):747-53. NCT02430155. Comparison of condom-loaded foley's catheter versus bakri balloon for treatment of primary postpartum hemorrhage: a randomized controlled trial. clinicaltrials.gov/show/NCT02430155 (first received 30 April 2015). ">Darwish 2018</a>; <a href="./references#CD013663-bbs2-0008" title="KhalilMI , Al-DohamiH , AldahishMM . A method to improve the effectiveness of the Bakri balloon for management of postpartum hemorrhage at cesarean. International Journal of Gynecology &amp; Obstetrics2011;115(2):198-200. ">Khalil 2011</a>) ‐ it was not possible to combine these data due to the nature of the interventions under investigation. </p> <section id="CD013663-sec-0074"> <p><b>Bakri balloon tamponade versus condom‐loaded Foley catheter (comparison 6)</b></p> <p><a href="./references#CD013663-bbs2-0003" title="DarwishAM , AbdallahMM , ShaabanOM , AliMK , KhalafM , SabraAM . Bakri balloon versus condom-loaded foley's catheter for treatment of atonic postpartum hemorrhage secondary to vaginal delivery: a randomized controlled trial. Journal of Maternal-Fetal &amp; Neonatal Medicine2018;31(6):747-53. NCT02430155. Comparison of condom-loaded foley's catheter versus bakri balloon for treatment of primary postpartum hemorrhage: a randomized controlled trial. clinicaltrials.gov/show/NCT02430155 (first received 30 April 2015). ">Darwish 2018</a> compared Bakri balloon with a condom‐loaded Foley catheter. The Bakri balloon or condom‐loaded Foley catheter was positioned correctly and then inflated with saline (150 mL initially, and subsequently inflated to 400 mL to 500 mL) until there was a decrease in blood draining through the catheter. </p> </section> <section id="CD013663-sec-0075"> <p><b>Bakri balloon + traction stitch versus Bakri balloon without traction stitch (comparison 7)</b></p> <p>Khalil 2011 compared the use of Bakri balloon with a traction stitch (to help hold it in place) with Bakri balloon without a traction stitch. The trial report did not provide information about how much saline was used to inflate the Bakri balloons. All women were given intravenous antibiotics for the first 48 hours and oxytocin for the first eight hours. </p> </section> <section id="CD013663-sec-0076"> <p><b>Condom‐loaded catheter versus uterovaginal packing (comparison 8)</b></p> <p>Ashraf 2018 compared the use of a condom‐loaded catheter intrauterine balloon tamponade with the use of uterovaginal packing. Each intervention was left in place for 24 hours and all women were given prophylactic antibiotics (no further information provided in the trial report). </p> </section> </section> <section id="CD013663-sec-0077"> <h6 class="title">One uterine compression suture technique versus another uterine compression suture technique </h6> <section id="CD013663-sec-0078"> <p><b>Modified B‐Lynch compression suture versus standard B‐Lynch compression suture (comparison 9)</b></p> <p><a href="./references#CD013663-bbs2-0005" title='El-SokkaryM , WahbaK , El-ShahawyY . Uterine salvage management for atonic postpartum hemorrhage using "modified lynch suture". BMC Pregnancy and Childbirth2016;16:251. '>El‐Sokkary 2016</a> compared the standard B‐Lynch compression suture technique with a modified version of the technique in which the sutures are applied in a figure of eight in order to exert greater uterine compression than the standard B‐Lynch compression sutures. </p> </section> </section> </section> <section id="CD013663-sec-0079"> <h5 class="title">Outcomes</h5> <p><a href="./references#CD013663-bbs2-0002" title="ChantrapitakW , SrijanteokK , Puangsa-artS . Lower uterine segment compression for management of early postpartum hemorrhage after vaginal delivery at Charoenkrung Pracharak Hospital. Journal of the Medical Association of Thailand2009;92(5):600-5. [PMID: 19459518]">Chantrapitak 2009</a> reported blood loss (mL) before treatment, mean blood loss and standard deviations, and median blood loss after treatment. Incidence of blood transfusion, and need for additional uterotonic agent to control bleeding (prostaglandin) were also reported. </p> <p><a href="./references#CD013663-bbs2-0003" title="DarwishAM , AbdallahMM , ShaabanOM , AliMK , KhalafM , SabraAM . Bakri balloon versus condom-loaded foley's catheter for treatment of atonic postpartum hemorrhage secondary to vaginal delivery: a randomized controlled trial. Journal of Maternal-Fetal &amp; Neonatal Medicine2018;31(6):747-53. NCT02430155. Comparison of condom-loaded foley's catheter versus bakri balloon for treatment of primary postpartum hemorrhage: a randomized controlled trial. clinicaltrials.gov/show/NCT02430155 (first received 30 April 2015). ">Darwish 2018</a> reported the number of women who needed some sort of further surgical intervention (i.e. hysterectomy, B‐Lynch compression suture) to stop bleeding. Secondary outcomes included time (minutes) between intervention and cessation of bleeding, blood transfusion, referral to intensive care unit, development of disseminated intravascular coagulation (DIC), and post‐insertion fever. </p> <p><a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a> employed a composite outcome as their primary outcome ‐ "the proportion of women with recourse to an invasive surgery (arterial ligatures, uterine compression sutures, hysterectomy) or who died before hospital discharge" (p3). Secondary outcomes included, arterial ligations, uterine compression sutures, hysterectomy to control bleeding, transfer to intensive care, total blood loss greater than 1000 mL, and maternal death. </p> <p>The main outcome in <a href="./references#CD013663-bbs2-0005" title='El-SokkaryM , WahbaK , El-ShahawyY . Uterine salvage management for atonic postpartum hemorrhage using "modified lynch suture". BMC Pregnancy and Childbirth2016;16:251. '>El‐Sokkary 2016</a> was whether the intervention was successful: successful (cessation of bleeding and hysterectomy not needed), unsuccessful (bleeding continued and hysterectomy needed). Other outcomes reported include postoperative blood loss; hysterectomy; blood transfusion; hospital stay; duration of the procedure; pre‐ and postoperative haemoglobin (Hb); bleeding from multiple bites; haematoma; wound haematoma; wound infection; fever. </p> <p><a href="./references#CD013663-bbs2-0006" title="FaroukO , ElbasuonyW , ElbohoutyA . Uterine artery embolization versus surgical management in primary atonic postpartum hemorrhage: A randomized clinical trial. Egyptian Journal of Radiology and Nuclear Medicine2016;47(3):817-23. ">Farouk 2016</a> reported cessation of bleeding, hysterectomy to control bleeding, postpartum fever (temperature &gt; 38.5 deg C), and complications. </p> <p><a href="./references#CD013663-bbs2-0007" title="KavakSB , AtilganR , DemirelI , CelikE , IlhanR , SapmazE . Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa. Journal of Perinatal Medicine2013;41(6):705-9. ">Kavak 2013</a> reported mortality, hysterectomy, intraoperative blood loss and blood transfusion as well as postoperative blood loss. Postoperative Hb and haematocrit are also reported along with 'time of operation' (assumed to be duration). Adverse effects were also recorded along with postoperative fever. We tried to contact the authors to provide data on post‐randomisation blood loss only (rather than the quoted 'intrapartum blood loss') but we did not receive a response. We therefore used the data provided on 'total intrapartum blood loss' assuming that the randomisation process would equalise the pre‐randomisation blood loss between the two arms of the study. </p> <p><a href="./references#CD013663-bbs2-0008" title="KhalilMI , Al-DohamiH , AldahishMM . A method to improve the effectiveness of the Bakri balloon for management of postpartum hemorrhage at cesarean. International Journal of Gynecology &amp; Obstetrics2011;115(2):198-200. ">Khalil 2011</a> reports the 'estimated blood loss', 'hysterectomy required', 'other surgeries required', along with three outcomes not in this review: 'displacement of the balloon', 'bleeding after displacement of the balloon', and 'bleeding after deflation of balloon'. The author provided data on the number of women with blood loss of 1000 mL and with blood loss over 1000 mL. The continuous variable for blood loss was provided as mean and range only (not mean and standard deviation), so it was not possible to use this outcome. </p> <p>The primary outcome in the <a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a> trial was maternal mortality. Secondary outcomes were treatment failure, abdominal hysterectomy, surgical operations, reinsertion of the balloon, balloon rupture, pyrexia, allergic reactions, The author provided data on units of syntocinon and ampoules of ergometrine, but these were provided as means and standard deviations and it is unclear whether these were 'additional' uterotonics or part of the normal care (WHO ecobolic protocol) that both groups received. Similarly, the author provided continuous data for number of units of blood transfused, and days stay in intensive care unit, but since these are in mean and standard deviation format it is not possible to identify the number of women in each group with these outcomes. <a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a> also reported Hb and haematocrit on discharge, time to resuscitate, and time to regain normal uterine tone. <a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a> reports that 19 women in the normal care group were given the intervention (El‐Menia balloon) because bleeding did not stop. The women remain in the 'control' group despite having received the intervention thus preserving intention‐to‐treat but since these data were not reported separately we are unaware of the impact that this may have on the outcome data for the control group. </p> <p>The <a href="./references#CD013663-bbs2-0001" title="AshrafN , AshrafA , KhursheedK . Efficacy and safety of intrauterine balloon tamponade versus ueterovaginal roll gauze packing in patient presenting with primary postpartum haemorrhage after normal vaginal delivery. Annals of King Edward Medical University2018;24(Special Issue):889-92. ">Ashraf 2018</a> reports fever (side effect of the intervention) relevant to the outcomes in this review. The study also reported on the following outcomes not featured in this review: Mean blood loss; efficacy (defined as blood loss stopped within 15 minutes of insertion and no recurrence of bleeding after removal of tamponade/packing); safety (no infection or fever; perforation (no further information given). </p> </section> <section id="CD013663-sec-0080"> <h5 class="title">Sources of trial funding</h5> <p>Sources of trial funding were not mentioned in seven studies (<a href="./references#CD013663-bbs2-0002" title="ChantrapitakW , SrijanteokK , Puangsa-artS . Lower uterine segment compression for management of early postpartum hemorrhage after vaginal delivery at Charoenkrung Pracharak Hospital. Journal of the Medical Association of Thailand2009;92(5):600-5. [PMID: 19459518]">Chantrapitak 2009</a>; <a href="./references#CD013663-bbs2-0003" title="DarwishAM , AbdallahMM , ShaabanOM , AliMK , KhalafM , SabraAM . Bakri balloon versus condom-loaded foley's catheter for treatment of atonic postpartum hemorrhage secondary to vaginal delivery: a randomized controlled trial. Journal of Maternal-Fetal &amp; Neonatal Medicine2018;31(6):747-53. NCT02430155. Comparison of condom-loaded foley's catheter versus bakri balloon for treatment of primary postpartum hemorrhage: a randomized controlled trial. clinicaltrials.gov/show/NCT02430155 (first received 30 April 2015). ">Darwish 2018</a>; <a href="./references#CD013663-bbs2-0005" title='El-SokkaryM , WahbaK , El-ShahawyY . Uterine salvage management for atonic postpartum hemorrhage using "modified lynch suture". BMC Pregnancy and Childbirth2016;16:251. '>El‐Sokkary 2016</a>; <a href="./references#CD013663-bbs2-0006" title="FaroukO , ElbasuonyW , ElbohoutyA . Uterine artery embolization versus surgical management in primary atonic postpartum hemorrhage: A randomized clinical trial. Egyptian Journal of Radiology and Nuclear Medicine2016;47(3):817-23. ">Farouk 2016</a>; <a href="./references#CD013663-bbs2-0007" title="KavakSB , AtilganR , DemirelI , CelikE , IlhanR , SapmazE . Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa. Journal of Perinatal Medicine2013;41(6):705-9. ">Kavak 2013</a>, <a href="./references#CD013663-bbs2-0008" title="KhalilMI , Al-DohamiH , AldahishMM . A method to improve the effectiveness of the Bakri balloon for management of postpartum hemorrhage at cesarean. International Journal of Gynecology &amp; Obstetrics2011;115(2):198-200. ">Khalil 2011</a>; <a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a>). <a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a>, was funded by the Research Institute for Development (IRD) and United Nations Children's Fund (UNICEF). <a href="./references#CD013663-bbs2-0001" title="AshrafN , AshrafA , KhursheedK . Efficacy and safety of intrauterine balloon tamponade versus ueterovaginal roll gauze packing in patient presenting with primary postpartum haemorrhage after normal vaginal delivery. Annals of King Edward Medical University2018;24(Special Issue):889-92. ">Ashraf 2018</a> reported that there were no sources of trial funding. </p> </section> <section id="CD013663-sec-0081"> <h5 class="title">Trial authors' declarations of interest</h5> <p>Six trial authors reported that they had no conflicts of interest (<a href="./references#CD013663-bbs2-0003" title="DarwishAM , AbdallahMM , ShaabanOM , AliMK , KhalafM , SabraAM . Bakri balloon versus condom-loaded foley's catheter for treatment of atonic postpartum hemorrhage secondary to vaginal delivery: a randomized controlled trial. Journal of Maternal-Fetal &amp; Neonatal Medicine2018;31(6):747-53. NCT02430155. Comparison of condom-loaded foley's catheter versus bakri balloon for treatment of primary postpartum hemorrhage: a randomized controlled trial. clinicaltrials.gov/show/NCT02430155 (first received 30 April 2015). ">Darwish 2018</a>; <a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a>; <a href="./references#CD013663-bbs2-0005" title='El-SokkaryM , WahbaK , El-ShahawyY . Uterine salvage management for atonic postpartum hemorrhage using "modified lynch suture". BMC Pregnancy and Childbirth2016;16:251. '>El‐Sokkary 2016</a>; <a href="./references#CD013663-bbs2-0007" title="KavakSB , AtilganR , DemirelI , CelikE , IlhanR , SapmazE . Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa. Journal of Perinatal Medicine2013;41(6):705-9. ">Kavak 2013</a>; <a href="./references#CD013663-bbs2-0008" title="KhalilMI , Al-DohamiH , AldahishMM . A method to improve the effectiveness of the Bakri balloon for management of postpartum hemorrhage at cesarean. International Journal of Gynecology &amp; Obstetrics2011;115(2):198-200. ">Khalil 2011</a>; <a href="./references#CD013663-bbs2-0001" title="AshrafN , AshrafA , KhursheedK . Efficacy and safety of intrauterine balloon tamponade versus ueterovaginal roll gauze packing in patient presenting with primary postpartum haemorrhage after normal vaginal delivery. Annals of King Edward Medical University2018;24(Special Issue):889-92. ">Ashraf 2018</a>). Trial authors' declarations were not mentioned in <a href="./references#CD013663-bbs2-0002" title="ChantrapitakW , SrijanteokK , Puangsa-artS . Lower uterine segment compression for management of early postpartum hemorrhage after vaginal delivery at Charoenkrung Pracharak Hospital. Journal of the Medical Association of Thailand2009;92(5):600-5. [PMID: 19459518]">Chantrapitak 2009</a>, <a href="./references#CD013663-bbs2-0006" title="FaroukO , ElbasuonyW , ElbohoutyA . Uterine artery embolization versus surgical management in primary atonic postpartum hemorrhage: A randomized clinical trial. Egyptian Journal of Radiology and Nuclear Medicine2016;47(3):817-23. ">Farouk 2016</a> or <a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a>. </p> </section> <section id="CD013663-sec-0082"> <h5 class="title">Was informed consent obtained from the trial participants?</h5> <p>Five trials reported that consent was sought from the trial participants (<a href="./references#CD013663-bbs2-0003" title="DarwishAM , AbdallahMM , ShaabanOM , AliMK , KhalafM , SabraAM . Bakri balloon versus condom-loaded foley's catheter for treatment of atonic postpartum hemorrhage secondary to vaginal delivery: a randomized controlled trial. Journal of Maternal-Fetal &amp; Neonatal Medicine2018;31(6):747-53. NCT02430155. Comparison of condom-loaded foley's catheter versus bakri balloon for treatment of primary postpartum hemorrhage: a randomized controlled trial. clinicaltrials.gov/show/NCT02430155 (first received 30 April 2015). ">Darwish 2018</a>; <a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a>; <a href="./references#CD013663-bbs2-0006" title="FaroukO , ElbasuonyW , ElbohoutyA . Uterine artery embolization versus surgical management in primary atonic postpartum hemorrhage: A randomized clinical trial. Egyptian Journal of Radiology and Nuclear Medicine2016;47(3):817-23. ">Farouk 2016</a>; <a href="./references#CD013663-bbs2-0007" title="KavakSB , AtilganR , DemirelI , CelikE , IlhanR , SapmazE . Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa. Journal of Perinatal Medicine2013;41(6):705-9. ">Kavak 2013</a>; <a href="./references#CD013663-bbs2-0008" title="KhalilMI , Al-DohamiH , AldahishMM . A method to improve the effectiveness of the Bakri balloon for management of postpartum hemorrhage at cesarean. International Journal of Gynecology &amp; Obstetrics2011;115(2):198-200. ">Khalil 2011</a>), and in one trial (<a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a>), informed consent was sought from the women's husbands. Informed consent was not mentioned in two trials (<a href="./references#CD013663-bbs2-0002" title="ChantrapitakW , SrijanteokK , Puangsa-artS . Lower uterine segment compression for management of early postpartum hemorrhage after vaginal delivery at Charoenkrung Pracharak Hospital. Journal of the Medical Association of Thailand2009;92(5):600-5. [PMID: 19459518]">Chantrapitak 2009</a>; <a href="./references#CD013663-bbs2-0005" title='El-SokkaryM , WahbaK , El-ShahawyY . Uterine salvage management for atonic postpartum hemorrhage using "modified lynch suture". BMC Pregnancy and Childbirth2016;16:251. '>El‐Sokkary 2016</a>). <a href="./references#CD013663-bbs2-0001" title="AshrafN , AshrafA , KhursheedK . Efficacy and safety of intrauterine balloon tamponade versus ueterovaginal roll gauze packing in patient presenting with primary postpartum haemorrhage after normal vaginal delivery. Annals of King Edward Medical University2018;24(Special Issue):889-92. ">Ashraf 2018</a> reports that informed consent was obtained from the women regarding "using their data for study purpose" p891, but it is not clear whether the women gave informed consent to receive the intervention. </p> </section> <section id="CD013663-sec-0083"> <h5 class="title">Was ethical approval sought?</h5> <p>Seven trials reported having obtained ethical approval for the trial (<a href="./references#CD013663-bbs2-0003" title="DarwishAM , AbdallahMM , ShaabanOM , AliMK , KhalafM , SabraAM . Bakri balloon versus condom-loaded foley's catheter for treatment of atonic postpartum hemorrhage secondary to vaginal delivery: a randomized controlled trial. Journal of Maternal-Fetal &amp; Neonatal Medicine2018;31(6):747-53. NCT02430155. Comparison of condom-loaded foley's catheter versus bakri balloon for treatment of primary postpartum hemorrhage: a randomized controlled trial. clinicaltrials.gov/show/NCT02430155 (first received 30 April 2015). ">Darwish 2018</a>; <a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a>; <a href="./references#CD013663-bbs2-0005" title='El-SokkaryM , WahbaK , El-ShahawyY . Uterine salvage management for atonic postpartum hemorrhage using "modified lynch suture". BMC Pregnancy and Childbirth2016;16:251. '>El‐Sokkary 2016</a>; <a href="./references#CD013663-bbs2-0006" title="FaroukO , ElbasuonyW , ElbohoutyA . Uterine artery embolization versus surgical management in primary atonic postpartum hemorrhage: A randomized clinical trial. Egyptian Journal of Radiology and Nuclear Medicine2016;47(3):817-23. ">Farouk 2016</a>; <a href="./references#CD013663-bbs2-0007" title="KavakSB , AtilganR , DemirelI , CelikE , IlhanR , SapmazE . Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa. Journal of Perinatal Medicine2013;41(6):705-9. ">Kavak 2013</a>; <a href="./references#CD013663-bbs2-0008" title="KhalilMI , Al-DohamiH , AldahishMM . A method to improve the effectiveness of the Bakri balloon for management of postpartum hemorrhage at cesarean. International Journal of Gynecology &amp; Obstetrics2011;115(2):198-200. ">Khalil 2011</a>; <a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a>), but ethical approval was not mentioned in <a href="./references#CD013663-bbs2-0002" title="ChantrapitakW , SrijanteokK , Puangsa-artS . Lower uterine segment compression for management of early postpartum hemorrhage after vaginal delivery at Charoenkrung Pracharak Hospital. Journal of the Medical Association of Thailand2009;92(5):600-5. [PMID: 19459518]">Chantrapitak 2009</a>. In the <a href="./references#CD013663-bbs2-0001" title="AshrafN , AshrafA , KhursheedK . Efficacy and safety of intrauterine balloon tamponade versus ueterovaginal roll gauze packing in patient presenting with primary postpartum haemorrhage after normal vaginal delivery. Annals of King Edward Medical University2018;24(Special Issue):889-92. ">Ashraf 2018</a> trial report, it states, "ethical approval: Given" p902 but not further detail is provided. </p> </section> </section> <section id="CD013663-sec-0084"> <h4 class="title">Excluded studies</h4> <p>We excluded 17 trials.</p> <p>Two trials were quasi‐RCTs (<a href="./references#CD013663-bbs2-0024" title="SoltanMH , FaragallahMF , MosabahMH , Al-AdawyAR . External aortic compression device: the first aid for postpartum hemorrhage control. Journal of Obstetrics and Gynaecology Research2009;35(3):453-8. ">Soltan 2009</a>; <a href="./references#CD013663-bbs2-0025" title="SoltanMH , ImamHH , ZahranKA , AtallahSM . Assessing changes in flow velocimetry and clinical outcome following use of an external aortic compression device in women with postpartum hemorrhage. International Journal of Gynecology &amp; Obstetrics2010;110(3):257-61. ">Soltan 2010</a>), and four were only available in abstract and had insufficient information to assess risk of bias (<a href="./references#CD013663-bbs2-0014" title="GelanySA , SoltanMH . External aortic compression device, manual aortic compression &amp; El Minya air inflated balloon: simple, cost-effective, and saving many lives in low resource settings. International Journal of Gynaecology and Obstetrics2012;119:S335. ">Gelany 2012</a>; <a href="./references#CD013663-bbs2-0015" title="KhalilM . Upper segment caesarean section, bilateral uterine artery ligation, with Khalil, s traction stitch for Bakri balloon tamponade to control postpartum hemorrhage from morbid adherent placenta previa. Journal of Maternal-Fetal &amp; Neonatal Medicine2014;27(Suppl 1):40. ">Khalil 2014</a>; <a href="./references#CD013663-bbs2-0018" title="MohamedAM , AgawanyAS , Abd RabboS . Stepwise devascularization versus B-Lynch for massive postpartum haemorrhage. BJOG: an international journal of obstetrics and gynaecology2014;121(Suppl 2):120. ">Mohamed 2014</a>; <a href="./references#CD013663-bbs2-0026" title="vonBeckerathAK , MaulH , ElmohandesAM , ShaabanM , HabibDM , NasrA , et al. Comparison of Celox and Bakri balloon in management of primary atonic postpartum hemorrhage. American Journal of Obstetrics and Gynecology2016;214(1 Suppl):S335, Abstract no: 628. ">von Beckerath 2016</a>). One trial (<a href="./references#CD013663-bbs2-0010" title="NCT02910310. Introduction of a uterine balloon tamponade for postpartum hemorrhage in three low income countries: a stepped wedge cluster randomized trial. clinicaltrials.gov/show/NCT02910310 (first received 22 September 2016). ">Anger 2016</a>) was a stepped‐wedge cluster‐RCT which randomised 18 hospitals to a policy of introducing uterine balloon tamponade (UBT) into standard care. The participants included all women (not just women with PPH) and sensitivity analysis for women with PPH was not provided. One trial (<a href="./references#CD013663-bbs2-0016" title="LetouzeyV , NCT01980173. Medico-economic comparison of postpartum hemorrhage management using the bakri balloon and standard care. https://clinicaltrials.gov/show/NCT01980173 (first received 8 Novemmber 2013). ">Letouzey 2013</a>), comparing Bakri balloon versus routine care was terminated due to recruitment difficulties. One trial (<a href="./references#CD013663-bbs2-0021" title="NCT02416089. Tampostat: a low-cost, self-regulating tamponade for management of postpartum hemorrhage in Bangladesh. clinicaltrials.gov/show/NCT02416089 (first received 14 April 2015). ">Rahman 2015</a>), comparing Tampostat <sup>(TM)</sup> balloon tamponade device versus a condom catheter tamponade was also terminated. </p> <p>Six trials were prevention of PPH studies (<a href="./references#CD013663-bbs2-0011" title="NCT02660567. The impacts of using amr's maneuver (cervical traction) on atonic postpartum hemorrhage; multi-centre randomized controlled study. clinicaltrials.gov/show/NCT02660567 (first received 21 January 2016). ">Azmy 2016</a>; <a href="./references#CD013663-bbs2-0012" title="ChiCTR-IOR-17012244. Bilateral internal iliac artery balloon occlusion for the management of pernicious placenta previa and accreta. www.chictr.org.cn/showproj.aspx?proj=20741 (first received 4 August 2017). ">Chen 2017</a>; <a href="./references#CD013663-bbs2-0013" title="FaroukH , NCT03570723. Glove-loaded foley's catheter tamponade to reducing blood loss during cesarean delivery for complete placenta previa: a randomized controlled trial. clinicaltrials.gov/ct2/show/NCT03570723 (first received 27 June 2018). ">Farouk 2018</a>; <a href="./references#CD013663-bbs2-0019" title="NermeenSE , AlyK , SamehSE , AmrAE . Uterine compression sutures and the amount of post partum blood loss in high risk cases of atonic post partum hemorrhage. Journal of Perinatal Medicine2015;43(Suppl 1):Abstract no: O-0006. ">Nermeen 2015</a>; <a href="./references#CD013663-bbs2-0022" title="PACTR201610001803327. Bilateral uterine artery ligation and square sutures versus a novel combined suture for controlling bleeding from the placental bed in placenta previa centralis at cesarean section: a randomized clinical trial. pactr.org/ATMWeb/appmanager/atm/atmregistry?dar=true&amp;tNo=PACTR201610001803327 (first received 3 October 2016). ">Rezk 2016</a>; <a href="./references#CD013663-bbs2-0023" title="SallamHF , ShadyNW . A sandwich technique (N&amp;H variation technique) to reduce blood loss during cesarean delivery for complete placenta previa: a randomized controlled trial. Journal of Maternal-Fetal &amp; Neonatal Medicine2019;32(19):3145-152. ">Sallam 2019</a>). One trial was not an RCT (<a href="./references#CD013663-bbs2-0020" title="PurwosonuY , Widyastuti. Control of post-partum hemorrhage by vacuum induced uterine tamponade. Journal of Obstetrics and Gynaecology Research2015;41(Suppl S1):47, Abstract no: FC 9.01. ">Purwosonu 2015</a>), and one other (<a href="./references#CD013663-bbs2-0017" title="LiuM , LiD . Effect of overall care for postpartum major hemorrhage patients with uterine artery embolization. Chinese Journal of Interventional Imaging and Therapy2016;13(6):338-41. ">Liu 2016</a>), was a comparison of two different nursing methods for women who had all had uterine embolisation for PPH. </p> <p>See <a href="./references#CD013663-sec-0216" title="">Characteristics of excluded studies</a> for further information. </p> </section> </section> <section id="CD013663-sec-0085"> <h3 class="title">Risk of bias in included studies</h3> <p>Overall, the included trials were at an unclear risk of bias. See <a href="#CD013663-fig-0002">Figure 2</a> and <a href="#CD013663-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD013663-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD013663-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD013663-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD013663-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD013663-sec-0086"> <h4 class="title">Allocation</h4> <section id="CD013663-sec-0087"> <h5 class="title">Random sequence generation</h5> <p>We assessed seven studies as low risk of bias for sequence generation (<a href="./references#CD013663-bbs2-0001" title="AshrafN , AshrafA , KhursheedK . Efficacy and safety of intrauterine balloon tamponade versus ueterovaginal roll gauze packing in patient presenting with primary postpartum haemorrhage after normal vaginal delivery. Annals of King Edward Medical University2018;24(Special Issue):889-92. ">Ashraf 2018</a>; <a href="./references#CD013663-bbs2-0003" title="DarwishAM , AbdallahMM , ShaabanOM , AliMK , KhalafM , SabraAM . Bakri balloon versus condom-loaded foley's catheter for treatment of atonic postpartum hemorrhage secondary to vaginal delivery: a randomized controlled trial. Journal of Maternal-Fetal &amp; Neonatal Medicine2018;31(6):747-53. NCT02430155. Comparison of condom-loaded foley's catheter versus bakri balloon for treatment of primary postpartum hemorrhage: a randomized controlled trial. clinicaltrials.gov/show/NCT02430155 (first received 30 April 2015). ">Darwish 2018</a>; <a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a>; <a href="./references#CD013663-bbs2-0005" title='El-SokkaryM , WahbaK , El-ShahawyY . Uterine salvage management for atonic postpartum hemorrhage using "modified lynch suture". BMC Pregnancy and Childbirth2016;16:251. '>El‐Sokkary 2016</a>; <a href="./references#CD013663-bbs2-0006" title="FaroukO , ElbasuonyW , ElbohoutyA . Uterine artery embolization versus surgical management in primary atonic postpartum hemorrhage: A randomized clinical trial. Egyptian Journal of Radiology and Nuclear Medicine2016;47(3):817-23. ">Farouk 2016</a>; <a href="./references#CD013663-bbs2-0008" title="KhalilMI , Al-DohamiH , AldahishMM . A method to improve the effectiveness of the Bakri balloon for management of postpartum hemorrhage at cesarean. International Journal of Gynecology &amp; Obstetrics2011;115(2):198-200. ">Khalil 2011</a>; <a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a>). Methods included computer‐generated random tables (<a href="./references#CD013663-bbs2-0003" title="DarwishAM , AbdallahMM , ShaabanOM , AliMK , KhalafM , SabraAM . Bakri balloon versus condom-loaded foley's catheter for treatment of atonic postpartum hemorrhage secondary to vaginal delivery: a randomized controlled trial. Journal of Maternal-Fetal &amp; Neonatal Medicine2018;31(6):747-53. NCT02430155. Comparison of condom-loaded foley's catheter versus bakri balloon for treatment of primary postpartum hemorrhage: a randomized controlled trial. clinicaltrials.gov/show/NCT02430155 (first received 30 April 2015). ">Darwish 2018</a>; <a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a>; <a href="./references#CD013663-bbs2-0005" title='El-SokkaryM , WahbaK , El-ShahawyY . Uterine salvage management for atonic postpartum hemorrhage using "modified lynch suture". BMC Pregnancy and Childbirth2016;16:251. '>El‐Sokkary 2016</a>), a computer‐generated list (<a href="./references#CD013663-bbs2-0006" title="FaroukO , ElbasuonyW , ElbohoutyA . Uterine artery embolization versus surgical management in primary atonic postpartum hemorrhage: A randomized clinical trial. Egyptian Journal of Radiology and Nuclear Medicine2016;47(3):817-23. ">Farouk 2016</a>), computer‐based randomisation (<a href="./references#CD013663-bbs2-0008" title="KhalilMI , Al-DohamiH , AldahishMM . A method to improve the effectiveness of the Bakri balloon for management of postpartum hemorrhage at cesarean. International Journal of Gynecology &amp; Obstetrics2011;115(2):198-200. ">Khalil 2011</a>;<a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a>,) or using the lottery method (<a href="./references#CD013663-bbs2-0001" title="AshrafN , AshrafA , KhursheedK . Efficacy and safety of intrauterine balloon tamponade versus ueterovaginal roll gauze packing in patient presenting with primary postpartum haemorrhage after normal vaginal delivery. Annals of King Edward Medical University2018;24(Special Issue):889-92. ">Ashraf 2018</a>). </p> <p>In <a href="./references#CD013663-bbs2-0002" title="ChantrapitakW , SrijanteokK , Puangsa-artS . Lower uterine segment compression for management of early postpartum hemorrhage after vaginal delivery at Charoenkrung Pracharak Hospital. Journal of the Medical Association of Thailand2009;92(5):600-5. [PMID: 19459518]">Chantrapitak 2009</a> and <a href="./references#CD013663-bbs2-0007" title="KavakSB , AtilganR , DemirelI , CelikE , IlhanR , SapmazE . Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa. Journal of Perinatal Medicine2013;41(6):705-9. ">Kavak 2013</a>, the methods of sequence generation were unclear. <a href="./references#CD013663-bbs2-0002" title="ChantrapitakW , SrijanteokK , Puangsa-artS . Lower uterine segment compression for management of early postpartum hemorrhage after vaginal delivery at Charoenkrung Pracharak Hospital. Journal of the Medical Association of Thailand2009;92(5):600-5. [PMID: 19459518]">Chantrapitak 2009</a> reported that the two groups were 'equally divided' and were 'randomly assigned' to the treatment groups, and <a href="./references#CD013663-bbs2-0007" title="KavakSB , AtilganR , DemirelI , CelikE , IlhanR , SapmazE . Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa. Journal of Perinatal Medicine2013;41(6):705-9. ">Kavak 2013</a> reported that the participants were 'randomly divided' ‐ but in both cases, no further information was provided. </p> </section> <section id="CD013663-sec-0088"> <h5 class="title">Allocation concealment</h5> <p>We assessed two trials as being low risk of bias for allocation concealment. <a href="./references#CD013663-bbs2-0003" title="DarwishAM , AbdallahMM , ShaabanOM , AliMK , KhalafM , SabraAM . Bakri balloon versus condom-loaded foley's catheter for treatment of atonic postpartum hemorrhage secondary to vaginal delivery: a randomized controlled trial. Journal of Maternal-Fetal &amp; Neonatal Medicine2018;31(6):747-53. NCT02430155. Comparison of condom-loaded foley's catheter versus bakri balloon for treatment of primary postpartum hemorrhage: a randomized controlled trial. clinicaltrials.gov/show/NCT02430155 (first received 30 April 2015). ">Darwish 2018</a> used serially numbered opaque sealed envelopes. <a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a> used closed opaque envelopes. </p> <p>We assessed the remaining seven studies as being at unclear risk of bias. No information pertaining to allocation concealment was mentioned in <a href="./references#CD013663-bbs2-0001" title="AshrafN , AshrafA , KhursheedK . Efficacy and safety of intrauterine balloon tamponade versus ueterovaginal roll gauze packing in patient presenting with primary postpartum haemorrhage after normal vaginal delivery. Annals of King Edward Medical University2018;24(Special Issue):889-92. ">Ashraf 2018</a>; <a href="./references#CD013663-bbs2-0002" title="ChantrapitakW , SrijanteokK , Puangsa-artS . Lower uterine segment compression for management of early postpartum hemorrhage after vaginal delivery at Charoenkrung Pracharak Hospital. Journal of the Medical Association of Thailand2009;92(5):600-5. [PMID: 19459518]">Chantrapitak 2009</a>; <a href="./references#CD013663-bbs2-0007" title="KavakSB , AtilganR , DemirelI , CelikE , IlhanR , SapmazE . Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa. Journal of Perinatal Medicine2013;41(6):705-9. ">Kavak 2013</a>; and <a href="./references#CD013663-bbs2-0008" title="KhalilMI , Al-DohamiH , AldahishMM . A method to improve the effectiveness of the Bakri balloon for management of postpartum hemorrhage at cesarean. International Journal of Gynecology &amp; Obstetrics2011;115(2):198-200. ">Khalil 2011</a>. Two trials (<a href="./references#CD013663-bbs2-0005" title='El-SokkaryM , WahbaK , El-ShahawyY . Uterine salvage management for atonic postpartum hemorrhage using "modified lynch suture". BMC Pregnancy and Childbirth2016;16:251. '>El‐Sokkary 2016</a>; <a href="./references#CD013663-bbs2-0006" title="FaroukO , ElbasuonyW , ElbohoutyA . Uterine artery embolization versus surgical management in primary atonic postpartum hemorrhage: A randomized clinical trial. Egyptian Journal of Radiology and Nuclear Medicine2016;47(3):817-23. ">Farouk 2016</a>) mentioned 'closed' or 'sealed' envelopes, but it was not clear whether these were sequentially numbered opaque sealed envelopes. In <a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a> ‐ the randomisation code was known to four people (suggesting this was a revealed list) and the trial supervisor decided over the telephone whether to randomise or not. </p> </section> </section> <section id="CD013663-sec-0089"> <h4 class="title">Blinding</h4> <section id="CD013663-sec-0090"> <h5 class="title">Blinding of participants and personnel (performance bias)</h5> <p>The studies of <a href="./references#CD013663-bbs2-0003" title="DarwishAM , AbdallahMM , ShaabanOM , AliMK , KhalafM , SabraAM . Bakri balloon versus condom-loaded foley's catheter for treatment of atonic postpartum hemorrhage secondary to vaginal delivery: a randomized controlled trial. Journal of Maternal-Fetal &amp; Neonatal Medicine2018;31(6):747-53. NCT02430155. Comparison of condom-loaded foley's catheter versus bakri balloon for treatment of primary postpartum hemorrhage: a randomized controlled trial. clinicaltrials.gov/show/NCT02430155 (first received 30 April 2015). ">Darwish 2018</a> and <a href="./references#CD013663-bbs2-0007" title="KavakSB , AtilganR , DemirelI , CelikE , IlhanR , SapmazE . Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa. Journal of Perinatal Medicine2013;41(6):705-9. ">Kavak 2013</a> were described as single‐blinded. In both <a href="./references#CD013663-bbs2-0003" title="DarwishAM , AbdallahMM , ShaabanOM , AliMK , KhalafM , SabraAM . Bakri balloon versus condom-loaded foley's catheter for treatment of atonic postpartum hemorrhage secondary to vaginal delivery: a randomized controlled trial. Journal of Maternal-Fetal &amp; Neonatal Medicine2018;31(6):747-53. NCT02430155. Comparison of condom-loaded foley's catheter versus bakri balloon for treatment of primary postpartum hemorrhage: a randomized controlled trial. clinicaltrials.gov/show/NCT02430155 (first received 30 April 2015). ">Darwish 2018</a> and <a href="./references#CD013663-bbs2-0007" title="KavakSB , AtilganR , DemirelI , CelikE , IlhanR , SapmazE . Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa. Journal of Perinatal Medicine2013;41(6):705-9. ">Kavak 2013</a>, it is not specified who was blinded, but presumably it was the patients who were all under general anaesthetic. The surgeons could not have been blinded due to the nature of the intervention, and so the risk of bias is still judged to be 'high risk' (please refer to <a href="#CD013663-fig-0002">Figure 2</a>. <a href="./references#CD013663-bbs2-0002" title="ChantrapitakW , SrijanteokK , Puangsa-artS . Lower uterine segment compression for management of early postpartum hemorrhage after vaginal delivery at Charoenkrung Pracharak Hospital. Journal of the Medical Association of Thailand2009;92(5):600-5. [PMID: 19459518]">Chantrapitak 2009</a>, <a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a>, <a href="./references#CD013663-bbs2-0005" title='El-SokkaryM , WahbaK , El-ShahawyY . Uterine salvage management for atonic postpartum hemorrhage using "modified lynch suture". BMC Pregnancy and Childbirth2016;16:251. '>El‐Sokkary 2016</a>, <a href="./references#CD013663-bbs2-0008" title="KhalilMI , Al-DohamiH , AldahishMM . A method to improve the effectiveness of the Bakri balloon for management of postpartum hemorrhage at cesarean. International Journal of Gynecology &amp; Obstetrics2011;115(2):198-200. ">Khalil 2011</a>, <a href="./references#CD013663-bbs2-0006" title="FaroukO , ElbasuonyW , ElbohoutyA . Uterine artery embolization versus surgical management in primary atonic postpartum hemorrhage: A randomized clinical trial. Egyptian Journal of Radiology and Nuclear Medicine2016;47(3):817-23. ">Farouk 2016</a> and <a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a> used closed opaque envelopes to conceal allocation, but there was no blinding reported. Blinding was not mentioned in <a href="./references#CD013663-bbs2-0001" title="AshrafN , AshrafA , KhursheedK . Efficacy and safety of intrauterine balloon tamponade versus ueterovaginal roll gauze packing in patient presenting with primary postpartum haemorrhage after normal vaginal delivery. Annals of King Edward Medical University2018;24(Special Issue):889-92. ">Ashraf 2018</a>. Blinding was difficult in all of these studies because the investigators were also the surgeons who were the involved in applying the surgical techniques ‐ it is therefore very difficult to blind them.  </p> </section> <section id="CD013663-sec-0091"> <h5 class="title">Blinding of outcome assessors (detection bias)</h5> <p>The outcome data were not reported to be blinded in any of the studies and we assessed seven of trials as 'unclear' risk of detection bias. We assessed two trials as being at a high risk of detection bias. In the <a href="./references#CD013663-bbs2-0003" title="DarwishAM , AbdallahMM , ShaabanOM , AliMK , KhalafM , SabraAM . Bakri balloon versus condom-loaded foley's catheter for treatment of atonic postpartum hemorrhage secondary to vaginal delivery: a randomized controlled trial. Journal of Maternal-Fetal &amp; Neonatal Medicine2018;31(6):747-53. NCT02430155. Comparison of condom-loaded foley's catheter versus bakri balloon for treatment of primary postpartum hemorrhage: a randomized controlled trial. clinicaltrials.gov/show/NCT02430155 (first received 30 April 2015). ">Darwish 2018</a> trial, it is possible that non‐independent blinded providers have biased the outcomes assessments. In the <a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a> it is possible that non‐independent blinded providers have biased the outcomes assessments (please refer to <a href="#CD013663-fig-0002">Figure 2</a>).  </p> </section> </section> <section id="CD013663-sec-0092"> <h4 class="title">Incomplete outcome data</h4> <p>We assessed one trial <a href="./references#CD013663-bbs2-0002" title="ChantrapitakW , SrijanteokK , Puangsa-artS . Lower uterine segment compression for management of early postpartum hemorrhage after vaginal delivery at Charoenkrung Pracharak Hospital. Journal of the Medical Association of Thailand2009;92(5):600-5. [PMID: 19459518]">Chantrapitak 2009</a>) to be at a high risk of attrition bias. In the trial report, there are two women with cervical and vaginal tears whose outcomes are not reported. It is unclear whether these were excluded before or after randomisation. However, cervical and vaginal tears are only usually found upon detailed examination after failure of primary treatment (in this case oxytocics plus uterine compression). It therefore seems likely that they were excluded after randomisation. </p> <p>In the <a href="./references#CD013663-bbs2-0003" title="DarwishAM , AbdallahMM , ShaabanOM , AliMK , KhalafM , SabraAM . Bakri balloon versus condom-loaded foley's catheter for treatment of atonic postpartum hemorrhage secondary to vaginal delivery: a randomized controlled trial. Journal of Maternal-Fetal &amp; Neonatal Medicine2018;31(6):747-53. NCT02430155. Comparison of condom-loaded foley's catheter versus bakri balloon for treatment of primary postpartum hemorrhage: a randomized controlled trial. clinicaltrials.gov/show/NCT02430155 (first received 30 April 2015). ">Darwish 2018</a> study, the study's main outcomes were reported for all 66 women recruited. However, treatment failed in eight women across the study and they went on to have either the insertion of a B‐Lynch compression suture (n = 5) or a hysterectomy (n = 3). The study's secondary outcome data on blood transfusion, intensive care unit referral, DIC and fever were not reported for these eight women and the data in the trial report relate to the remaining 58 (analysed 'per protocol'). The incomplete data (especially given that they were the ones who had the worst outcomes) led to a score of 'high risk' for attrition bias. </p> <p>We assessed six trials as being at low risk of attrition bias (<a href="./references#CD013663-bbs2-0001" title="AshrafN , AshrafA , KhursheedK . Efficacy and safety of intrauterine balloon tamponade versus ueterovaginal roll gauze packing in patient presenting with primary postpartum haemorrhage after normal vaginal delivery. Annals of King Edward Medical University2018;24(Special Issue):889-92. ">Ashraf 2018</a>; <a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a>; <a href="./references#CD013663-bbs2-0006" title="FaroukO , ElbasuonyW , ElbohoutyA . Uterine artery embolization versus surgical management in primary atonic postpartum hemorrhage: A randomized clinical trial. Egyptian Journal of Radiology and Nuclear Medicine2016;47(3):817-23. ">Farouk 2016</a>; <a href="./references#CD013663-bbs2-0007" title="KavakSB , AtilganR , DemirelI , CelikE , IlhanR , SapmazE . Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa. Journal of Perinatal Medicine2013;41(6):705-9. ">Kavak 2013</a>; <a href="./references#CD013663-bbs2-0008" title="KhalilMI , Al-DohamiH , AldahishMM . A method to improve the effectiveness of the Bakri balloon for management of postpartum hemorrhage at cesarean. International Journal of Gynecology &amp; Obstetrics2011;115(2):198-200. ">Khalil 2011</a>; <a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a>). </p> <p>We assessed one trial <a href="./references#CD013663-bbs2-0005" title='El-SokkaryM , WahbaK , El-ShahawyY . Uterine salvage management for atonic postpartum hemorrhage using "modified lynch suture". BMC Pregnancy and Childbirth2016;16:251. '>El‐Sokkary 2016</a> as 'unclear' for this domain because, in table 1 of the trial report, the authors did not state the number of women. In the text, there was no mention of incomplete data but we cannot assume that data were complete. </p> </section> <section id="CD013663-sec-0093"> <h4 class="title">Selective reporting</h4> <p>In six trials there was no mention of a protocol and we assessed these trials as having an unclear risk of reporting bias (<a href="./references#CD013663-bbs2-0002" title="ChantrapitakW , SrijanteokK , Puangsa-artS . Lower uterine segment compression for management of early postpartum hemorrhage after vaginal delivery at Charoenkrung Pracharak Hospital. Journal of the Medical Association of Thailand2009;92(5):600-5. [PMID: 19459518]">Chantrapitak 2009</a>; <a href="./references#CD013663-bbs2-0005" title='El-SokkaryM , WahbaK , El-ShahawyY . Uterine salvage management for atonic postpartum hemorrhage using "modified lynch suture". BMC Pregnancy and Childbirth2016;16:251. '>El‐Sokkary 2016</a>; <a href="./references#CD013663-bbs2-0006" title="FaroukO , ElbasuonyW , ElbohoutyA . Uterine artery embolization versus surgical management in primary atonic postpartum hemorrhage: A randomized clinical trial. Egyptian Journal of Radiology and Nuclear Medicine2016;47(3):817-23. ">Farouk 2016</a>; <a href="./references#CD013663-bbs2-0007" title="KavakSB , AtilganR , DemirelI , CelikE , IlhanR , SapmazE . Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa. Journal of Perinatal Medicine2013;41(6):705-9. ">Kavak 2013</a>; <a href="./references#CD013663-bbs2-0008" title="KhalilMI , Al-DohamiH , AldahishMM . A method to improve the effectiveness of the Bakri balloon for management of postpartum hemorrhage at cesarean. International Journal of Gynecology &amp; Obstetrics2011;115(2):198-200. ">Khalil 2011</a>; <a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a>). We assessed <a href="./references#CD013663-bbs2-0003" title="DarwishAM , AbdallahMM , ShaabanOM , AliMK , KhalafM , SabraAM . Bakri balloon versus condom-loaded foley's catheter for treatment of atonic postpartum hemorrhage secondary to vaginal delivery: a randomized controlled trial. Journal of Maternal-Fetal &amp; Neonatal Medicine2018;31(6):747-53. NCT02430155. Comparison of condom-loaded foley's catheter versus bakri balloon for treatment of primary postpartum hemorrhage: a randomized controlled trial. clinicaltrials.gov/show/NCT02430155 (first received 30 April 2015). ">Darwish 2018</a> as unclear risk of bias ‐ whilst the trial was prospectively registered, there are outcomes in the trial report that were not mentioned in the protocol. Similarly, <a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a> was prospectively registered but there were some minor differences between the outcomes in the protocol and the published trial report, but we assessed the trial as low risk of reporting bias. We assessed <a href="./references#CD013663-bbs2-0001" title="AshrafN , AshrafA , KhursheedK . Efficacy and safety of intrauterine balloon tamponade versus ueterovaginal roll gauze packing in patient presenting with primary postpartum haemorrhage after normal vaginal delivery. Annals of King Edward Medical University2018;24(Special Issue):889-92. ">Ashraf 2018</a> as having a high risk of bias for selective reporting ‐ a protocol was not available for this study. We note that one outcome (perforation) not detailed in the methods, is reported in the results. Generally, there are very few outcomes reported, including none of the outcomes listed in the article background, and there are no escalation outcomes reported (e.g. hysterectomy due to bleeding). It is also unclear from the report whether the mean blood loss outcome is pre‐randomisation (i.e. a participant characteristic) or post‐randomisation. </p> </section> <section id="CD013663-sec-0094"> <h4 class="title">Other potential sources of bias</h4> <p>We assessed six studies as low risk of other bias as no other potential sources of bias were identified. The remaining three trials were at unclear (<a href="./references#CD013663-bbs2-0001" title="AshrafN , AshrafA , KhursheedK . Efficacy and safety of intrauterine balloon tamponade versus ueterovaginal roll gauze packing in patient presenting with primary postpartum haemorrhage after normal vaginal delivery. Annals of King Edward Medical University2018;24(Special Issue):889-92. ">Ashraf 2018</a>) and high (<a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a>; <a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a>) risk of other bias. </p> <p><a href="./references#CD013663-bbs2-0001" title="AshrafN , AshrafA , KhursheedK . Efficacy and safety of intrauterine balloon tamponade versus ueterovaginal roll gauze packing in patient presenting with primary postpartum haemorrhage after normal vaginal delivery. Annals of King Edward Medical University2018;24(Special Issue):889-92. ">Ashraf 2018</a> was assessed as having an unclear risk of other bias ‐ the trial methods contain discrepancies with the reported participant characteristics and there is no mention of whether the women also received usual care in addition to the interventions of interest and, if so, what that was comprised of. <a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a> was assessed as having a high risk of other bias because 19 women in the control group also received the intervention as a second‐line treatment. This secondary use of UBT was not prespecified in the methods </p> </section> </section> <section id="CD013663-sec-0095"> <h3 class="title" id="CD013663-sec-0095">Effects of interventions</h3> <p>See: <a href="./full#CD013663-tbl-0001"><b>Summary of findings 1</b> External uterine compression (all methods) plus normal care compared to normal care for treating primary postpartum haemorrhage</a>; <a href="./full#CD013663-tbl-0002"><b>Summary of findings 2</b> One uterine devascularisation technique (uterine arterial embolisation) versus another uterine devascularisation technique (surgical devascularisation plus B‐Lynch)</a>; <a href="./full#CD013663-tbl-0003"><b>Summary of findings 3</b> Intrauterine balloon tamponade plus normal care (misoprostol) compared to normal care (misoprostol) for treating primary postpartum haemorrhage</a>; <a href="./full#CD013663-tbl-0004"><b>Summary of findings 4</b> Intrauterine balloon tamponade (latex balloon inflated with air) plus cerclage and normal care compared to normal care for treating primary postpartum haemorrhage</a>; <a href="./full#CD013663-tbl-0005"><b>Summary of findings 5</b> Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (intrauterine tamponade versus another mechanical/surgical method) for treating primary postpartum haemorrhage</a>; <a href="./full#CD013663-tbl-0006"><b>Summary of findings 6</b> Bakri balloon tamponade versus condom‐loaded Foley Catheter (one intrauterine tamponade compared to another intrauterine tamponade technique) for treating primary postpartum haemorrhage</a>; <a href="./full#CD013663-tbl-0007"><b>Summary of findings 7</b> Bakri balloon tamponade+traction stitch versus Bakri balloon (one intrauterine tamponade compared to another intrauterine tamponade technique) for treating primary postpartum haemorrhage)</a>; <a href="./full#CD013663-tbl-0008"><b>Summary of findings 8</b> Intrauterine balloon tamponade (condom‐loaded catheter) versus uterovaginal packing (intrauterine tamponade versus another intrauterine tamponade method) for treating primary postpartum haemorrhage</a>; <a href="./full#CD013663-tbl-0009"><b>Summary of findings 9</b> Modified B‐Lynch compression suture technique versus standard B‐Lynch compression suture (one uterine compression suture technique versus another uterine compression suture technique) for treating primary postpartum haemorrhage</a> </p> <p>We included nine small studies, involving a total of 944 women with primary PPH following either caesarean section or vaginal birth. It was not possible to combine any of the studies in meta‐analysis due to differences in the interventions and comparisons under investigation. We therefore present outcome data for individual studies below. Outcomes that form part of a core outcome set that will be used in all PPH reviews are highlighted below with an asterisk. </p> <section id="CD013663-sec-0096"> <h4 class="title">External uterine compression versus normal care (external uterine compression versus normal care) (comparison 1) </h4> <p>One small study (<a href="./references#CD013663-bbs2-0002" title="ChantrapitakW , SrijanteokK , Puangsa-artS . Lower uterine segment compression for management of early postpartum hemorrhage after vaginal delivery at Charoenkrung Pracharak Hospital. Journal of the Medical Association of Thailand2009;92(5):600-5. [PMID: 19459518]">Chantrapitak 2009</a>) contributed data to this comparison. The study, which involved 64 women diagnosed with uncontrolled primary PPH following vaginal birth. The study was conducted in Thailand and examined the use of external lower uterine compression versus usual care for treating primary PPH. </p> <section id="CD013663-sec-0097"> <h5 class="title">Primary outcomes</h5> <section id="CD013663-sec-0098"> <h6 class="title">Mortality due to bleeding</h6> <p>This outcome was not reported in the included study under this comparison.</p> </section> <section id="CD013663-sec-0099"> <h6 class="title">Hysterectomy to control bleeding</h6> <p>This outcome was not reported in the included study under this comparison.</p> </section> <section id="CD013663-sec-0100"> <h6 class="title">Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) </h6> <p>This outcome was not reported in the included study under this comparison.</p> </section> </section> <section id="CD013663-sec-0101"> <h5 class="title">Secondary outcomes</h5> <section id="CD013663-sec-0102"> <h6 class="title">Mean blood loss (mL) (trialist defined)*</h6> <p><a href="./references#CD013663-bbs2-0002" title="ChantrapitakW , SrijanteokK , Puangsa-artS . Lower uterine segment compression for management of early postpartum hemorrhage after vaginal delivery at Charoenkrung Pracharak Hospital. Journal of the Medical Association of Thailand2009;92(5):600-5. [PMID: 19459518]">Chantrapitak 2009</a> reported amount of blood loss (mL) after treatment (data were reported as medians with interquartile range ‐ external uterine compression:120 mL (∓ 211.0 mL); normal care: 225.0 mL (∓ 401.0 mL). </p> </section> <section id="CD013663-sec-0103"> <h6 class="title">Blood transfusion (red cell or whole blood)*</h6> <p>Very low‐certainty evidence means that we are unclear about the evidence relating to the incidence of red cell or whole blood transfusion (risk ratio (RR) 2.33, 95% confidence interval (CI) 0.66 to 8.23; 64 women; 1 study; <a href="./references#CD013663-fig-0004" title="">Analysis 1.1</a>). There were 7/32 women with red cell or whole blood transfusion in the external uterine compression group and 3/32 women in the normal care control. </p> </section> <section id="CD013663-sec-0104"> <h6 class="title">Post‐randomisation additional uterotonic agent used to control bleeding*</h6> <p>Two of the 32 women in the external uterine compression group and 3/32 women in the normal care group required post‐randomisation additional uterotonic agent to control bleeding (RR 0.67, 95% CI 0.12 to 3.73; 64 women, 1 study). </p> </section> <section id="CD013663-sec-0105"> <h6 class="title">Secondary outcomes not reported by the study under this comparison</h6> <p>The following secondary outcomes of interest in this review were not reported in the one included study under this comparison. </p> <p> <ul id="CD013663-list-0019"> <li> <p>All‐cause mortality*</p> </li> <li> <p>Mortality from causes other than bleeding</p> </li> <li> <p>Shock as defined by trialist*</p> </li> <li> <p>Coagulopathy as defined by trialist*</p> </li> <li> <p>Number of women with total blood loss 500 mL or more after randomisation*</p> </li> <li> <p>Number of women with total blood loss 1000 mL or more after randomisation*</p> </li> <li> <p>Blood product transfusion*</p> </li> <li> <p>Post‐randomisation additional surgical interventions used to control bleeding (arterial ligation, compressive, uterine sutures, arterial embolisation, laparotomy)* </p> </li> <li> <p>Post‐randomisation additional non‐surgical intervention to control bleeding (uterine packing, bimanual uterine massage, tamponade, external aortic compression and compression garments) </p> </li> <li> <p>Admission to higher level of care*</p> </li> <li> <p>Side effects of the intervention (e.g. trauma, necrosis)</p> </li> <li> <p>Days in hospital</p> </li> <li> <p>Breastfeeding (defined as any breastfeeding at hospital discharge)*</p> </li> <li> <p>Maternal satisfaction with therapy (trialist defined)*</p> </li> <li> <p>Quality of life, including physiological activity and social and emotional changes (sense of well‐being) (trialist defined)* </p> </li> </ul> </p> </section> </section> </section> <section id="CD013663-sec-0106"> <h4 class="title">Uterine arterial embolisation versus surgical devascularisation plus B‐Lynch (<i>One uterine devascularisation technique versus another uterine devascularisation technique)</i> (comparison 2) </h4> <p>One small study (<a href="./references#CD013663-bbs2-0006" title="FaroukO , ElbasuonyW , ElbohoutyA . Uterine artery embolization versus surgical management in primary atonic postpartum hemorrhage: A randomized clinical trial. Egyptian Journal of Radiology and Nuclear Medicine2016;47(3):817-23. ">Farouk 2016</a>) contributed data to this comparison. The study was conducted in Egypt and examined the use of uterine arterial embolisation (UAE) versus surgical devascularisation for treating primary PPH. The study involved 23 women with uncontrolled primary atonic PPH following vaginal delivery (9/11 in the UAE group and 8/12 in the surgical devascularisation+B‐Lynch group) or caesarean section (2/11 in the UAE group and 4/12 in the surgical devascularisation+B‐Lynch group). </p> <section id="CD013663-sec-0107"> <h5 class="title">Primary outcomes</h5> <section id="CD013663-sec-0108"> <h6 class="title">Mortality due to bleeding</h6> <p>This outcome was not reported by <a href="./references#CD013663-bbs2-0006" title="FaroukO , ElbasuonyW , ElbohoutyA . Uterine artery embolization versus surgical management in primary atonic postpartum hemorrhage: A randomized clinical trial. Egyptian Journal of Radiology and Nuclear Medicine2016;47(3):817-23. ">Farouk 2016</a>. </p> </section> <section id="CD013663-sec-0109"> <h6 class="title">Hysterectomy to control bleeding</h6> <p>Very low‐certainty evidence means that we are unclear about the results for hysterectomy to control bleeding, with 2/11 women having hysterectomy to control bleeding in the uterine arterial embolisation group compared with 3/12 women in the surgical devascularisation+ B‐Lynch group (RR 0.73, 95% CI 0.15 to 3.57; 23 women, 1 study; <a href="./references#CD013663-fig-0006" title="">Analysis 2.1</a>). </p> </section> <section id="CD013663-sec-0110"> <h6 class="title">Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) </h6> <p>This outcome was not reported by <a href="./references#CD013663-bbs2-0006" title="FaroukO , ElbasuonyW , ElbohoutyA . Uterine artery embolization versus surgical management in primary atonic postpartum hemorrhage: A randomized clinical trial. Egyptian Journal of Radiology and Nuclear Medicine2016;47(3):817-23. ">Farouk 2016</a>. </p> </section> </section> <section id="CD013663-sec-0111"> <h5 class="title">Secondary outcomes</h5> <section id="CD013663-sec-0112"> <h6 class="title">Side effects of the intervention (e.g. trauma, necrosis)</h6> <p>Very low‐certainty evidence means we are unclear about the results for this outcome, with just one woman in each group reporting side effects (RR 1.09, 95% CI 0.08 to 15.41; 23 women, 1 study). One woman in the embolisation group reported gluteal pain and one women in the surgical group had bladder injury. There were other 'complications' in each group (sepsis, fever, renal failure) but we do not consider these to be side effects of the intervention. See <a href="./references#CD013663-fig-0007" title="">Analysis 2.2</a>. </p> </section> <section id="CD013663-sec-0113"> <h6 class="title">Secondary outcomes not reported by the study under this comparison</h6> <p> <ul id="CD013663-list-0020"> <li> <p>All‐cause mortality*</p> </li> <li> <p>Mortality from causes other than bleeding</p> </li> <li> <p>Shock as defined by trialist*</p> </li> <li> <p>Number of women with total blood loss 500 mL or more after randomisation*</p> </li> <li> <p>Number of women with total blood loss 1000 mL or more after randomisation*</p> </li> <li> <p>Mean blood loss (mL) (trialist defined)*</p> </li> <li> <p>Coagulopathy as defined by trialist*</p> </li> <li> <p>Blood transfusion (red cell or whole blood)*</p> </li> <li> <p>Blood product transfusion*</p> </li> <li> <p>Post‐randomisation additional uterotonic agent used to control bleeding*</p> </li> <li> <p>Post‐randomisation additional surgical interventions used to control bleeding (arterial ligation, compressive, uterine sutures, arterial embolisation, laparotomy)* </p> </li> <li> <p>Post‐randomisation additional non‐surgical intervention to control bleeding (uterine packing, bimanual uterine massage, tamponade, external aortic compression and compression garments) </p> </li> <li> <p>Admission to higher level of care*</p> </li> <li> <p>Days in hospital</p> </li> <li> <p>Breastfeeding (defined as any breastfeeding at hospital discharge)*</p> </li> <li> <p>Maternal satisfaction with therapy (trialist defined)*</p> </li> <li> <p>Quality of life, including physiological activity and social and emotional changes (sense of well‐being) (trialist defined)* </p> </li> </ul> </p> </section> </section> </section> <section id="CD013663-sec-0114"> <h4 class="title">Intrauterine balloon tamponade plus normal care (misoprostol) versus normal care (misoprostol) (intrauterine tamponade versus normal care) (comparison 3) </h4> <p>One small study (<a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a>) contributed data to this comparison. In this multi‐centre study, which involved 116 women with primary PPH (thought to be due to clinical atony) following vaginal birth. The study was conducted in seven different healthcare facilities in Benin and Mali and examined the use of an intrauterine balloon tamponade plus normal are (misoprostol) versus usual care (misoprostol) alone for treating primary PPH. </p> <section id="CD013663-sec-0115"> <h5 class="title">Primary outcomes</h5> <section id="CD013663-sec-0116"> <h6 class="title">Mortality due to bleeding</h6> <p>Due to very low‐certainty evidence, we are unclear about the results for maternal mortality due to bleeding (RR 6.21, 95% CI 0.77 to 49.98; 116 women, 1 study; very low‐certainty evidence; <a href="./references#CD013663-fig-0008" title="">Analysis 3.1</a>). There were 6/57 maternal deaths due to bleeding in the intrauterine tamponade group compared to 1/59 in the normal care control. </p> </section> <section id="CD013663-sec-0117"> <h6 class="title">Hysterectomy to control bleeding</h6> <p>Similarly, very low‐certainty evidence for the outcome 'hysterectomy to control bleeding' means that we are unclear about the results for this outcome (RR 4.14, 95% CI 0.48 to 35.93; 116 women, 1 study; very low‐certainty evidence; <a href="./references#CD013663-fig-0009" title="">Analysis 3.2</a>). </p> </section> <section id="CD013663-sec-0118"> <h6 class="title">Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) </h6> <p>This outcome was not reported by <a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a>. </p> </section> </section> <section id="CD013663-sec-0119"> <h5 class="title">Secondary outcomes</h5> <section id="CD013663-sec-0120"> <h6 class="title">All‐cause mortality*</h6> <p>There were 6/57 all cause maternal deaths in the intrauterine tamponade group compared to 1/59 in the normal care control (RR 6.21, 95% CI 0.77 to 49.98; 116 women, 1 study; <a href="./references#CD013663-fig-0010" title="">Analysis 3.3</a>). </p> </section> <section id="CD013663-sec-0121"> <h6 class="title">Mortality from causes other than bleeding</h6> <p>There were no maternal deaths in either group resulting from causes other than bleeding. <a href="./references#CD013663-fig-0011" title="">Analysis 3.4</a>. </p> </section> <section id="CD013663-sec-0122"> <h6 class="title">Number of women with total blood loss 1000 mL or more after randomisation*</h6> <p>Balloon tamponade may increase the incidence of total blood loss 1000 mL or more after randomisation, but the evidence is of very low certainty (RR 1.52, 95% CI 1.15 to 2.00, 113 women, 1 study; low‐certainty evidence; <a href="./references#CD013663-fig-0012" title="">Analysis 3.5</a>). There were 43/54 women with this outcome in the intrauterine tamponade group compared to 31/59 women receiving standard care. The reported blood loss includes all blood lost postnatally, rather than that just following randomisation. However, we have assumed that the correct randomisation has equally distributed the pre‐randomisation blood loss between the two study arms. </p> </section> <section id="CD013663-sec-0123"> <h6 class="title">Blood transfusion (red cell or whole blood)*</h6> <p>We found very low‐certainty evidence relating to blood transfusion which means we are unclear about the results for this outcome (RR 1.49, 95% CI 0.88 to 2.51; 116 women, 1 study). </p> </section> <section id="CD013663-sec-0124"> <h6 class="title">Post‐randomisation additional surgical interventions used to control bleeding (arterial ligation, compressive, uterine sutures, arterial embolisation, laparotomy)* </h6> <p>Additional surgical interventions to control bleeding included uterine compression sutures (2/57 in the intrauterine tamponade group and 0/59 in normal care group) and artery ligation (4/57 in the intrauterine tamponade group and 3/59 in the normal care group). See <a href="./references#CD013663-fig-0014" title="">Analysis 3.7</a>. Very low‐certainty evidence means we are uncertain about the results for this outcome. </p> </section> <section id="CD013663-sec-0125"> <h6 class="title">Admission to higher level of care*</h6> <p>The number of women admitted to a higher level of care was (10/57) in the intrauterine tamponade group (10/57) and 8/59 in the standard care group (8/59) (RR 1.29, 95% CI 0.55 to 3.04; 116 women, 1 study; <a href="./references#CD013663-fig-0015" title="">Analysis 3.8</a>).Very low‐certainty evidence means the results are unclear for this outcome. </p> </section> <section id="CD013663-sec-0126"> <h6 class="title">Side effects of the intervention (e.g. trauma, necrosis)</h6> <p>We are uncertain about the results for this outcome due to very low‐certainty evidence. <a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a> reported that none of the women in either group experienced side effects of the intervention (reported as severe shivering, diarrhoea, vomiting or high temperature). See <a href="./references#CD013663-fig-0016" title="">Analysis 3.9</a>. </p> </section> <section id="CD013663-sec-0127"> <h6 class="title">Secondary outcomes not reported by the study under this comparison</h6> <p> <ul id="CD013663-list-0021"> <li> <p>Shock as defined by trialist*</p> </li> <li> <p>Coagulopathy as defined by trialist*</p> </li> <li> <p>Number of women with total blood loss 500 mL or more after randomisation*</p> </li> <li> <p>Mean blood loss (mL) (trialist defined)*</p> </li> <li> <p>Blood product transfusion*</p> </li> <li> <p>Post‐randomisation additional uterotonic agent used to control bleeding*</p> </li> <li> <p>Post‐randomisation additional non‐surgical intervention to control bleeding (uterine packing, bimanual uterine massage, tamponade, external aortic compression and compression garments) </p> </li> <li> <p>Days in hospital</p> </li> <li> <p>Breastfeeding (defined as any breastfeeding at hospital discharge)*</p> </li> <li> <p>Maternal satisfaction with therapy (trialist defined)*</p> </li> <li> <p>Quality of life, including physiological activity and social and emotional changes (sense of well‐being) (trialist defined)* </p> </li> </ul> </p> </section> </section> </section> <section id="CD013663-sec-0128"> <h4 class="title">Latex balloon (inflated with air) tamponade plus cerclage and normal care versus normal care (intrauterine tamponade versus normal care) (comparison 4) </h4> <p>One small study (<a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a>) contributed data to this comparison. The study, which involved 240 women with PPH due to uterine atony following vaginal birth. Women had given birth in either at home or in hospital. The study was conducted in Egypt and examined the use of a latex party balloon inflated with air and attached to a catheter with suture silk, the balloon was held in place with a cervical stitch. Women in the comparison group received standard care which comprised of uterine massage and ecbolics as per WHO protocol. Women in the intervention group also received antibiotics (metronidazole 500 mg, gentamycin 80 mg and ampicillin 500 mg after the balloon was inserted, and every eight hours for three days. </p> <p>The trial protocol for <a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a> stated that all of the women in the control group would receive standard care as the first‐line treatment. However, 19/120 women in the control group subsequently received the intervention as a second‐line treatment. The authors preserved intention‐to‐treat (the 19 women remained in the control group). </p> <section id="CD013663-sec-0129"> <h5 class="title">Primary outcomes</h5> <section id="CD013663-sec-0130"> <h6 class="title">Mortality due to bleeding</h6> <p>There were no maternal deaths due to bleeding.</p> </section> <section id="CD013663-sec-0131"> <h6 class="title">Hysterectomy to control bleeding</h6> <p>Very low‐certainty evidence for the outcome 'hysterectomy to control bleeding' means that we are unclear about the results for this outcome (RR 0.14, 95% CI 0.01 to 2.74; 240 women, one study; <a href="./references#CD013663-fig-0018" title="">Analysis 4.2</a>). </p> </section> <section id="CD013663-sec-0132"> <h6 class="title">Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) </h6> <p>This outcome was not reported in the included study under this comparison.</p> </section> </section> <section id="CD013663-sec-0133"> <h5 class="title">Secondary outcomes</h5> <section id="CD013663-sec-0134"> <h6 class="title">All‐cause mortality*</h6> <p>There were no mortalities reported in <a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a>. </p> </section> <section id="CD013663-sec-0135"> <h6 class="title">Mortality from causes other than bleeding</h6> <p>There were no mortalities from causes other than bleeding reported in <a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a>. </p> </section> <section id="CD013663-sec-0136"> <h6 class="title">Days in hospital</h6> <p>The length of time (days) that women spent in hospital appeared to be shorter in the intervention group compared to the normal care group but we are uncertain about this result because the evidence was very low certainty (MD ‐1.20 days, 95% CI ‐1.33 to ‐1.07; 240 women; one study; <a href="./references#CD013663-fig-0021" title="">Analysis 4.5</a>). </p> </section> <section id="CD013663-sec-0137"> <h6 class="title">Post‐randomisation additional surgical interventions used to control bleeding (arterial ligation, compressive, uterine sutures, arterial embolisation, laparotomy) </h6> <p>Two women in the control group required additional post‐randomisation surgical interventions (B‐lynch suture and artery ligation) in order to control bleeding compared to the intervention group where no women required additional surgical interventions to control bleeding (RR 0.20, 95% CI 0.01 to 4.12; 240 women, one study; <a href="./references#CD013663-fig-0022" title="">Analysis 4.6</a>) </p> </section> <section id="CD013663-sec-0138"> <h6 class="title">*Post‐randomisation additional non‐surgical intervention to control bleeding (uterine packing, bimanual uterine massage, tamponade, external aortic compression and compression garments) </h6> <p>The <a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a> trial methods specified that all women in the control group would receive standard care as the first‐line treatment. However, 19/120 women in the control group subsequently received the intervention as a second‐line treatment (RR 0.03, 95% CI 0.00 to 0.42; 240 women, one study; <a href="./references#CD013663-fig-0023" title="">Analysis 4.7</a>). </p> </section> <section id="CD013663-sec-0139"> <h6 class="title">Side effects of the intervention (e.g. trauma, necrosis)</h6> <p><a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a> reported that there were no cases of pyrexia, or allergic reaction ‐ <a href="./references#CD013663-fig-0024" title="">Analysis 4.8</a>. </p> <p>The trial report also mentioned that quote: "<i>undesired over inflation of the balloon, has results in three complications; two cases of cervical tear treated with surgical repair under general anaesthesia. The third one was a raise of uterine size above umbilicus; associated with tachycardia and hypotension, which had returned back to normal after deflation of the balloon bringing the uterine level just below the umbilicus</i>" (<a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a> page 59). However, it is unclear which group the three women were from (given that 19/120 women in the control group subsequently received the intervention as a second‐line treatment). We attempted to contact the author for clarification (20 January 2020) but received no response. </p> </section> <section id="CD013663-sec-0140"> <h6 class="title">Secondary outcomes not reported by the study under this comparison</h6> <p>The following prespecified secondary outcomes in this review were not reported by the included study/studies under this comparison. </p> <p> <ul id="CD013663-list-0022"> <li> <p>Shock as defined by trialist*</p> </li> <li> <p>Coagulopathy as defined by trialist*</p> </li> <li> <p>Number of women with total blood loss 500 mL or more after randomisation*</p> </li> <li> <p>Number of women with total blood loss 1000 mL or more after randomisation*</p> </li> <li> <p>Mean blood loss (mL) (trialist defined)*</p> </li> <li> <p>Blood transfusion (red cell or whole blood)*</p> </li> <li> <p>Blood product transfusion*</p> </li> <li> <p>Post‐randomisation additional uterotonic agent used to control bleeding*</p> </li> <li> <p>Admission to higher level of care*</p> </li> <li> <p>Breastfeeding (defined as any breastfeeding at hospital discharge)*</p> </li> <li> <p>Maternal satisfaction with therapy (trialist defined)*</p> </li> <li> <p>Quality of life, including physiological activity and social and emotional changes (sense of well‐being) (trialist defined)* </p> </li> </ul> </p> </section> </section> </section> <section id="CD013663-sec-0141"> <h4 class="title">Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (intrauterine tamponade versus another mechanical/surgical method) (comparison 5) </h4> <p>One very small study (<a href="./references#CD013663-bbs2-0007" title="KavakSB , AtilganR , DemirelI , CelikE , IlhanR , SapmazE . Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa. Journal of Perinatal Medicine2013;41(6):705-9. ">Kavak 2013</a>) contributed data to this comparison. The study, which involved 13 women with placenta praevia and primary PPH following caesarean section. The study was conducted in Turkey and examined the use of a Bakri balloon versus endouterine haemostatic square suturing to the lower segment of the uterus for treating primary PPH. </p> <section id="CD013663-sec-0142"> <h5 class="title">Primary outcomes</h5> <section id="CD013663-sec-0143"> <h6 class="title">Mortality due to bleeding</h6> <p>The effects of intervention on maternal mortality due to bleeding are unclear due to very low‐certainty evidence. There were no maternal deaths in either group. See <a href="./references#CD013663-fig-0025" title="">Analysis 5.1</a>. </p> </section> <section id="CD013663-sec-0144"> <h6 class="title">Hysterectomy to control bleeding</h6> <p>The effects of intervention on hysterectomy to control bleeding are also unclear due to very low‐certainty evidence. There were no hysterectomies to control bleeding in either group. See <a href="./references#CD013663-fig-0026" title="">Analysis 5.2</a>. </p> </section> <section id="CD013663-sec-0145"> <h6 class="title">Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) </h6> <p>The effects of intervention on serious maternal morbidity are also unclear, again due to very low‐certainty evidence. There were no serious maternal morbidities in either group. See <a href="./references#CD013663-fig-0027" title="">Analysis 5.3</a>. </p> </section> </section> <section id="CD013663-sec-0146"> <h5 class="title">Secondary outcomes</h5> <section id="CD013663-sec-0147"> <h6 class="title">Mean blood loss (mL) (trialist defined)*</h6> <p>Bakri balloon tamponade may reduce mean 'intraoperative' blood loss (mL) compared to haemostatic square suturing (mean difference (MD) ‐426 mL, 95% CI ‐631.28 to ‐220.72; very low‐certainty evidence; <a href="./references#CD013663-fig-0030" title="">Analysis 5.6</a>)), but we are uncertain about this result because the evidence was very low certainty . </p> </section> <section id="CD013663-sec-0148"> <h6 class="title">Blood transfusion (red cell or whole blood)*</h6> <p>We found very low‐certainty evidence relating to blood transfusion (red cell or whole blood) which means we are uncertain about the results for this outcome. There were 2/7 events in the intrauterine tamponade group and 3/6 in the uterine compression (control) group (RR 0.57, 95% CI 0.14 to 2.36, 13 women, 1 study; very low‐certainty evidence; <a href="./references#CD013663-fig-0031" title="">Analysis 5.7</a>). </p> </section> <section id="CD013663-sec-0149"> <h6 class="title">Post‐randomisation additional surgical interventions used to control bleeding (arterial ligation, compressive, uterine sutures, arterial embolisation, laparotomy)* </h6> <p>No women in either group required additional surgical interventions to control bleeding (13 women, one study). See <a href="./references#CD013663-fig-0032" title="">Analysis 5.8</a>. </p> </section> <section id="CD013663-sec-0150"> <h6 class="title">Side effects of the intervention (e.g. trauma, necrosis)</h6> <p><a href="./references#CD013663-bbs2-0007" title="KavakSB , AtilganR , DemirelI , CelikE , IlhanR , SapmazE . Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa. Journal of Perinatal Medicine2013;41(6):705-9. ">Kavak 2013</a> reported that there were no adverse effects requiring surgical intervention in either group, however there were two cases of fever in the control group. See <a href="./references#CD013663-fig-0033" title="">Analysis 5.9</a>. We identified very low‐certainty evidence for both of these outcomes which means we are uncertain about the results. </p> </section> <section id="CD013663-sec-0151"> <h6 class="title">Postnatal blood loss (outcome not prespecified in our review protocol)</h6> <p><a href="./references#CD013663-bbs2-0007" title="KavakSB , AtilganR , DemirelI , CelikE , IlhanR , SapmazE . Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa. Journal of Perinatal Medicine2013;41(6):705-9. ">Kavak 2013</a> reported on postnatal blood loss associated with the use of intrauterine tamponade compared with another mechanical/surgical method (haemostatic sutures) (MD ‐231.00 mL, 95% CI ‐300.70 to ‐161.30; 13 women, 1 study; <a href="./references#CD013663-fig-0034" title="">Analysis 5.10</a>) but this is very low‐certainty evidence which means we are uncertain about the results for this outcome. </p> </section> <section id="CD013663-sec-0152"> <h6 class="title">Secondary outcomes not reported by the study under this comparison</h6> <p> <ul id="CD013663-list-0023"> <li> <p>All‐cause mortality*</p> </li> <li> <p>Mortality from causes other than bleeding</p> </li> <li> <p>Shock as defined by trialist*.</p> </li> <li> <p>Coagulopathy as defined by trialist*</p> </li> <li> <p>Number of women with total blood loss 500 mL or more after randomisation*</p> </li> <li> <p>Number of women with total blood loss 1000 mL or more after randomisation*</p> </li> <li> <p>Blood product transfusion*</p> </li> <li> <p>Post‐randomisation additional uterotonic agent used to control bleeding*</p> </li> <li> <p>Post‐randomisation additional non‐surgical intervention to control bleeding (uterine packing, bimanual uterine massage, tamponade, external aortic compression and compression garments) </p> </li> <li> <p>Admission to higher level of care*</p> </li> <li> <p>Days in hospital</p> </li> <li> <p>Breastfeeding (defined as any breastfeeding at hospital discharge)*</p> </li> <li> <p>Maternal satisfaction with therapy (trialist defined)*</p> </li> <li> <p>Quality of life, including physiological activity and social and emotional changes (sense of well‐being) (trialist defined)* </p> </li> </ul> </p> </section> </section> </section> <section id="CD013663-sec-0153"> <h4 class="title">Bakri balloon tamponade versus condom‐loaded Foley catheter (one intrauterine tamponade technique versus another intrauterine tamponade technique) (comparison 6) </h4> <p>One small study (<a href="./references#CD013663-bbs2-0003" title="DarwishAM , AbdallahMM , ShaabanOM , AliMK , KhalafM , SabraAM . Bakri balloon versus condom-loaded foley's catheter for treatment of atonic postpartum hemorrhage secondary to vaginal delivery: a randomized controlled trial. Journal of Maternal-Fetal &amp; Neonatal Medicine2018;31(6):747-53. NCT02430155. Comparison of condom-loaded foley's catheter versus bakri balloon for treatment of primary postpartum hemorrhage: a randomized controlled trial. clinicaltrials.gov/show/NCT02430155 (first received 30 April 2015). ">Darwish 2018</a>) contributed data to this comparison. The study, which involved 66 women with uncontrolled primary atonic PPH following vaginal birth. The study was conducted in Egypt and examined the use of a Bakri balloon versus a condom‐loaded Foley catheter for treating primary PPH. It is important to note that women in whom the treatment failed were excluded from the results for the trial's secondary outcomes, making it difficult to draw conclusions from the published results. </p> <section id="CD013663-sec-0154"> <h5 class="title">Primary outcomes</h5> <section id="CD013663-sec-0155"> <h6 class="title">Mortality due to bleeding</h6> <p>This outcome was not reported in the included study under this comparison.</p> </section> <section id="CD013663-sec-0156"> <h6 class="title">Hysterectomy to control bleeding</h6> <p>The certainty of the evidence is very low, which means that it is uncertain whether the Bakri balloon tamponade reduces the risk of hysterectomy to control bleeding: Bakri balloon group (1/33) versus condom‐loaded Foley catheter group (2/33) (RR 0.50, 95% CI 0.05 to 5.25; 66 women, 1 study; <a href="./references#CD013663-fig-0035" title="">Analysis 6.1</a>). </p> </section> <section id="CD013663-sec-0157"> <h6 class="title">Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) </h6> <p>This outcome was not reported in the included study under this comparison.</p> </section> </section> <section id="CD013663-sec-0158"> <h5 class="title">Secondary outcomes</h5> <section id="CD013663-sec-0159"> <h6 class="title">Mean blood loss (mL) (trialist defined)*</h6> </section> <section id="CD013663-sec-0160"> <h6 class="title">Blood transfusion (red cell or whole blood)*</h6> <p>We are uncertain of the effects of intervention on the risk of blood transfusion (red cell or whole blood) between the Bakri balloon and condom‐loaded Foley catheter groups because the evidence is very low certainty. There were 29/30 events in the Bakri balloon group and 28/28 in the condom‐loaded Foley catheter group (RR 0.97, 95% CI 0.88 to 1.06, 58 women ‐ eight women with 'treatment failure' excluded from these data, 1 study; <a href="./references#CD013663-fig-0037" title="">Analysis 6.3</a>). </p> </section> <section id="CD013663-sec-0161"> <h6 class="title">Post‐randomisation additional surgical interventions used to control bleeding (arterial ligation, compressive, uterine sutures, arterial embolisation, laparotomy)* </h6> <p>There were 2/33 women in the Bakri balloon group who needed additional surgical interventions (B‐Lynch compression sutures) to control bleeding and (3/33) in the condom‐loaded Foley catheter group (RR 0.67, 95% CI 0.12 to 3.73; 66 women; <a href="./references#CD013663-fig-0038" title="">Analysis 6.4</a>). These results are unclear due to very low‐certainty evidence. </p> </section> <section id="CD013663-sec-0162"> <h6 class="title">Admission to higher level of care*</h6> <p>The number of women who were admitted to a higher level of care was 2/30 in the Bakri balloon group (2/30) and 4/28 in the condom‐loaded Foley catheter group (RR 0.47, 95% CI 0.09 to 2.35; 66 women but with five women with 'treatment failure' excluded from this data, 1 study; <a href="./references#CD013663-fig-0039" title="">Analysis 6.5</a>). Very low‐certainty evidence means we are unclear about the results for this outcome. </p> </section> <section id="CD013663-sec-0163"> <h6 class="title">Coagulopathy (as defined by trialist)</h6> <p>The number of women who developed coagulopathy (reported as 'Disseminated Intravascular Coagulopathy' or 'DIC') was 1/30 in the Bakri balloon group and 2/28 in the condom‐loaded Foley catheter group (RR 0.47, 95% CI 0.04 to 4.87; 58 women but five with 'treatment failure' excluded from this data, 1 study; <a href="./references#CD013663-fig-0036" title="">Analysis 6.2</a>). Very low‐certainty evidence means we are unclear about the results for this outcome. </p> </section> <section id="CD013663-sec-0164"> <h6 class="title">Secondary outcomes not reported by the study under this comparison</h6> <p> <ul id="CD013663-list-0024"> <li> <p>All‐cause mortality*</p> </li> <li> <p>Mortality from causes other than bleeding</p> </li> <li> <p>Shock as defined by trialist*</p> </li> <li> <p>Number of women with total blood loss 500 mL or more after randomisation*</p> </li> <li> <p>Number of women with total blood loss 1000 mL or more after randomisation*</p> </li> <li> <p>Blood product transfusion*</p> </li> <li> <p>Post‐randomisation additional uterotonic agent used to control bleeding*</p> </li> <li> <p>Post‐randomisation additional non‐surgical intervention to control bleeding (uterine packing, bimanual uterine massage, tamponade, external aortic compression and compression garments) </p> </li> <li> <p>Side effects of the intervention (e.g. trauma, necrosis)</p> </li> <li> <p>Days in hospital</p> </li> <li> <p>Breastfeeding (defined as any breastfeeding at hospital discharge)*</p> </li> <li> <p>Maternal satisfaction with therapy (trialist defined)*</p> </li> <li> <p>Quality of life, including physiological activity and social and emotional changes (sense of well‐being) (trialist defined)* </p> </li> </ul> </p> </section> </section> </section> <section id="CD013663-sec-0165"> <h4 class="title">Bakri balloon + traction stitch versus Bakri balloon without traction stitch (one intrauterine tamponade versus another intrauterine tamponade technique (comparison 7) </h4> <p>One small study (<a href="./references#CD013663-bbs2-0008" title="KhalilMI , Al-DohamiH , AldahishMM . A method to improve the effectiveness of the Bakri balloon for management of postpartum hemorrhage at cesarean. International Journal of Gynecology &amp; Obstetrics2011;115(2):198-200. ">Khalil 2011</a>) contributed data to this comparison. The study, which involved 50 women with uncontrolled primary atonic PPH following caesarean section. The study was conducted in Saudi Arabia and examined the use of a Bakri balloon held in place with a traction stitch versus Bakri balloon without traction stitch for treating primary PPH. </p> <section id="CD013663-sec-0166"> <h5 class="title">Primary outcomes</h5> <section id="CD013663-sec-0167"> <h6 class="title">Mortality due to bleeding</h6> <p>This outcome was not reported by <a href="./references#CD013663-bbs2-0008" title="KhalilMI , Al-DohamiH , AldahishMM . A method to improve the effectiveness of the Bakri balloon for management of postpartum hemorrhage at cesarean. International Journal of Gynecology &amp; Obstetrics2011;115(2):198-200. ">Khalil 2011</a>. </p> </section> <section id="CD013663-sec-0168"> <h6 class="title">Hysterectomy to control bleeding</h6> <p>We are uncertain about the results for hysterectomy to control bleeding because the evidence was very low certainty. There were 0/25 women who had hysterectomy to control bleeding in the group of women who received Bakri balloon+traction stitch and 2/25 women who had hysterectomy to control bleeding in the group who received Bakri balloon without traction stitch (RR 0.20, 95% CI 0.01 to 3.97; 50 women, 1 study; <a href="./references#CD013663-fig-0041" title="">Analysis 7.1</a>). </p> </section> <section id="CD013663-sec-0169"> <h6 class="title">Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) </h6> <p>This outcome was not reported by <a href="./references#CD013663-bbs2-0008" title="KhalilMI , Al-DohamiH , AldahishMM . A method to improve the effectiveness of the Bakri balloon for management of postpartum hemorrhage at cesarean. International Journal of Gynecology &amp; Obstetrics2011;115(2):198-200. ">Khalil 2011</a>. </p> </section> </section> <section id="CD013663-sec-0170"> <h5 class="title">Secondary outcomes</h5> <section id="CD013663-sec-0171"> <h6 class="title">Post‐randomisation additional surgical interventions used to control bleeding (arterial ligation, compressive, uterine sutures, arterial embolisation, laparotomy)* </h6> <p>The incidence of post‐randomisation additional non‐surgical interventions to control bleeding was 1/25 in the Bakri+traction stitch group, where the woman in the intervention group received uterine artery embolisation) and 3/25 in the Bakri balloon without traction stitch group, where al three women received uterine artery ligation and iliac artery ligation (RR 0.33, 95% CI 0.04 to 2.99, 50 women, 1 study; <a href="./references#CD013663-fig-0042" title="">Analysis 7.2</a>). Very low‐certainty evidence means we are unclear about the results for this outcome. </p> </section> <section id="CD013663-sec-0172"> <h6 class="title">Total blood loss &gt;/= 1000 mL before and after randomisation (outcome not prespecified in our review protocol) </h6> <p><a href="./references#CD013663-bbs2-0008" title="KhalilMI , Al-DohamiH , AldahishMM . A method to improve the effectiveness of the Bakri balloon for management of postpartum hemorrhage at cesarean. International Journal of Gynecology &amp; Obstetrics2011;115(2):198-200. ">Khalil 2011</a> reported 100% of women in both groups had a total blood loss of greater than or equal to 1000 mL (RR 1.00, 95% CI 0.93 to 1.08; 50 women, 1 study; low‐certainty evidence; <a href="./references#CD013663-fig-0043" title="">Analysis 7.3</a>). </p> </section> <section id="CD013663-sec-0173"> <h6 class="title">Secondary outcomes not reported by the study under this comparison</h6> <p>The following prespecified secondary outcomes in this review were not reported by the included study/studies under this comparison. </p> <p> <ul id="CD013663-list-0025"> <li> <p>All‐cause mortality*</p> </li> <li> <p>Mortality from causes other than bleeding</p> </li> <li> <p>Shock as defined by trialist*</p> </li> <li> <p>Coagulopathy as defined by trialist*</p> </li> <li> <p>Number of women with total blood loss 500 mL or more after randomisation*</p> </li> <li> <p>Number of women with total blood loss 1000 mL or more after randomisation*</p> </li> <li> <p>Mean blood loss (mL) (trialist defined)*</p> </li> <li> <p>Blood product transfusion*</p> </li> <li> <p>Blood transfusion (red cell or whole blood)*</p> </li> <li> <p>Post‐randomisation additional uterotonic agent used to control bleeding*</p> </li> <li> <p>Post‐randomisation additional non‐surgical intervention to control bleeding (uterine packing, bimanual uterine massage, tamponade, external aortic compression and compression garments) </p> </li> <li> <p>Admission to higher level of care*</p> </li> <li> <p>Side effects of the intervention (e.g. trauma, necrosis)</p> </li> <li> <p>Days in hospital</p> </li> <li> <p>Breastfeeding (defined as any breastfeeding at hospital discharge)*</p> </li> <li> <p>Maternal satisfaction with therapy (trialist defined)*</p> </li> <li> <p>Quality of life, including physiological activity and social and emotional changes (sense of well‐being) (trialist defined)* </p> </li> </ul> </p> </section> </section> </section> <section id="CD013663-sec-0174"> <h4 class="title">Intrauterine balloon tamponade (condom‐loaded catheter) versus uterovaginal packing (intrauterine tamponade versus another intrauterine tamponade method) (comparison 8) </h4> <p>One small study (<a href="./references#CD013663-bbs2-0001" title="AshrafN , AshrafA , KhursheedK . Efficacy and safety of intrauterine balloon tamponade versus ueterovaginal roll gauze packing in patient presenting with primary postpartum haemorrhage after normal vaginal delivery. Annals of King Edward Medical University2018;24(Special Issue):889-92. ">Ashraf 2018</a>) contributed data to this comparison. The study, which involved 212 women with uncontrolled primary PPH following vaginal birth. The study was conducted in Pakistan and examined the use of modified condom catheter balloon tamponade compared with uterovaginal packing for treating primary PPH. </p> <section id="CD013663-sec-0175"> <h5 class="title">Primary outcomes</h5> <section id="CD013663-sec-0176"> <h6 class="title">Mortality due to bleeding</h6> <p>This outcome was not reported in the included study under this comparison.</p> </section> <section id="CD013663-sec-0177"> <h6 class="title">Hysterectomy to control bleeding</h6> <p>This outcome was not reported in the included study under this comparison.</p> </section> <section id="CD013663-sec-0178"> <h6 class="title">Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) </h6> <p>This outcome was not reported in the included study under this comparison.</p> </section> </section> <section id="CD013663-sec-0179"> <h5 class="title">Secondary outcomes</h5> <section id="CD013663-sec-0180"> <h6 class="title">Mean blood loss (mL) (trialist defined)*</h6> <p>In the results section of <a href="./references#CD013663-bbs2-0001" title="AshrafN , AshrafA , KhursheedK . Efficacy and safety of intrauterine balloon tamponade versus ueterovaginal roll gauze packing in patient presenting with primary postpartum haemorrhage after normal vaginal delivery. Annals of King Edward Medical University2018;24(Special Issue):889-92. ">Ashraf 2018</a>, mean blood loss is reported as 600.28 mL (+/‐ 25.33 mL) in the condom catheter group and 699 mL (+/‐ 70.176 mL) in the intrauterine packing group. However, it is unclear whether this is pre‐ or post‐randomisation, especially as this is also presented in a table detailing participant characteristics of each group (age, parity, gestational age, and blood loss). For this reason, we have not included these data in our data and analysis tables. </p> </section> <section id="CD013663-sec-0181"> <h6 class="title">Side effects of the intervention (e.g. trauma, necrosis)</h6> <section id="CD013663-sec-0182"> <p><b>Fever</b></p> <p><a href="./references#CD013663-bbs2-0001" title="AshrafN , AshrafA , KhursheedK . Efficacy and safety of intrauterine balloon tamponade versus ueterovaginal roll gauze packing in patient presenting with primary postpartum haemorrhage after normal vaginal delivery. Annals of King Edward Medical University2018;24(Special Issue):889-92. ">Ashraf 2018</a> reported that the incidence of fever may be reduced (46/106 in the condom catheter group versus 98/106 in the intrauterine packing group) (RR 0.47, 95% CI 0.38 to 0.59, 212 women, one study, very low certainty) (<a href="./references#CD013663-fig-0044" title="">Analysis 8.1</a>), but we are uncertain about this result because the evidence was very low certainty . </p> </section> <section id="CD013663-sec-0183"> <p><b>Perforation</b></p> <p><a href="./references#CD013663-bbs2-0001" title="AshrafN , AshrafA , KhursheedK . Efficacy and safety of intrauterine balloon tamponade versus ueterovaginal roll gauze packing in patient presenting with primary postpartum haemorrhage after normal vaginal delivery. Annals of King Edward Medical University2018;24(Special Issue):889-92. ">Ashraf 2018</a> reported that 30 of the 106 women in the condom catheter group and 46 out of 106 women in the intrauterine packing group had 'perforation' but no definition or details were provided. We have not included these data in our data and analysis table. </p> </section> </section> <section id="CD013663-sec-0184"> <h6 class="title">Secondary outcomes not reported by the study under this comparison</h6> <p>The following prespecified secondary outcomes in this review were not reported by the included study/studies under this comparison. </p> <p> <ul id="CD013663-list-0026"> <li> <p>All‐cause mortality*</p> </li> <li> <p>Mortality from causes other than bleeding</p> </li> <li> <p>Shock as defined by trialist*</p> </li> <li> <p>Coagulopathy as defined by trialist*</p> </li> <li> <p>Number of women with total blood loss 500 mL or more after randomisation*</p> </li> <li> <p>Number of women with total blood loss 1000 mL or more after randomisation*</p> </li> <li> <p>Blood transfusion (red cell or whole blood)*</p> </li> <li> <p>Blood product transfusion*</p> </li> <li> <p>Post‐randomisation additional uterotonic agent used to control bleeding*</p> </li> <li> <p>Post‐randomisation additional surgical interventions used to control bleeding (arterial ligation, compressive, uterine sutures, arterial embolisation, laparotomy)* </p> </li> <li> <p>Post‐randomisation additional non‐surgical intervention to control bleeding (uterine packing, bimanual uterine massage, tamponade, external aortic compression and compression garments) </p> </li> <li> <p>Admission to higher level of care*</p> </li> <li> <p>Days in hospital</p> </li> <li> <p>Breastfeeding (defined as any breastfeeding at hospital discharge)*</p> </li> <li> <p>Maternal satisfaction with therapy (trialist defined)*</p> </li> <li> <p>Quality of life, including physiological activity and social and emotional changes (sense of well‐being) (trialist defined)* </p> </li> </ul> </p> </section> </section> </section> <section id="CD013663-sec-0185"> <h4 class="title">Modified B‐Lynch compression suture versus standard B‐Lynch compression suture (one uterine compression suture technique versus another uterine compression suture technique) (comparison 9) </h4> <p>One small study (<a href="./references#CD013663-bbs2-0005" title='El-SokkaryM , WahbaK , El-ShahawyY . Uterine salvage management for atonic postpartum hemorrhage using "modified lynch suture". BMC Pregnancy and Childbirth2016;16:251. '>El‐Sokkary 2016</a>) contributed data to this comparison. The study, which involved 160 women with uncontrolled PPH following caesarean section. The study was conducted in Egypt and examined the use of modified B‐Lynch compression sutures compared with standard B‐Lynch compression sutures for treating primary PPH. </p> <section id="CD013663-sec-0186"> <h5 class="title">Primary outcomes</h5> <section id="CD013663-sec-0187"> <h6 class="title">Mortality due to bleeding</h6> <p>This outcome was not reported in the included study under this comparison.</p> </section> <section id="CD013663-sec-0188"> <h6 class="title">Hysterectomy to control bleeding</h6> <p>There is low‐certainty evidence to suggest that one type of compression suture technique (modified B‐Lynch) may reduce the incidence of hysterectomy to control bleeding (four out of 80 women) compared to another type of compression suture technique (the classic B‐Lynch technique) (12 out of 80 women) (RR 0.33, 95% CI 0.11 to 0.99; 160 women, 1 study; low‐certainty evidence; <a href="./references#CD013663-fig-0045" title="">Analysis 9.1</a>). </p> </section> <section id="CD013663-sec-0189"> <h6 class="title">Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) </h6> <p>This outcome was not reported in the included study under this comparison.</p> </section> </section> <section id="CD013663-sec-0190"> <h5 class="title">Secondary outcomes</h5> <section id="CD013663-sec-0191"> <h6 class="title">Mean blood loss (mL) (trialist defined as postoperative blood loss)*</h6> <p>There is low‐certainty evidence to suggest that the modified B‐Lynch suture technique may be associated with a reduction in mean postoperative blood loss compared to the classic B‐Lynch technique (MD ‐244.00 mL, 95% CI ‐295.25 to ‐192.75; 160 women, 1 study; low‐certainty evidence; <a href="./references#CD013663-fig-0046" title="">Analysis 9.2</a>). </p> </section> <section id="CD013663-sec-0192"> <h6 class="title">Days in hospital</h6> <p>The length of time (days) that women spent in hospital was similar between the two types of uterine compression suturing technique (MD 0.10, 95% CI ‐0.38 to 0.58; 160 women, 1 study;low‐certainty evidence; <a href="./references#CD013663-fig-0047" title="">Analysis 9.3</a>). </p> </section> <section id="CD013663-sec-0193"> <h6 class="title">Secondary outcomes not reported by the study under this comparison</h6> <p>The following prespecified secondary outcomes in this review were not reported by the included study/studies under this comparison. </p> <p> <ul id="CD013663-list-0027"> <li> <p>All‐cause mortality*</p> </li> <li> <p>Mortality from causes other than bleeding</p> </li> <li> <p>Shock as defined by trialist*</p> </li> <li> <p>Coagulopathy as defined by trialist*</p> </li> <li> <p>Number of women with total blood loss 500 mL or more after randomisation*</p> </li> <li> <p>Number of women with total blood loss 1000 mL or more after randomisation*</p> </li> <li> <p>Blood transfusion (red cell or whole blood)*</p> </li> <li> <p>Blood product transfusion*</p> </li> <li> <p>Post‐randomisation additional uterotonic agent used to control bleeding*</p> </li> <li> <p>Post‐randomisation additional surgical interventions used to control bleeding (arterial ligation, compressive, uterine sutures, arterial embolisation, laparotomy)* </p> </li> <li> <p>Post‐randomisation additional non‐surgical intervention to control bleeding (uterine packing, bimanual uterine massage, tamponade, external aortic compression and compression garments) </p> </li> <li> <p>Admission to higher level of care*</p> </li> <li> <p>Side effects of the intervention (e.g. trauma, necrosis)</p> </li> <li> <p>Breastfeeding (defined as any breastfeeding at hospital discharge)*</p> </li> <li> <p>Maternal satisfaction with therapy (trialist defined)*</p> </li> <li> <p>Quality of life, including physiological activity and social and emotional changes (sense of well‐being) (trialist defined)* </p> </li> </ul> </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD013663-sec-0194" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD013663-sec-0194"></div> <section id="CD013663-sec-0195"> <h3 class="title" id="CD013663-sec-0195">Summary of main results</h3> <p>We identified nine trials involving a total of 944 women with primary postpartum haemorrhage (PPH) for inclusion in this review. The trials were all small (with sample sizes ranging from 13 to 240 women) and no two studies compared the same interventions meaning that no data meta‐analysis was possible. The trials studied a wide range of interventions including external uterine compression (<a href="./references#CD013663-bbs2-0002" title="ChantrapitakW , SrijanteokK , Puangsa-artS . Lower uterine segment compression for management of early postpartum hemorrhage after vaginal delivery at Charoenkrung Pracharak Hospital. Journal of the Medical Association of Thailand2009;92(5):600-5. [PMID: 19459518]">Chantrapitak 2009</a>), arterial embolisation versus stepwise surgical devascularisation (<a href="./references#CD013663-bbs2-0006" title="FaroukO , ElbasuonyW , ElbohoutyA . Uterine artery embolization versus surgical management in primary atonic postpartum hemorrhage: A randomized clinical trial. Egyptian Journal of Radiology and Nuclear Medicine2016;47(3):817-23. ">Farouk 2016</a>), Bakri balloon tamponade versus square sutures for placenta praevia (<a href="./references#CD013663-bbs2-0007" title="KavakSB , AtilganR , DemirelI , CelikE , IlhanR , SapmazE . Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa. Journal of Perinatal Medicine2013;41(6):705-9. ">Kavak 2013</a>), Bakri balloon tamponade versus condom catheter tamponade (<a href="./references#CD013663-bbs2-0003" title="DarwishAM , AbdallahMM , ShaabanOM , AliMK , KhalafM , SabraAM . Bakri balloon versus condom-loaded foley's catheter for treatment of atonic postpartum hemorrhage secondary to vaginal delivery: a randomized controlled trial. Journal of Maternal-Fetal &amp; Neonatal Medicine2018;31(6):747-53. NCT02430155. Comparison of condom-loaded foley's catheter versus bakri balloon for treatment of primary postpartum hemorrhage: a randomized controlled trial. clinicaltrials.gov/show/NCT02430155 (first received 30 April 2015). ">Darwish 2018</a>), Bakri balloon, with our without traction suture (<a href="./references#CD013663-bbs2-0008" title="KhalilMI , Al-DohamiH , AldahishMM . A method to improve the effectiveness of the Bakri balloon for management of postpartum hemorrhage at cesarean. International Journal of Gynecology &amp; Obstetrics2011;115(2):198-200. ">Khalil 2011</a>), condom‐loaded catheter tamponade versus uterovaginal packing (<a href="./references#CD013663-bbs2-0001" title="AshrafN , AshrafA , KhursheedK . Efficacy and safety of intrauterine balloon tamponade versus ueterovaginal roll gauze packing in patient presenting with primary postpartum haemorrhage after normal vaginal delivery. Annals of King Edward Medical University2018;24(Special Issue):889-92. ">Ashraf 2018</a>), latex air‐inflated balloon tamponade plus cerclage versus normal care (<a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a>), two types of B‐Lynch suture (<a href="./references#CD013663-bbs2-0005" title='El-SokkaryM , WahbaK , El-ShahawyY . Uterine salvage management for atonic postpartum hemorrhage using "modified lynch suture". BMC Pregnancy and Childbirth2016;16:251. '>El‐Sokkary 2016</a>), and the use of a condom‐loaded Foley catheter versus normal care (<a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a>). There are currently six ongoing studies; the results of these studies will be added to this review in future updates.<br/><br/>It is difficult to draw any definitive conclusions. Most of the included studies had small sample sizes and substantial differences between studies meant it was not possible to combine any trials in meta‐analysis. GRADE assessments ranged from very low to low certainty, with the majority of results rated as very low certainty. Downgrading decisions were mainly based on study design limitations and imprecision. This means that we cannot be confident about the main findings. However, in the randomised trial by <a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a>, use of the condom catheter for intrauterine tamponade in health centres in Mali and Benin was associated with increased blood loss (very low‐certainty evidence). In the <a href="./references#CD013663-bbs2-0007" title="KavakSB , AtilganR , DemirelI , CelikE , IlhanR , SapmazE . Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa. Journal of Perinatal Medicine2013;41(6):705-9. ">Kavak 2013</a> study, those treated with the Bakri balloon had lower mean blood losses both during and after surgery than those who had uterine square sutures, and in the <a href="./references#CD013663-bbs2-0001" title="AshrafN , AshrafA , KhursheedK . Efficacy and safety of intrauterine balloon tamponade versus ueterovaginal roll gauze packing in patient presenting with primary postpartum haemorrhage after normal vaginal delivery. Annals of King Edward Medical University2018;24(Special Issue):889-92. ">Ashraf 2018</a> study the condom catheter resulted in less postpartum fever than uterine packing with gauze (very low‐certainty evidence). Finally, in the <a href="./references#CD013663-bbs2-0005" title='El-SokkaryM , WahbaK , El-ShahawyY . Uterine salvage management for atonic postpartum hemorrhage using "modified lynch suture". BMC Pregnancy and Childbirth2016;16:251. '>El‐Sokkary 2016</a> study, women treated with a modified B‐Lynch suture (where the B‐Lynch suture is crossed, and then also wrapped around the proximal end of the uterus to close off the uterine arteries) required fewer hysterectomies to control the bleeding and had a lower mean blood loss than those with the standard suture (low‐certainty evidence). </p> </section> <section id="CD013663-sec-0196"> <h3 class="title" id="CD013663-sec-0196">Overall completeness and applicability of evidence</h3> <p>The nine studies included in this review are of insufficient size and/or quality to have a major effect on clinical practice. Most are small, and conducted by those who have invented a new technique, making them prone to bias. Furthermore, with only one study of each technique, none of the trial results have been replicated and so the results must all be treated with caution. Additionally, the use of non‐standardised outcomes in the trials also makes it difficult to compare studies. The scattergun nature of the studies reflects the overall lack of a co‐ordinated research strategy in this area. It is to be hoped that as the global postpartum haemorrhage focus moves away from uterotonics and towards quality of care, more high‐quality studies will be forthcoming. </p> <p>The lack of data is not surprising as randomised trials of both surgical techniques and devices are uncommon generally, and especially for emergency situations where the rarity and urgency of the situation make it logistically very difficult to conduct high‐quality research. It is especially complex to obtain informed consent. Recently, however, emergency intrapartum studies have started using emergency consent procedures (<a href="./references#CD013663-bbs2-0052" title="The carboprost or oxytocin postpartum haemorrhage effectiveness study. https://doi.org/10.1186/ISRCTN16416766.">COPE 2019</a>; <a href="./references#CD013663-bbs2-0053" title="DuleyL , DorlingJ , Pushpa-RajahA , OddieSJ , YoxallCW , SchoonakkerB , et al. Randomised trial of cord clamping and initial stabilisation at very preterm birth. Archives of Disease in Childhood. Fetal and Neonatal Edition2018;103(1):F6-F14.">CORD 2018</a>; <a href="./references#CD013663-bbs2-0115" title="WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet2017;389(10084):2105-16. [DOI: 10.1016/S0140-6736(17)30638-4]">WOMAN 2017</a>) meaning that an abbreviated, short oral or no consent is required before study entry. This should expand greatly the number of high‐quality randomised controlled trials conducted in this area.<br/><br/>There is evidence from the studies reviewed here that will help to direct clinical care. First, the small study by <a href="./references#CD013663-bbs2-0007" title="KavakSB , AtilganR , DemirelI , CelikE , IlhanR , SapmazE . Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa. Journal of Perinatal Medicine2013;41(6):705-9. ">Kavak 2013</a> suggests that use of the Bakri intrauterine balloon tamponade could be more effective than haemostatic square sutures for those with bleeding placenta praevia. Both the intrauterine balloon tamponade and external uterine square sutures were originally designed to treat the atonic uterus rather than placenta praevia. In placenta praevia, the bleeding vessels arise from the lower segment and can been accessed directly at the time of caesarean section. The tendency has therefore been for clinicians to use surgical sutures to compress the bleeding vessels, rather than the more complex act of placing a balloon vaginally during the caesarean section, inflating it within the lower segment and closing the uterus without bursting or trapping the balloon. Whilst the study was too small to assess the risk of uterine scar breakdown due to balloon pressure, it is encouraging that the authors found it effective and usable in practice. </p> <p>For those with a true atonic uterus at caesarean section, the study by <a href="./references#CD013663-bbs2-0005" title='El-SokkaryM , WahbaK , El-ShahawyY . Uterine salvage management for atonic postpartum hemorrhage using "modified lynch suture". BMC Pregnancy and Childbirth2016;16:251. '>El‐Sokkary 2016</a> suggests that there may be benefits to using a modification of the B‐Lynch suture in which (a) the sutures are crossed from left to right and vice versa as they cross the fundus, and (b) at the end of the procedure, the ends of the suture are passed back through the broad ligament bilaterally, around the back of the uterus before being tied anteriorly so as to obliterate the uterine arteries. Whilst this provides only low‐certainty evidence from a single‐centre study, it does provide an intriguing alternative for care and deserves to be tested in a further randomised trial.<br/><br/>Finally, the <a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a> study provides surprising evidence that the use of a condom catheter might not improve care in low‐ and middle‐income countries (LMICs) settings in comparison to normal care – indeed the study found more blood loss in the condom group. The results are very much at odds with the clinical experience of most clinicians and implementation studies where the roll‐out of condom catheters has been associated with impressive improvements in severe PPH outcomes (<a href="./references#CD013663-bbs2-0045" title="BurkeTF , AhnR , NelsonBD , HinesR , KamaraJ , OguttuM , et al. A postpartum haemorrhage package with condom uterine balloon tamponade: a prospective multi-centre case series in Kenya, Sierra Leone, Senegal, and Nepal. BJOG: an international journal of obstetrics and gynaecology2016;123(9):1532-40.">Burke 2016</a>). The reasons for this discrepancy are not clear. It may be that the condom catheter produces insufficient intrauterine pressure (<a href="./references#CD013663-bbs2-0040" title="AntonyKM , RacusinDA , BelfortMA , Dildy GA 3rd. Under pressure: intraluminal filling pressures of postpartum hemorrhage tamponade balloons. AJP Reports2017;7(2):e86-e92.">Antony 2017</a>), or that the time taken to set up the catheter delays care as it allows ongoing blood loss. The increased blood loss could also have been caused by the requirement to manually explore the uterus prior to insertion, or by delays meaning that clotting disorders had already commenced. However, a step‐wedge cluster‐randomised trial which was not eligible to be included in this review (<a href="./references#CD013663-bbs2-0010" title="NCT02910310. Introduction of a uterine balloon tamponade for postpartum hemorrhage in three low income countries: a stepped wedge cluster randomized trial. clinicaltrials.gov/show/NCT02910310 (first received 22 September 2016). ">Anger 2016</a>) supports the findings of <a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a>. Further studies are now planned to determine whether it is the setting or the balloon type that is at fault. </p> </section> <section id="CD013663-sec-0197"> <h3 class="title" id="CD013663-sec-0197">Quality of the evidence</h3> <p>Overall, the trials were of a mixed methodological quality (risk of bias). Whilst most of the trials (7/9) used adequate methods of sequence generation, nearly all trials (6/9) were unclear in terms of allocation concealment. All of the trials (9/9) were at a high risk of performance bias and detection bias was unclear in 7/9 trials and high risk in the remaining 2/9 trials. Attrition bias was suspected in two trials (<a href="./references#CD013663-bbs2-0002" title="ChantrapitakW , SrijanteokK , Puangsa-artS . Lower uterine segment compression for management of early postpartum hemorrhage after vaginal delivery at Charoenkrung Pracharak Hospital. Journal of the Medical Association of Thailand2009;92(5):600-5. [PMID: 19459518]">Chantrapitak 2009</a>; <a href="./references#CD013663-bbs2-0003" title="DarwishAM , AbdallahMM , ShaabanOM , AliMK , KhalafM , SabraAM . Bakri balloon versus condom-loaded foley's catheter for treatment of atonic postpartum hemorrhage secondary to vaginal delivery: a randomized controlled trial. Journal of Maternal-Fetal &amp; Neonatal Medicine2018;31(6):747-53. NCT02430155. Comparison of condom-loaded foley's catheter versus bakri balloon for treatment of primary postpartum hemorrhage: a randomized controlled trial. clinicaltrials.gov/show/NCT02430155 (first received 30 April 2015). ">Darwish 2018</a>), unclear in one trial (<a href="./references#CD013663-bbs2-0005" title='El-SokkaryM , WahbaK , El-ShahawyY . Uterine salvage management for atonic postpartum hemorrhage using "modified lynch suture". BMC Pregnancy and Childbirth2016;16:251. '>El‐Sokkary 2016</a>) and low risk in the remaining six trials. Reporting bias was low risk in one trial, unclear in seven trials, and high risk in one trial (<a href="./references#CD013663-bbs2-0001" title="AshrafN , AshrafA , KhursheedK . Efficacy and safety of intrauterine balloon tamponade versus ueterovaginal roll gauze packing in patient presenting with primary postpartum haemorrhage after normal vaginal delivery. Annals of King Edward Medical University2018;24(Special Issue):889-92. ">Ashraf 2018</a>). No sources of other bias was identified in the majority of trials (6/9), with one trial at unclear risk of other bias and two trials assessed as being high risk of other bias (<a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a>; <a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a>).<br/><br/>Our GRADE assessments of the certainty of the evidence ranged from very low to low, with the majority of outcomes rated as very low quality. Downgrading decisions were based on study limitations, and imprecision (small sample sizes, few or zero events, wide confidence intervals crossing the line of no effect). For one study (<a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a>), outcomes were also downgraded for indirectness. </p> </section> <section id="CD013663-sec-0198"> <h3 class="title" id="CD013663-sec-0198">Potential biases in the review process</h3> <p>The strength of this review is that it only contains randomised trials. This is particularly important in studies of postpartum haemorrhage as spontaneous resolution of bleeding is very common. Thus, observational studies almost always show very high success rates, and it is not until the publication of randomised trials that the true efficacy is revealed. This was seen in the randomised trials of misoprostol for PPH treatment (<a href="./references#CD013663-bbs2-0057" title="GellerSE , AdamsMG , KellyPJ , KodkanyBS , DermanRJ . Postpartum hemorrhage in resource-poor settings. International Journal of Gynaecology and Obstetrics2006;92(3):202-11.">Geller 2006</a>; <a href="./references#CD013663-bbs2-0087" title="MousaHA , BlumJ , Abou El SenounG , ShakurH , AlfirevicZ . Treatment for primary postpartum haemorrhage. Cochrane Database of Systematic Reviews2014, Issue 2. [DOI: 10.1002/14651858.CD003249.pub3]">Mousa 2014c</a>), and is suggested in the contrast between the cohort studies of intrauterine balloon tamponade (<a href="./references#CD013663-bbs2-0107" title="TindellK , GarfinkelR , Abu-HaydarE , AhnR , BurkeTF , ConnK , et al. Uterine balloon tamponade for the treatment of postpartum haemorrhage in resource-poor settings: a systematic review. BJOG: an international journal of obstetrics and gynaecology2013;120(1):5-14.">Tindell 2013</a>) and those found in the <a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a> study. The presence of randomised trials in this difficult area (and the future ones in progress) are therefore very much welcomed.<br/>This review also has weaknesses. Whilst the review processes were robust and according to current Cochrane methodology, the study reports did not always provide the full dataset required, and not all authors responded to requests for further data. The review authors have therefore had to make some assumptions about the studies' methodologies (e.g. unclear ratings for 'Risk of bias' assessments when no information was provided). </p> </section> <section id="CD013663-sec-0199"> <h3 class="title" id="CD013663-sec-0199">Agreements and disagreements with other studies or reviews</h3> <p>To our knowledge, there are no systematic reviews of randomised trials of balloon tamponade. <a href="./references#CD013663-bbs2-0107" title="TindellK , GarfinkelR , Abu-HaydarE , AhnR , BurkeTF , ConnK , et al. Uterine balloon tamponade for the treatment of postpartum haemorrhage in resource-poor settings: a systematic review. BJOG: an international journal of obstetrics and gynaecology2013;120(1):5-14.">Tindell 2013</a>, however, reviewed the evidence from case series and cohort studies and found a 96% success rate with the condom catheter in LMICs. This contrasts greatly with the findings from the <a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a> study as discussed above. However, a large step‐wedged, cluster‐randomised trial of condom‐balloon tamponade versus normal care was conducted by <a href="./references#CD013663-bbs2-0010" title="NCT02910310. Introduction of a uterine balloon tamponade for postpartum hemorrhage in three low income countries: a stepped wedge cluster randomized trial. clinicaltrials.gov/show/NCT02910310 (first received 22 September 2016). ">Anger 2016</a>. In this study, all women in the participating health units were included, irrespective of whether they had PPH or not. This meant that it did not meet the inclusion criteria for the review. It does, however, provide strong evidence that supports the surprising findings of <a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a>, the only other randomised trial of condom‐balloon tamponade. In the <a href="./references#CD013663-bbs2-0010" title="NCT02910310. Introduction of a uterine balloon tamponade for postpartum hemorrhage in three low income countries: a stepped wedge cluster randomized trial. clinicaltrials.gov/show/NCT02910310 (first received 22 September 2016). ">Anger 2016</a> study, the technique was introduced in a randomised fashion into 18 secondary‐level hospitals over 18 months. After the introduction, there was a significant increase in the incidence of the composite outcome of 'PPH surgery or maternal death' from 6.7 to 11.6 per 10,000 births, an adjusted incidence ratio of 4.08 (95% confidence interval 1.07 to 15.58). The results are unlikely to be due to the failure of the technique as most deaths occurred in women in whom it was not used, but it does emphasise that PPH is a multi‐system problem and that the condom catheter it not enough to reduce maternal deaths from PPH on its own (<a href="./references#CD013663-bbs2-0111" title="WeeksAD . Does balloon tamponade really make postpartum haemorrhage worse?BJOG2019;126:1622. [DOI: 10.1111/1471-0528.15948]">Weeks 2019</a>). <br/><br/><a href="./references#CD013663-bbs2-0101" title="ShahinY , PangCL . Endovascular interventional modalities for haemorrhage control in abnormal placental implantation deliveries: a systematic review and meta-analysis. European Radiology2018;28(7):2713-26.">Shahin 2018</a> conducted a systematic review of endovascular interventional modalities for haemorrhage control in abnormal placentation deliveries. They included cohort and case series in their review and most of the studies placed the devices prophylactically prior to surgery in case of bleeding at the time of surgery. They found that the highest success rate was with prophylactic balloon occlusion of the abdominal aorta. These findings were echoed by the findings of the systematic review of <a href="./references#CD013663-bbs2-0078" title="Manzano-NunezR , Escobar-VidarteMF , NaranjoMP , RodriguezF , FerradaP , CasallasJD , et al. Expanding the field of acute care surgery: a systematic review of the use of resuscitative endovascular balloon occlusion of the aorta (REBOA) in cases of morbidly adherent placenta. European Journal of Trauma and Emergency Surgery2018;44(4):519-26.">Manzando‐Nunez 2018</a> who also found the endovascular balloon occlusion of the aorta to be highly effective. This method was not however addressed by any of the studies in this review.<br/><br/><a href="./references#CD013663-bbs2-0104" title="SoroMP , DenysA , deRhamM , BaudD . Short &amp; long term adverse outcomes after arterial embolisation for the treatment of postpartum haemorrhage: a systematic review. European Radiology2017;27(2):749-62.">Soro 2017</a> conducted a systematic review of outcomes following arterial embolisation for PPH treatment. They found high success rates, and no effect on future menstrual cycle, or fertility. There was, however higher rates than expected of abnormal placentation in future pregnancies. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD013663-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD013663-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/full#CD013663-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-FIG-02" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD013663-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/full#CD013663-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-FIG-03" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD013663-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/full#CD013663-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: External lower uterine compression versus normal care, Outcome 1: Blood transfusion (red cell or whole blood)" data-id="CD013663-fig-0004" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: External lower uterine compression versus normal care, Outcome 1: Blood transfusion (red cell or whole blood) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: External lower uterine compression versus normal care, Outcome 2: Post‐randomisation additional uterotonic agent used to control bleeding" data-id="CD013663-fig-0005" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: External lower uterine compression versus normal care, Outcome 2: Post‐randomisation additional uterotonic agent used to control bleeding </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Uterine arterial embolisation versus surgical devascularisation plus B‐Lynch (one uterine devascularisation technique versus another uterine devascularisation technique), Outcome 1: Hysterectomy to control bleeding" data-id="CD013663-fig-0006" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Uterine arterial embolisation versus surgical devascularisation plus B‐Lynch (one uterine devascularisation technique versus another uterine devascularisation technique), Outcome 1: Hysterectomy to control bleeding </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Uterine arterial embolisation versus surgical devascularisation plus B‐Lynch (one uterine devascularisation technique versus another uterine devascularisation technique), Outcome 2: Side effects of the intervention (e.g. trauma, necrosis)" data-id="CD013663-fig-0007" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Uterine arterial embolisation versus surgical devascularisation plus B‐Lynch (one uterine devascularisation technique versus another uterine devascularisation technique), Outcome 2: Side effects of the intervention (e.g. trauma, necrosis) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Intrauterine balloon tamponade plus normal care (misoprostol) versus normal care (misoprostol), Outcome 1: Mortality due to bleeding" data-id="CD013663-fig-0008" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Intrauterine balloon tamponade plus normal care (misoprostol) versus normal care (misoprostol), Outcome 1: Mortality due to bleeding </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Intrauterine balloon tamponade plus normal care (misoprostol) versus normal care (misoprostol), Outcome 2: Hysterectomy to control bleeding" data-id="CD013663-fig-0009" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Intrauterine balloon tamponade plus normal care (misoprostol) versus normal care (misoprostol), Outcome 2: Hysterectomy to control bleeding </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Intrauterine balloon tamponade plus normal care (misoprostol) versus normal care (misoprostol), Outcome 3: All cause mortality" data-id="CD013663-fig-0010" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: Intrauterine balloon tamponade plus normal care (misoprostol) versus normal care (misoprostol), Outcome 3: All cause mortality </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Intrauterine balloon tamponade plus normal care (misoprostol) versus normal care (misoprostol), Outcome 4: Mortality from causes other than bleeding" data-id="CD013663-fig-0011" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: Intrauterine balloon tamponade plus normal care (misoprostol) versus normal care (misoprostol), Outcome 4: Mortality from causes other than bleeding </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-003.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Intrauterine balloon tamponade plus normal care (misoprostol) versus normal care (misoprostol), Outcome 5: Number of women with total blood loss 1000 mL or more after randomisation" data-id="CD013663-fig-0012" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-003.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-003.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3: Intrauterine balloon tamponade plus normal care (misoprostol) versus normal care (misoprostol), Outcome 5: Number of women with total blood loss 1000 mL or more after randomisation </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-003.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-003.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Intrauterine balloon tamponade plus normal care (misoprostol) versus normal care (misoprostol), Outcome 6: Blood transfusion (red cell or whole blood)" data-id="CD013663-fig-0013" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-003.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-003.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3: Intrauterine balloon tamponade plus normal care (misoprostol) versus normal care (misoprostol), Outcome 6: Blood transfusion (red cell or whole blood) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-003.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-003.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Intrauterine balloon tamponade plus normal care (misoprostol) versus normal care (misoprostol), Outcome 7: Post‐randomisation additional surgical interventions used to control bleeding (arterial ligation, compressive, uterine sutures, arterial embolisation, laparotomy)" data-id="CD013663-fig-0014" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-003.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-003.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3: Intrauterine balloon tamponade plus normal care (misoprostol) versus normal care (misoprostol), Outcome 7: Post‐randomisation additional surgical interventions used to control bleeding (arterial ligation, compressive, uterine sutures, arterial embolisation, laparotomy) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-003.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-003.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Intrauterine balloon tamponade plus normal care (misoprostol) versus normal care (misoprostol), Outcome 8: Admission to higher level of care" data-id="CD013663-fig-0015" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-003.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-003.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3: Intrauterine balloon tamponade plus normal care (misoprostol) versus normal care (misoprostol), Outcome 8: Admission to higher level of care </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-003.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-003.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Intrauterine balloon tamponade plus normal care (misoprostol) versus normal care (misoprostol), Outcome 9: Side effects of the intervention (e.g. trauma, necrosis)" data-id="CD013663-fig-0016" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-003.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-003.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3: Intrauterine balloon tamponade plus normal care (misoprostol) versus normal care (misoprostol), Outcome 9: Side effects of the intervention (e.g. trauma, necrosis) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-003.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Latex balloon (air filled) tamponade + stitch and normal care versus normal care (Intrauterine tamponade versus normal care), Outcome 1: Mortality due to bleeding" data-id="CD013663-fig-0017" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: Latex balloon (air filled) tamponade + stitch and normal care versus normal care (Intrauterine tamponade versus normal care), Outcome 1: Mortality due to bleeding </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-004.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Latex balloon (air filled) tamponade + stitch and normal care versus normal care (Intrauterine tamponade versus normal care), Outcome 2: Hysterectomy to control bleeding" data-id="CD013663-fig-0018" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-004.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-004.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4: Latex balloon (air filled) tamponade + stitch and normal care versus normal care (Intrauterine tamponade versus normal care), Outcome 2: Hysterectomy to control bleeding </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-004.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-004.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Latex balloon (air filled) tamponade + stitch and normal care versus normal care (Intrauterine tamponade versus normal care), Outcome 3: All‐case mortality" data-id="CD013663-fig-0019" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-004.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-004.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4: Latex balloon (air filled) tamponade + stitch and normal care versus normal care (Intrauterine tamponade versus normal care), Outcome 3: All‐case mortality </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-004.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-004.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Latex balloon (air filled) tamponade + stitch and normal care versus normal care (Intrauterine tamponade versus normal care), Outcome 4: Mortality from causes other than bleeding" data-id="CD013663-fig-0020" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-004.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-004.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4: Latex balloon (air filled) tamponade + stitch and normal care versus normal care (Intrauterine tamponade versus normal care), Outcome 4: Mortality from causes other than bleeding </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-004.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-004.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Latex balloon (air filled) tamponade + stitch and normal care versus normal care (Intrauterine tamponade versus normal care), Outcome 5: Days in hospital" data-id="CD013663-fig-0021" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-004.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-004.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4: Latex balloon (air filled) tamponade + stitch and normal care versus normal care (Intrauterine tamponade versus normal care), Outcome 5: Days in hospital </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-004.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-004.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Latex balloon (air filled) tamponade + stitch and normal care versus normal care (Intrauterine tamponade versus normal care), Outcome 6: Post‐randomisation additional surgical interventions used to control bleeding" data-id="CD013663-fig-0022" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-004.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-004.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4: Latex balloon (air filled) tamponade + stitch and normal care versus normal care (Intrauterine tamponade versus normal care), Outcome 6: Post‐randomisation additional surgical interventions used to control bleeding </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-004.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-004.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Latex balloon (air filled) tamponade + stitch and normal care versus normal care (Intrauterine tamponade versus normal care), Outcome 7: Post‐randomisation additional non‐surgical interventions used to control bleeding" data-id="CD013663-fig-0023" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-004.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-004.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4: Latex balloon (air filled) tamponade + stitch and normal care versus normal care (Intrauterine tamponade versus normal care), Outcome 7: Post‐randomisation additional non‐surgical interventions used to control bleeding </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-004.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-004.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Latex balloon (air filled) tamponade + stitch and normal care versus normal care (Intrauterine tamponade versus normal care), Outcome 8: Side effects of the intervention (e.g. trauma, necrosis)" data-id="CD013663-fig-0024" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-004.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-004.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4: Latex balloon (air filled) tamponade + stitch and normal care versus normal care (Intrauterine tamponade versus normal care), Outcome 8: Side effects of the intervention (e.g. trauma, necrosis) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-004.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-005.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (Intrauterine tamponade versus another mechanical/surgical method), Outcome 1: Mortality due to bleeding" data-id="CD013663-fig-0025" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-005.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-005.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5: Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (Intrauterine tamponade versus another mechanical/surgical method), Outcome 1: Mortality due to bleeding </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-005.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-005.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (Intrauterine tamponade versus another mechanical/surgical method), Outcome 2: Hysterectomy to control bleeding" data-id="CD013663-fig-0026" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-005.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-005.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5: Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (Intrauterine tamponade versus another mechanical/surgical method), Outcome 2: Hysterectomy to control bleeding </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-005.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-005.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (Intrauterine tamponade versus another mechanical/surgical method), Outcome 3: Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure)" data-id="CD013663-fig-0027" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-005.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-005.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5: Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (Intrauterine tamponade versus another mechanical/surgical method), Outcome 3: Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-005.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-005.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (Intrauterine tamponade versus another mechanical/surgical method), Outcome 4: All cause mortality" data-id="CD013663-fig-0028" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-005.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-005.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5: Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (Intrauterine tamponade versus another mechanical/surgical method), Outcome 4: All cause mortality </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-005.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-005.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (Intrauterine tamponade versus another mechanical/surgical method), Outcome 5: Mortality from causes other than bleeding" data-id="CD013663-fig-0029" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-005.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-005.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5: Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (Intrauterine tamponade versus another mechanical/surgical method), Outcome 5: Mortality from causes other than bleeding </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-005.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-005.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (Intrauterine tamponade versus another mechanical/surgical method), Outcome 6: Mean blood loss (mL) (trialist defined)" data-id="CD013663-fig-0030" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-005.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-005.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5: Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (Intrauterine tamponade versus another mechanical/surgical method), Outcome 6: Mean blood loss (mL) (trialist defined) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-005.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-005.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (Intrauterine tamponade versus another mechanical/surgical method), Outcome 7: Blood transfusion (red cell or whole blood)" data-id="CD013663-fig-0031" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-005.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-005.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5: Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (Intrauterine tamponade versus another mechanical/surgical method), Outcome 7: Blood transfusion (red cell or whole blood) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-005.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-005.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (Intrauterine tamponade versus another mechanical/surgical method), Outcome 8: Post‐randomisation additional surgical interventions used to control bleeding (arterial ligation, compressive, uterine sutures, arterial embolisation, laparotomy)" data-id="CD013663-fig-0032" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-005.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-005.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.8</div> <div class="figure-caption"> <p>Comparison 5: Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (Intrauterine tamponade versus another mechanical/surgical method), Outcome 8: Post‐randomisation additional surgical interventions used to control bleeding (arterial ligation, compressive, uterine sutures, arterial embolisation, laparotomy) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-005.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-005.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (Intrauterine tamponade versus another mechanical/surgical method), Outcome 9: Side effects of the intervention (e.g. trauma, necrosis)" data-id="CD013663-fig-0033" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-005.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-005.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.9</div> <div class="figure-caption"> <p>Comparison 5: Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (Intrauterine tamponade versus another mechanical/surgical method), Outcome 9: Side effects of the intervention (e.g. trauma, necrosis) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-005.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-005.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (Intrauterine tamponade versus another mechanical/surgical method), Outcome 10: Postnatal blood loss (not pre‐specified)" data-id="CD013663-fig-0034" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-005.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-005.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.10</div> <div class="figure-caption"> <p>Comparison 5: Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (Intrauterine tamponade versus another mechanical/surgical method), Outcome 10: Postnatal blood loss (not pre‐specified) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-005.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-006.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Bakri balloon tamponade versus condom‐loaded Foley catheter (one intrauterine tamponade technique versus another intrauterine tamponade technique), Outcome 1: Hysterectomy to control bleeding" data-id="CD013663-fig-0035" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-006.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-006.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6: Bakri balloon tamponade versus condom‐loaded Foley catheter (one intrauterine tamponade technique versus another intrauterine tamponade technique), Outcome 1: Hysterectomy to control bleeding </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-006.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-006.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Bakri balloon tamponade versus condom‐loaded Foley catheter (one intrauterine tamponade technique versus another intrauterine tamponade technique), Outcome 2: Coagulopathy as defined by trialist" data-id="CD013663-fig-0036" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-006.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-006.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6: Bakri balloon tamponade versus condom‐loaded Foley catheter (one intrauterine tamponade technique versus another intrauterine tamponade technique), Outcome 2: Coagulopathy as defined by trialist </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-006.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-006.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Bakri balloon tamponade versus condom‐loaded Foley catheter (one intrauterine tamponade technique versus another intrauterine tamponade technique), Outcome 3: Blood transfusion (red cell or whole blood)" data-id="CD013663-fig-0037" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-006.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-006.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6: Bakri balloon tamponade versus condom‐loaded Foley catheter (one intrauterine tamponade technique versus another intrauterine tamponade technique), Outcome 3: Blood transfusion (red cell or whole blood) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-006.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-006.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Bakri balloon tamponade versus condom‐loaded Foley catheter (one intrauterine tamponade technique versus another intrauterine tamponade technique), Outcome 4: Post‐randomisation additional surgical interventions used to control bleeding (arterial ligation, compressive, uterine sutures, arterial embolisation, laparotomy)" data-id="CD013663-fig-0038" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-006.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-006.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6: Bakri balloon tamponade versus condom‐loaded Foley catheter (one intrauterine tamponade technique versus another intrauterine tamponade technique), Outcome 4: Post‐randomisation additional surgical interventions used to control bleeding (arterial ligation, compressive, uterine sutures, arterial embolisation, laparotomy) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-006.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-006.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Bakri balloon tamponade versus condom‐loaded Foley catheter (one intrauterine tamponade technique versus another intrauterine tamponade technique), Outcome 5: Admission to higher level of care" data-id="CD013663-fig-0039" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-006.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-006.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6: Bakri balloon tamponade versus condom‐loaded Foley catheter (one intrauterine tamponade technique versus another intrauterine tamponade technique), Outcome 5: Admission to higher level of care </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-006.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-006.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Bakri balloon tamponade versus condom‐loaded Foley catheter (one intrauterine tamponade technique versus another intrauterine tamponade technique), Outcome 6: Side effects of the intervention" data-id="CD013663-fig-0040" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-006.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-006.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6: Bakri balloon tamponade versus condom‐loaded Foley catheter (one intrauterine tamponade technique versus another intrauterine tamponade technique), Outcome 6: Side effects of the intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-006.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-007.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Bakri balloon + stitch versus Bakri balloon without stitch (one intrauterine tamponade versus another intrauterine tamponade technique), Outcome 1: Hysterectomy to control bleeding" data-id="CD013663-fig-0041" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-007.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-007.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7: Bakri balloon + stitch versus Bakri balloon without stitch (one intrauterine tamponade versus another intrauterine tamponade technique), Outcome 1: Hysterectomy to control bleeding </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-007.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-007.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Bakri balloon + stitch versus Bakri balloon without stitch (one intrauterine tamponade versus another intrauterine tamponade technique), Outcome 2: Post‐randomisation additional surgical interventions used to control bleeding (arterial ligation, compressive, uterine sutures, arterial embolisation, laparotomy)" data-id="CD013663-fig-0042" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-007.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-007.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7: Bakri balloon + stitch versus Bakri balloon without stitch (one intrauterine tamponade versus another intrauterine tamponade technique), Outcome 2: Post‐randomisation additional surgical interventions used to control bleeding (arterial ligation, compressive, uterine sutures, arterial embolisation, laparotomy) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-007.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-007.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Bakri balloon + stitch versus Bakri balloon without stitch (one intrauterine tamponade versus another intrauterine tamponade technique), Outcome 3: Total blood loss &gt;= 1000 mL (before and after randomisation, not pre‐specified)" data-id="CD013663-fig-0043" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-007.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-007.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7: Bakri balloon + stitch versus Bakri balloon without stitch (one intrauterine tamponade versus another intrauterine tamponade technique), Outcome 3: Total blood loss &gt;= 1000 mL (before and after randomisation, not pre‐specified) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-007.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-008.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Intrauterine balloon tamponade (condom catheter) versus uterovaginal packing (Intrauterine tamponade versus another mechanical/surgical method), Outcome 1: Side effects of the intervention" data-id="CD013663-fig-0044" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-008.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-008.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8: Intrauterine balloon tamponade (condom catheter) versus uterovaginal packing (Intrauterine tamponade versus another mechanical/surgical method), Outcome 1: Side effects of the intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-008.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-009.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Modified B‐Lynch compression suture versus standard B‐Lynch compression suture (one uterine compression suture technique versus another uterine compression suture technique), Outcome 1: Hysterectomy to control bleeding" data-id="CD013663-fig-0045" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-009.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-009.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9: Modified B‐Lynch compression suture versus standard B‐Lynch compression suture (one uterine compression suture technique versus another uterine compression suture technique), Outcome 1: Hysterectomy to control bleeding </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-009.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-009.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Modified B‐Lynch compression suture versus standard B‐Lynch compression suture (one uterine compression suture technique versus another uterine compression suture technique), Outcome 2: Mean blood loss (mL) (trialist defined)" data-id="CD013663-fig-0046" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-009.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-009.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9: Modified B‐Lynch compression suture versus standard B‐Lynch compression suture (one uterine compression suture technique versus another uterine compression suture technique), Outcome 2: Mean blood loss (mL) (trialist defined) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-009.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013663-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/urn:x-wiley:14651858:media:CD013663:CD013663-CMP-009.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Modified B‐Lynch compression suture versus standard B‐Lynch compression suture (one uterine compression suture technique versus another uterine compression suture technique), Outcome 3: Days in hospital" data-id="CD013663-fig-0047" src="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-009.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_t/tCD013663-CMP-009.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9: Modified B‐Lynch compression suture versus standard B‐Lynch compression suture (one uterine compression suture technique versus another uterine compression suture technique), Outcome 3: Days in hospital </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013663/media/CDSR/CD013663/image_n/nCD013663-CMP-009.03.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD013663-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">External uterine compression (all methods) plus normal care compared to normal care for treating primary postpartum haemorrhage</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>External uterine compression (all methods) compared to normal care for treating primary postpartum haemorrhage</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women diagnosed with primary PPH following vaginal birth. PPH was defined as quote: "blood loss &gt; 500mL after delivery" p 601<br/><b>Setting:</b> hospital setting in Bangkok, Thailand (<a href="./references#CD013663-bbs2-0002" title="ChantrapitakW , SrijanteokK , Puangsa-artS . Lower uterine segment compression for management of early postpartum hemorrhage after vaginal delivery at Charoenkrung Pracharak Hospital. Journal of the Medical Association of Thailand2009;92(5):600-5. [PMID: 19459518]">Chantrapitak 2009</a>)<br/><b>Intervention:</b> external lower uterine compression (either by grasping the uterus through a lax abdominal wall or compressing the uterus against the sacrum and lower vertebrae) for a duration of 10 minutes (plus standard care)<br/><b>Comparison:</b> normal care alone ‐ consisting of "massage, oxytocin (10‐20 units in 1,000 ml of intravenous solution, 200 ml/min), intravenous ergometrine (Methergin<sup>®</sup>, 0.2 mg), placed cold pack on uterus, and urinary catheterisation" p 601. </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with normal care</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with external uterine compression (all methods)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mortality due to bleeding ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hysterectomy to control bleeding ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) ‐ not reported </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of women with total blood loss 1000 mL or more after randomisation ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean blood loss (mL) (trialist defined)</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Blood transfusion (red cell or whole blood)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.33<br/>(0.66 to 8.23) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>64<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>94 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>218 per 1000<br/>(62 to 772) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Side effects of the intervention (e.g. trauma, necrosis) ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded (1) level for serious limitations in study design (risk of bias) </p> <p><sup>2</sup> We downgraded (2) levels for very serious imprecision due to small sample size, few events and wide confidence interval crossing the line of no effect </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">External uterine compression (all methods) plus normal care compared to normal care for treating primary postpartum haemorrhage</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013663/full#CD013663-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD013663-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">One uterine devascularisation technique (uterine arterial embolisation) versus another uterine devascularisation technique (surgical devascularisation plus B‐Lynch)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>One uterine devascularisation technique (uterine arterial embolisation) versus another uterine devascularisation technique (surgical devascularisation plus B‐Lynch)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> treating primary postpartum haemorrhage<br/><b>Setting:</b> Ain‐Shams University Maternity Hospital, Egypt (<a href="./references#CD013663-bbs2-0006" title="FaroukO , ElbasuonyW , ElbohoutyA . Uterine artery embolization versus surgical management in primary atonic postpartum hemorrhage: A randomized clinical trial. Egyptian Journal of Radiology and Nuclear Medicine2016;47(3):817-23. ">Farouk 2016</a>)<br/><b>Intervention:</b> uterine devascularisation (uterine arterial embolisation)<br/><b>Comparison:</b> another uterine devascularisation technique (surgical devascularisation plus B‐Lynch compression sutures) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with another uterine devascularisation technique (surgical devascularisation plus B‐Lynch compression suture)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with uterine arterial embolisation</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mortality due to bleeding ‐ not reported</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Hysterectomy to control bleeding</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.73<br/>(0.15 to 3.57) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>23<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>250 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>183 per 1000<br/>(38 to 893) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of women with total blood loss 1000 mL or more after randomisation</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean blood loss (mL) (trialist defined)</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion (red cell or whole blood)</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Side effects of the intervention (e.g. trauma, necrosis)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.09<br/>(0.08 to 15.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>23<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>83 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>91 per 1000<br/>(7 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded (1) level for serious limitations in study design </p> <p><sup>2</sup> We downgraded (2) levels for very serious imprecision due to small sample size with few events and wide confidence intervals crossing the line of no effect </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">One uterine devascularisation technique (uterine arterial embolisation) versus another uterine devascularisation technique (surgical devascularisation plus B‐Lynch)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013663/full#CD013663-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD013663-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Intrauterine balloon tamponade plus normal care (misoprostol) compared to normal care (misoprostol) for treating primary postpartum haemorrhage</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Intrauterine balloon tamponade plus normal care (misoprostol) compared to normal care (misoprostol) for treating primary postpartum haemorrhage</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women diagnosed with primary PPH following vaginal birth. Women were suspected to have PPH due to clinical atony and who were quote: "unresponsive to oxytocin and who needed additional uterotonics" p1. PPH was defined as quote: "visual estimation of excessive blood loss and patient status (blood pressure and cardiac frequency)" p 2 (<a href="./references#CD013663-bbs2-0004" title="DumontA , BodinC , HounkpatinB , PopowskiT , TraoreM , PerrinR , et al. Uterine balloon tamponade as an adjunct to misoprostol for the treatment of uncontrolled postpartum haemorrhage: a randomised controlled trial in benin and mali. BMJ Open2017;7(9):e016590. ISRCTN01202389. Evaluation of intrauterine balloon tamponade efficacy with condom catheter and misoprostol (usual treatment) compared to misoprostol alone in the severe postpartum management hemorrhage management in Benin and Mali: a randomized controlled trial. www.isrctn.com/ISRCTN01202389 (first received 9 September 2013). TortJ , HounkpatinB , PopowskiT , TraoreM , BodinC , PerrinR , et al. A randomized controlled trial to test the effectiveness of intrauterine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. Journal of Women's Health Care2013;2(4):135. ">Dumont 2017</a>) </p> <p><b>Setting:</b> 7 healthcare facilities in Benin and Mail<br/><b>Intervention:</b> intrauterine balloon tamponade (plus misoprostol 'standard care')<br/><b>Comparison:</b> standard care (misoprostol) alone </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with normal care</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with intrauterine balloon tamponade (all methods)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Mortality due to bleeding</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 6.21<br/>(0.77 to 49.98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>116<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>17 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>105 per 1000<br/>(13 to 847) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Hysterectomy to control bleeding</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 4.14<br/>(0.48 to 35.93) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>116<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>17 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>70 per 1000<br/>(8 to 609) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Number of women with total blood loss 1000 mL or more after randomisation</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.52<br/>(1.15 to 2.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>113<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>525 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>799 per 1000<br/>(604 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean blood loss (mL) (trialist defined)</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Blood transfusion (red cell or whole blood)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.49<br/>(0.88 to 2.51) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>116<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>271 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>404 per 1000<br/>(239 to 681) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Side effects of the intervention (e.g. trauma, necrosis) ‐ Severe shivering, diarrhoea, vomiting or high temperature </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>116<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/>(0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded (‐2) levels for very serious limitations in study design (risk of bias) </p> <p><sup>2</sup> We downgraded (‐2) levels for very serious imprecision due to small sample size, few events and wide confidence interval crossing the line of no effect </p> <p><sup>3</sup> We downgraded (‐1) level for serious imprecision due to a small sample size </p> <p><sup>4</sup> We downgraded (‐2) levels for very serious imprecision due to small sample size, and wide confidence interval crossing the line of no effect </p> <p><sup>5</sup> We downgraded (‐2) levels for very serious imprecision due to small sample size and zero events </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Intrauterine balloon tamponade plus normal care (misoprostol) compared to normal care (misoprostol) for treating primary postpartum haemorrhage</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013663/full#CD013663-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD013663-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Intrauterine balloon tamponade (latex balloon inflated with air) plus cerclage and normal care compared to normal care for treating primary postpartum haemorrhage</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Intrauterine balloon tamponade (latex balloon inflated with air) plus cerclage and normal care compared to normal care for treating primary postpartum haemorrhage</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with PPH, due to atony, following vaginal birth at home or in hospital (<a href="./references#CD013663-bbs2-0009" title="SoltanMH , MohamedA , IbrahimE , GoharA , RagabH . El-Menia air inflated balloon in controlling atonic post partum hemorrhage. International Journal of Health Sciences, Qassim University2007;1(1):53-9. ">Soltan 2007</a>) </p> <p><b>Setting:</b> Hospital (Egypt)<br/><b>Intervention:</b> Latex balloon‐loaded Nelson catheter intrauterine tamponade (air filled) plus stitch and standard care (uterine massage and uterotonics)<br/><b>Comparison:</b> standard care (uterine massage and uterotonics) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with normal care</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with intrauterine balloon tamponade (all methods)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Mortality due to bleeding</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>240<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>There were no maternal deaths due to bleeding</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Hysterectomy to control bleeding</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.14<br/>(0.01 to 2.74) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>240<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>25 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4 per 1,000</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of women with total blood loss 1000 mL or more after randomisation</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean blood loss (mL) (trialist defined)</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion (red cell or whole blood)</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Side effects of the intervention (e.g. trauma, necrosis) ‐ trauma, pyrexia, allergic reaction </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>240</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2 3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>There were no side effects of the intervention (reported as trauma, pyrexia, or allergic reaction) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded (‐1) level for serious limitations in study design (risk of bias) </p> <p><sup>2</sup> We downgraded (‐2) levels for very serious indirectness (the study population included all women with PPH (UBT used as a first‐line treatment), rather than only those who did not respond to treatment with uterotonics </p> <p>3 We downgraded (‐2) levels for very serious imprecision (small sample size, no events, not estimable) </p> <p><sup>4</sup> We downgraded (‐2) levels for very serious imprecision due to small sample size, few events and wide confidence interval including appreciable benefit and appreciable harm </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Intrauterine balloon tamponade (latex balloon inflated with air) plus cerclage and normal care compared to normal care for treating primary postpartum haemorrhage</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013663/full#CD013663-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD013663-tbl-0005"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (intrauterine tamponade versus another mechanical/surgical method) for treating primary postpartum haemorrhage</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (intrauterine tamponade versus another mechanical/surgical method) for treating primary postpartum haemorrhage</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with complete placenta praevia and intractable bleeding following caesarean section<br/><b>Setting:</b> university hospital setting in Turkey (<a href="./references#CD013663-bbs2-0007" title="KavakSB , AtilganR , DemirelI , CelikE , IlhanR , SapmazE . Endouterine hemostatic square suture vs. Bakri balloon tamponade for intractable hemorrhage due to complete placenta previa. Journal of Perinatal Medicine2013;41(6):705-9. ">Kavak 2013</a>)<br/><b>Intervention:</b> intrauterine tamponade (Bakri balloon)<br/><b>Comparison:</b> endouterine compression suturing to the lower segment of the uterus </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with another mechanical/surgical method (endouterine compression sutures)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with Intrauterine Bakri balloon tamponade</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Mortality due to bleeding</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>13<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>There were zero events</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/>(0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Hysterectomy to control bleeding</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>13<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>There were zero events</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/>(0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>13<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>There were zero events</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/>(0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of women with total blood loss 1000 mL or more after randomisation</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean blood loss (mL) (trialist defined)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean blood loss in endouterine compression suture group was 1946 mL</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean difference in blood loss (mL) in the intervention group was 426 mL lower (631.28 lower to 220.72 mL lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/>VERY LOW </p> <p><sup>1 3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Blood transfusion (red cell or whole blood)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.57<br/>(0.14 to 2.36) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>13<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>500 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>285 per 1000<br/>(70 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Side effects of the intervention (e.g. trauma, necrosis)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>13<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/>(0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded (2) levels for very serious limitations in study design (risk of bias) </p> <p><sup>2</sup> We downgraded (2) levels for very serious imprecision due to small sample size and zero events (not estimable) </p> <p><sup>3</sup> We downgraded (1) level for serious imprecision due to a small sample size (continuous data) </p> <p><sup>4</sup> We downgraded (2) levels for very serious imprecision due to small sample size, few events and wide confidence interval crossing the line of no effect </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (intrauterine tamponade versus another mechanical/surgical method) for treating primary postpartum haemorrhage</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013663/full#CD013663-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD013663-tbl-0006"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Bakri balloon tamponade versus condom‐loaded Foley Catheter (one intrauterine tamponade compared to another intrauterine tamponade technique) for treating primary postpartum haemorrhage</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Bakri balloon tamponade versus condom‐loaded Foley Catheter (one intrauterine tamponade compared to another intrauterine tamponade technique for treating primary postpartum haemorrhage)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with primary atonic postpartum haemorrhage following vaginal delivery<br/><b>Setting:</b> Assuit Women's Health Hospital in Egypt (<a href="./references#CD013663-bbs2-0003" title="DarwishAM , AbdallahMM , ShaabanOM , AliMK , KhalafM , SabraAM . Bakri balloon versus condom-loaded foley's catheter for treatment of atonic postpartum hemorrhage secondary to vaginal delivery: a randomized controlled trial. Journal of Maternal-Fetal &amp; Neonatal Medicine2018;31(6):747-53. NCT02430155. Comparison of condom-loaded foley's catheter versus bakri balloon for treatment of primary postpartum hemorrhage: a randomized controlled trial. clinicaltrials.gov/show/NCT02430155 (first received 30 April 2015). ">Darwish 2018</a>)<br/><b>Intervention:</b> 1 intrauterine tamponade: Bakri balloon<br/><b>Comparison:</b> another intrauterine tamponade technique: condom‐loaded Foley catheter </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with condom‐loaded Foley catheter</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with Bakri balloon tamponade</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mortality due to bleeding</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Hysterectomy to control bleeding</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.50<br/>(0.05 to 5.25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>66<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>61 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>30 per 1000<br/>(3 to 318) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of women with total blood loss 1000 mL or more after randomisation</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean blood loss (mL) (trialist defined)</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Blood transfusion (red cell or whole blood)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.97<br/>(0.88 to 1.06) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>58<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Note: the trial report states that analysis for this and other trial secondary outcomes excluded those women in whom there was treatment failure. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1000 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>970 per 1000<br/>(880 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Side effects of the intervention (e.g. trauma, necrosis)</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded (1) level for serious limitations in study design (risk of bias) </p> <p><sup>2</sup> We downgraded (2) levels for very serious imprecision (small sample size, few events, and wide confidence interval including appreciable benefit and appreciable harm) </p> <p><sup>3</sup> We downgraded (1) level for serious imprecision due to small sample size </p> <p><sup>4</sup> We downgraded (2) levels for very serious limitations in study design (post‐randomisation exclusions ‐ analysis excluded those women in whom there was treatment failure) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Bakri balloon tamponade versus condom‐loaded Foley Catheter (one intrauterine tamponade compared to another intrauterine tamponade technique) for treating primary postpartum haemorrhage</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013663/full#CD013663-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD013663-tbl-0007"> <div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Bakri balloon tamponade+traction stitch versus Bakri balloon (one intrauterine tamponade compared to another intrauterine tamponade technique) for treating primary postpartum haemorrhage)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Bakri balloon tamponade+traction stitch versus Bakri balloon (one intrauterine tamponade compared to another intrauterine tamponade technique) for treating primary postpartum haemorrhage</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with primary atonic postpartum haemorrhage<br/><b>Setting:</b> a security forces hospital in Riyadh, Saudi Arabia (<a href="./references#CD013663-bbs2-0008" title="KhalilMI , Al-DohamiH , AldahishMM . A method to improve the effectiveness of the Bakri balloon for management of postpartum hemorrhage at cesarean. International Journal of Gynecology &amp; Obstetrics2011;115(2):198-200. ">Khalil 2011</a>)<br/><b>Intervention:</b> intrauterine tamponade: Bakri balloon with traction stitch<br/><b>Comparison:</b> another intrauterine tamponade technique: Bakri balloon without traction stitch </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with Bakri balloon tamponade (without traction stitch)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with Bakri balloon tamponade+traction stitch)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mortality due to bleeding</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Hysterectomy to control bleeding</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.20<br/>(0.01 to 3.97) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>50<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>80 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16 per 1000<br/>(1 to 318) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of women with total blood loss 1000 mL or more after randomisation</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean blood loss (mL) (trialist defined)</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion (red cell or whole blood)</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Side effects of the intervention (e.g. trauma, necrosis)</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Total blood loss &gt;= 1000 mL (before and after randomisation, outcome not pre‐specified in our protocol) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.00<br/>(0.93 to 1.08) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>50<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1000 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1000 per 1000<br/>(930 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded (1) level for serious limitations in study design (risk of bias) </p> <p><sup>2</sup> We downgraded (2) levels for very serious imprecision due to small sample sizes, few events and wide confidence interval crossing the line of no effect </p> <p><sup>3</sup> We downgraded (1) level for serious imprecision due to small sample size </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Bakri balloon tamponade+traction stitch versus Bakri balloon (one intrauterine tamponade compared to another intrauterine tamponade technique) for treating primary postpartum haemorrhage)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013663/full#CD013663-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD013663-tbl-0008"> <div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Intrauterine balloon tamponade (condom‐loaded catheter) versus uterovaginal packing (intrauterine tamponade versus another intrauterine tamponade method) for treating primary postpartum haemorrhage</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Intrauterine balloon tamponade (condom‐loaded catheter) versus uterovaginal packing (intrauterine tamponade versus another intrauterine tamponade method) for treating primary postpartum haemorrhage</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> Women (aged between 20 and 40) diagnosed with primary PPH following 'normal' vaginal birth and unresponsive to medical treatment (<a href="./references#CD013663-bbs2-0001" title="AshrafN , AshrafA , KhursheedK . Efficacy and safety of intrauterine balloon tamponade versus ueterovaginal roll gauze packing in patient presenting with primary postpartum haemorrhage after normal vaginal delivery. Annals of King Edward Medical University2018;24(Special Issue):889-92. ">Ashraf 2018</a>) </p> <p><b>Setting:</b> Hospital setting in Pakistan<br/><b>Intervention:</b> Condom‐loaded catheter intrauterine balloon tamponade<br/><b>Comparison:</b> uterovaginal packing </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with normal care</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with intrauterine balloon tamponade (all methods)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mortality due to bleeding</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hysterectomy to control bleeding</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of women with total blood loss 1000 mL or more after randomisation</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean blood loss (mL) (trialist defined)</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean blood loss is reported as 600.28 mL (+/‐ 25.33 mL) in the condom catheter group and 699 mL (+/‐ 70.176 mL) in the intrauterine packing group. However, it is unclear whether this is pre‐ or post‐randomisation, especially as this is also presented in a table detailing participant characteristics of each group (age, parity, gestational age, and blood loss). For this reason, we have not included these data in our data and analysis tables. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion (red cell or whole blood)</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Side effects of the intervention (e.g. trauma, necrosis) ‐ fever</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.47<br/>(0.38 to 0.59) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>212</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊝⊝⊝<br/>VERY LOW <sup>1 2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>925 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>435 per 1000<br/>(351 to 545) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded (2) levels for very serious limitations in study design (risk of bias) </p> <p><sup>2</sup> We downgraded (1) level for serious imprecision (small sample size) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Intrauterine balloon tamponade (condom‐loaded catheter) versus uterovaginal packing (intrauterine tamponade versus another intrauterine tamponade method) for treating primary postpartum haemorrhage</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013663/full#CD013663-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD013663-tbl-0009"> <div class="table-heading"><span class="table-label">Summary of findings 9.</span> <span class="table-title">Modified B‐Lynch compression suture technique versus standard B‐Lynch compression suture (one uterine compression suture technique versus another uterine compression suture technique) for treating primary postpartum haemorrhage</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Modified B‐Lynch compression suture technique versus standard B‐Lynch compression suture (one uterine compression suture technique versus another uterine compression suture technique) for treating primary postpartum haemorrhage</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with uncontrolled atonic PPH following caesarean section, and not responding to standard care (uterine massage, ecbolics and bimanual compression). </p> <p><b>Setting:</b> university hospital in Cairo, Egypt (<a href="./references#CD013663-bbs2-0005" title='El-SokkaryM , WahbaK , El-ShahawyY . Uterine salvage management for atonic postpartum hemorrhage using "modified lynch suture". BMC Pregnancy and Childbirth2016;16:251. '>El‐Sokkary 2016</a>)<br/><b>Intervention:</b> 1 uterine compression suture technique: modified B‐Lynch compression suture<br/><b>Comparison:</b> another uterine compression suture technique: standard B‐Lynch compression suture </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with standard B‐Lynch uterine compression suture technique</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with modified B‐Lynch compression suture technique</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mortality due to bleeding</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Hysterectomy to control bleeding</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.33<br/>(0.11 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>160<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/>LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>150 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>50 per 1000<br/>(17 to 149) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Number of women with total blood loss 1000 mL or more after randomisation</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean blood loss (mL) (trialist defined)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean blood loss in the classic B‐Lynch group was 568 mL</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean difference in blood loss (mL) in the modified B‐Lynch group was 244 mL lower (295.25 mL lower to ‐ 192.75 mL lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/>LOW <sup>1 3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood transfusion (red cell or whole blood)</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Side effects of the intervention (e.g. trauma, necrosis)</p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Outcome not reported by trial authors</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded (1) level for serious limitations in study design (risk of bias) </p> <p><sup>2</sup> We downgraded (1) level for serious imprecision due to small sample size and few events </p> <p><sup>3</sup> We downgraded (1) level for serious imprecision due to small sample size </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 9.</span> <span class="table-title">Modified B‐Lynch compression suture technique versus standard B‐Lynch compression suture (one uterine compression suture technique versus another uterine compression suture technique) for treating primary postpartum haemorrhage</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013663/full#CD013663-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013663-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">External lower uterine compression versus normal care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Blood transfusion (red cell or whole blood) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.33 [0.66, 8.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Post‐randomisation additional uterotonic agent used to control bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.12, 3.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">External lower uterine compression versus normal care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013663-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Uterine arterial embolisation versus surgical devascularisation plus B‐Lynch (one uterine devascularisation technique versus another uterine devascularisation technique)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Hysterectomy to control bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.15, 3.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Side effects of the intervention (e.g. trauma, necrosis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.08, 15.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Uterine arterial embolisation versus surgical devascularisation plus B‐Lynch (one uterine devascularisation technique versus another uterine devascularisation technique)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013663-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Intrauterine balloon tamponade plus normal care (misoprostol) versus normal care (misoprostol)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Mortality due to bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>116</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.21 [0.77, 49.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Hysterectomy to control bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>116</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.14 [0.48, 35.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 All cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>116</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.21 [0.77, 49.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 Mortality from causes other than bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>116</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.5 Number of women with total blood loss 1000 mL or more after randomisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.52 [1.15, 2.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.6 Blood transfusion (red cell or whole blood) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>116</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.49 [0.88, 2.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.7 Post‐randomisation additional surgical interventions used to control bleeding (arterial ligation, compressive, uterine sutures, arterial embolisation, laparotomy) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7.1 Uterine compression sutures</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>116</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.17 [0.25, 105.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7.2 Artery ligation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>116</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.38 [0.32, 5.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.8 Admission to higher level of care <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>116</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.55, 3.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.9 Side effects of the intervention (e.g. trauma, necrosis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.9.1 Severe shivering, diarrhoea, vomiting or high temperature</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>116</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Intrauterine balloon tamponade plus normal care (misoprostol) versus normal care (misoprostol)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013663-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Latex balloon (air filled) tamponade + stitch and normal care versus normal care (Intrauterine tamponade versus normal care)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Mortality due to bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>240</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.2 Hysterectomy to control bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>240</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.01, 2.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.3 All‐case mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>240</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.4 Mortality from causes other than bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>240</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.5 Days in hospital <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>240</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.20 [‐1.33, ‐1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.6 Post‐randomisation additional surgical interventions used to control bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>240</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.01, 4.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.7 Post‐randomisation additional non‐surgical interventions used to control bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>240</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [0.00, 0.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.8 Side effects of the intervention (e.g. trauma, necrosis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.8.1 Pyrexia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>240</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.8.2 Allergic reaction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>240</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Latex balloon (air filled) tamponade + stitch and normal care versus normal care (Intrauterine tamponade versus normal care)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013663-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (Intrauterine tamponade versus another mechanical/surgical method)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.1 Mortality due to bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.2 Hysterectomy to control bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.3 Serious maternal morbidity (renal or respiratory failure, cardiac arrest or multiple organ failure) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.4 All cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.5 Mortality from causes other than bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.6 Mean blood loss (mL) (trialist defined) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐426.00 [‐631.28, ‐220.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.7 Blood transfusion (red cell or whole blood) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.14, 2.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.8 Post‐randomisation additional surgical interventions used to control bleeding (arterial ligation, compressive, uterine sutures, arterial embolisation, laparotomy) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.9 Side effects of the intervention (e.g. trauma, necrosis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.9.1 Adverse effects requiring surgical intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.9.2 Fever</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.10 Postnatal blood loss (not pre‐specified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐231.00 [‐300.70, ‐161.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Bakri balloon tamponade versus haemostatic square suturing to the lower segment of the uterus (Intrauterine tamponade versus another mechanical/surgical method)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013663-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Bakri balloon tamponade versus condom‐loaded Foley catheter (one intrauterine tamponade technique versus another intrauterine tamponade technique)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.1 Hysterectomy to control bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.05, 5.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.2 Coagulopathy as defined by trialist <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.04, 4.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.3 Blood transfusion (red cell or whole blood) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.88, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.4 Post‐randomisation additional surgical interventions used to control bleeding (arterial ligation, compressive, uterine sutures, arterial embolisation, laparotomy) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.12, 3.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.5 Admission to higher level of care <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.09, 2.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.6 Side effects of the intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6.1 Fever ≥ 38ºC in first 24 hours postpartum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.87 [0.18, 19.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6.2 Endometritis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6.3 Uterine perforation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Bakri balloon tamponade versus condom‐loaded Foley catheter (one intrauterine tamponade technique versus another intrauterine tamponade technique)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013663-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Bakri balloon + stitch versus Bakri balloon without stitch (one intrauterine tamponade versus another intrauterine tamponade technique)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.1 Hysterectomy to control bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.01, 3.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.2 Post‐randomisation additional surgical interventions used to control bleeding (arterial ligation, compressive, uterine sutures, arterial embolisation, laparotomy) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.04, 2.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.3 Total blood loss &gt;= 1000 mL (before and after randomisation, not pre‐specified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.93, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Bakri balloon + stitch versus Bakri balloon without stitch (one intrauterine tamponade versus another intrauterine tamponade technique)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013663-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Intrauterine balloon tamponade (condom catheter) versus uterovaginal packing (Intrauterine tamponade versus another mechanical/surgical method)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.1 Side effects of the intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1.1 Fever</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>212</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [0.38, 0.59]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Intrauterine balloon tamponade (condom catheter) versus uterovaginal packing (Intrauterine tamponade versus another mechanical/surgical method)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-tbl-0017">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013663-tbl-0018"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Modified B‐Lynch compression suture versus standard B‐Lynch compression suture (one uterine compression suture technique versus another uterine compression suture technique)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.1 Hysterectomy to control bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.11, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.2 Mean blood loss (mL) (trialist defined) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐244.00 [‐295.25, ‐192.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.3 Days in hospital <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.38, 0.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Modified B‐Lynch compression suture versus standard B‐Lynch compression suture (one uterine compression suture technique versus another uterine compression suture technique)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013663/references#CD013663-tbl-0018">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD013663&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD013663-note-0020">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD013663-note-0018">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD013663-note-0019">Français</a> </li> <li class="section-language"> <a class="" href="ko#CD013663-note-0016">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD013663-note-0017">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="th#CD013663-note-0015">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD013663-note-0014">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013663\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013663\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013663\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013663"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013663\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013663\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013663\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013663\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013663\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013663"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013663\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013663\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013663\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013663"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013663\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013663\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013663\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013663"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=nnwvukoo&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013663&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013663';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD013663/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD013663/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013663%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740728436191"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013663/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740728436195"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013663/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ec46eec369367',t:'MTc0MDcyODQzNi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 